<SEC-DOCUMENT>0001999371-24-004808.txt : 20240415
<SEC-HEADER>0001999371-24-004808.hdr.sgml : 20240415
<ACCEPTANCE-DATETIME>20240415170010
ACCESSION NUMBER:		0001999371-24-004808
CONFORMED SUBMISSION TYPE:	N-2/A
PUBLIC DOCUMENT COUNT:		17
FILED AS OF DATE:		20240415
DATE AS OF CHANGE:		20240415

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GAMCO Global Gold, Natural Resources & Income Trust
		CENTRAL INDEX KEY:			0001313510
		ORGANIZATION NAME:           	
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		N-2/A
		SEC ACT:		1940 Act
		SEC FILE NUMBER:	811-21698
		FILM NUMBER:		24845302

	BUSINESS ADDRESS:	
		STREET 1:		ONE CORPORATE CENTER
		CITY:			RYE
		STATE:			NY
		ZIP:			10580-1422
		BUSINESS PHONE:		800.422.3554

	MAIL ADDRESS:	
		STREET 1:		ONE CORPORATE CENTER
		CITY:			RYE
		STATE:			NY
		ZIP:			10580-1422

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GAMCO Global Gold, Natural Resources & Income Trust by Gabelli
		DATE OF NAME CHANGE:	20111222

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Gabelli Global Gold, Natural Resources & Income Trust
		DATE OF NAME CHANGE:	20050112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Gabelli Gold, Natural Resources & Income Trust
		DATE OF NAME CHANGE:	20050105

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GAMCO Global Gold, Natural Resources & Income Trust
		CENTRAL INDEX KEY:			0001313510
		ORGANIZATION NAME:           	
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		N-2/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-277179
		FILM NUMBER:		24845301

	BUSINESS ADDRESS:	
		STREET 1:		ONE CORPORATE CENTER
		CITY:			RYE
		STATE:			NY
		ZIP:			10580-1422
		BUSINESS PHONE:		800.422.3554

	MAIL ADDRESS:	
		STREET 1:		ONE CORPORATE CENTER
		CITY:			RYE
		STATE:			NY
		ZIP:			10580-1422

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GAMCO Global Gold, Natural Resources & Income Trust by Gabelli
		DATE OF NAME CHANGE:	20111222

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Gabelli Global Gold, Natural Resources & Income Trust
		DATE OF NAME CHANGE:	20050112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Gabelli Gold, Natural Resources & Income Trust
		DATE OF NAME CHANGE:	20050105
<IS-FILER-A-NEW-REGISTRANT>N
<IS-FILER-A-WELL-KNOWN-SEASONED-ISSUER>N
<FILED-PURSUANT-TO-GENERAL-INSTRUCTION-A2>Y
<IS-FUND-24F2-ELIGIBLE>N
</SEC-HEADER>
<DOCUMENT>
<TYPE>N-2/A
<SEQUENCE>1
<FILENAME>ggn-n2a_041524.htm
<DESCRIPTION>AMENDMENT TO FORM N-2
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:ggn="http://gabelli.com/20240415">
<head>
     <title>Amendment to Form N-2</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_CEF%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_03D_ggn_gabelli.com_20240415 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20240415_20240415 -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DAmendmentFlag_true -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0001313510 -->
<!-- Field: Set; Name: xdx; ID: xdx_079_XDX_ggn%2Dn2a__041224.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-04-15" id="Fact000003" name="dei:AmendmentFlag">true</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-04-15" id="Fact000004" name="dei:EntityCentralIndexKey">0001313510</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-04-15" id="xdx2ixbrl0013" name="dei:DocumentType">N-2/A</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-04-15" id="xdx2ixbrl0052" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="ggn-20240415.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-04-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001313510</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-15</xbrli:startDate>
        <xbrli:endDate>2024-04-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-152024-04-15_dei_BusinessContactMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001313510</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-15</xbrli:startDate>
        <xbrli:endDate>2024-04-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-10_custom_CommonStocksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001313510</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ggn:CommonStocksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-102024-04-10_custom_CommonStocksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001313510</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ggn:CommonStocksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-10</xbrli:startDate>
        <xbrli:endDate>2024-04-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-102024-04-10_custom_SeriesBCumulativePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001313510</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ggn:SeriesBCumulativePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-10</xbrli:startDate>
        <xbrli:endDate>2024-04-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-10_custom_SeriesBCumulativePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001313510</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ggn:SeriesBCumulativePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-152024-04-15_custom_PreferredStocksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001313510</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ggn:PreferredStocksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-15</xbrli:startDate>
        <xbrli:endDate>2024-04-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
filed with the Securities and Exchange Commission on April 15, 2024</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
Act File No. <span id="xdx_904_edei--EntityFileNumber_c20240415__20240415_z3zzRs42eHF3"><ix:nonNumeric contextRef="AsOf2024-04-15" id="Fact000010" name="dei:EntityFileNumber">333-277179</ix:nonNumeric></span></b></span><br/>
<b>Investment Company Act File No. <span id="xdx_90D_edei--InvestmentCompanyActFileNumber_c20240415__20240415_zivUSBUqlIKe"><ix:nonNumeric contextRef="AsOf2024-04-15" id="Fact000011" name="dei:InvestmentCompanyActFileNumber">811-21698</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>&#160;</b></p>

<!-- Field: Rule-Page --><div style="text-align: left"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>UNITED
STATES</b></span><br/>
<span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>SECURITIES AND EXCHANGE COMMISSION</b></span><br/>
<span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington, DC 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="text-align: left"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>Form
<span id="xdx_905_edei--EntityInvCompanyType_c20240415__20240415_zpxKswyHx6R3"><span id="xdx_901_edei--DocumentType_dxL_c20240415__20240415_zh302npiqI46" title="::XDX::N-2/A"><ix:nonNumeric contextRef="AsOf2024-04-15" id="Fact000012" name="dei:EntityInvCompanyType"><span style="-sec-ix-hidden: xdx2ixbrl0013">N-2</span></ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="text-align: left"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Check
Appropriate Box or Boxes)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><span id="xdx_908_edei--DocumentRegistrationStatement_c20240415__20240415_zESF8vuTh7ce"><ix:nonNumeric contextRef="AsOf2024-04-15" format="ixt:booleantrue" id="Fact000014" name="dei:DocumentRegistrationStatement">&#9746;</ix:nonNumeric></span>
<b>REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 11pt"><span id="xdx_90E_edei--PreEffectiveAmendment_c20240415__20240415_zb9NDBawmzic"><ix:nonNumeric contextRef="AsOf2024-04-15" format="ixt:booleantrue" id="Fact000015" name="dei:PreEffectiveAmendment">&#9746;</ix:nonNumeric></span>
<span style="font-family: Times New Roman, Times, Serif"><b>Pre-Effective Amendment No. <span id="xdx_909_edei--PreEffectiveAmendmentNumber_c20240415__20240415_zYIWy3TJMBnk"><ix:nonNumeric contextRef="AsOf2024-04-15" id="Fact000016" name="dei:PreEffectiveAmendmentNumber">1</ix:nonNumeric></span></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_904_edei--PostEffectiveAmendment_c20240415__20240415_z07mKzc8s6xa"><ix:nonNumeric contextRef="AsOf2024-04-15" format="ixt:booleanfalse" id="Fact000017" name="dei:PostEffectiveAmendment">&#9744;</ix:nonNumeric></span>
<b>Post-Effective Amendment No.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and/or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><span id="xdx_902_edei--InvestmentCompanyActRegistration_c20240415__20240415_zy01rWI02AVb"><span id="xdx_90E_edei--InvestmentCompanyRegistrationAmendment_c20240415__20240415_z7ZzFSSz40sa"><ix:nonNumeric contextRef="AsOf2024-04-15" format="ixt:booleantrue" id="Fact000018" name="dei:InvestmentCompanyActRegistration"><ix:nonNumeric contextRef="AsOf2024-04-15" format="ixt:booleantrue" id="Fact000019" name="dei:InvestmentCompanyRegistrationAmendment">&#9746;</ix:nonNumeric></ix:nonNumeric></span></span>
<b>REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_edei--InvestmentCompanyRegistrationAmendment_c20240415__20240415_zcKE5kMXAGmd"><ix:nonNumeric contextRef="AsOf2024-04-15" format="ixt:booleantrue" id="Fact000020" name="dei:InvestmentCompanyRegistrationAmendment">&#9746;</ix:nonNumeric></span>
<b>Amendment No. <span id="xdx_900_edei--InvestmentCompanyRegistrationAmendmentNumber_c20240415__20240415_z4U34oSZvt1b"><ix:nonNumeric contextRef="AsOf2024-04-15" id="Fact000021" name="dei:InvestmentCompanyRegistrationAmendmentNumber">55</ix:nonNumeric></span></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="text-align: left"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 24pt"><b><span id="xdx_902_edei--EntityRegistrantName_c20240415__20240415_zHjWxrdkjbRa"><ix:nonNumeric contextRef="AsOf2024-04-15" id="Fact000022" name="dei:EntityRegistrantName">GAMCO
GLOBAL GOLD, NATURAL RESOURCES &amp; INCOME TRUST</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact name of Registrant as specified in Charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="text-align: left"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityAddressAddressLine1_c20240415__20240415_zUUklpfowx1k"><ix:nonNumeric contextRef="AsOf2024-04-15" id="Fact000023" name="dei:EntityAddressAddressLine1">One Corporate Center</ix:nonNumeric></span><br/>
<span id="xdx_905_edei--EntityAddressCityOrTown_c20240415__20240415_zKz4nKzLygdg"><ix:nonNumeric contextRef="AsOf2024-04-15" id="Fact000024" name="dei:EntityAddressCityOrTown">Rye</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressStateOrProvince_c20240415__20240415_zh0lC0Ki8eu"><ix:nonNumeric contextRef="AsOf2024-04-15" format="ixt-sec:stateprovnameen" id="Fact000025" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span> <span id="xdx_909_edei--EntityAddressPostalZipCode_c20240415__20240415_zQkiMTiUaSqi"><ix:nonNumeric contextRef="AsOf2024-04-15" id="Fact000026" name="dei:EntityAddressPostalZipCode">10580-1422</ix:nonNumeric></span></b><br/>
(Address of Principal Executive Offices)<br/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s Telephone Number, including Area Code: <b><span id="xdx_90E_edei--CityAreaCode_c20240415__20240415_zSTVC6OKvcE6"><ix:nonNumeric contextRef="AsOf2024-04-15" id="Fact000027" name="dei:CityAreaCode">(800)</ix:nonNumeric></span> <span id="xdx_906_edei--LocalPhoneNumber_c20240415__20240415_zgk5R8PtZFM9"><ix:nonNumeric contextRef="AsOf2024-04-15" id="Fact000028" name="dei:LocalPhoneNumber">422-3554</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<!-- Field: Rule-Page --><div style="text-align: left"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--ContactPersonnelName_c20240415__20240415__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_z6KPIET743q5"><ix:nonNumeric contextRef="From2024-04-152024-04-15_dei_BusinessContactMember" id="Fact000029" name="dei:ContactPersonnelName">John
C. Ball</ix:nonNumeric></span></b><br/>
<b><span id="xdx_909_edei--EntityAddressAddressLine1_c20240415__20240415__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zFoPndsTzbUh"><ix:nonNumeric contextRef="From2024-04-152024-04-15_dei_BusinessContactMember" id="Fact000030" name="dei:EntityAddressAddressLine1">GAMCO Global Gold, Natural Resources &amp; Income Trust</ix:nonNumeric></span></b><br/>
<b><span id="xdx_900_edei--EntityAddressAddressLine2_c20240415__20240415__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zueVswFG9Yz8"><ix:nonNumeric contextRef="From2024-04-152024-04-15_dei_BusinessContactMember" id="Fact000031" name="dei:EntityAddressAddressLine2">One Corporate Center</ix:nonNumeric></span></b><br/>
<b><span id="xdx_90E_edei--EntityAddressCityOrTown_c20240415__20240415__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zhS73u67Ere1"><ix:nonNumeric contextRef="From2024-04-152024-04-15_dei_BusinessContactMember" id="Fact000032" name="dei:EntityAddressCityOrTown">Rye</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressStateOrProvince_c20240415__20240415__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zCQ8T53vIVch"><ix:nonNumeric contextRef="From2024-04-152024-04-15_dei_BusinessContactMember" format="ixt-sec:stateprovnameen" id="Fact000033" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span> <span id="xdx_905_edei--EntityAddressPostalZipCode_c20240415__20240415__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_z5KTE68BuJN"><ix:nonNumeric contextRef="From2024-04-152024-04-15_dei_BusinessContactMember" id="Fact000034" name="dei:EntityAddressPostalZipCode">10580-1422</ix:nonNumeric></span></b><br/>
<b><span id="xdx_90F_edei--CityAreaCode_c20240415__20240415__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zneH54ejxCW7"><ix:nonNumeric contextRef="From2024-04-152024-04-15_dei_BusinessContactMember" id="Fact000035" name="dei:CityAreaCode">(914)</ix:nonNumeric></span> <span id="xdx_906_edei--LocalPhoneNumber_c20240415__20240415__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_znLnsJPTyYBf"><ix:nonNumeric contextRef="From2024-04-152024-04-15_dei_BusinessContactMember" id="Fact000036" name="dei:LocalPhoneNumber">921-5070</ix:nonNumeric></span></b><br/>
(Name and Address of Agent for Service)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="text-align: left"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Copies
to:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Peter
Goldstein, Esq.</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GAMCO
Global Gold, Natural Resources &amp; Income Trust</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>One
Corporate Center</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rye,
New York 10580-1422</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(914)
921-5100</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Kenneth
E. Burdon, Esq.</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Skadden,
Arps, Slate, Meagher &amp; Flom LLP</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>500
Boylston Street</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Boston,
Massachusetts 02116</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(617)
573-4800</b></span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Approximate
date of proposed public offering:</b> <span id="xdx_90A_edei--ApproximateDateOfCommencementOfProposedSaleToThePublic_c20240415__20240415_zoixmKO8CHz6"><ix:nonNumeric contextRef="AsOf2024-04-15" id="Fact000037" name="dei:ApproximateDateOfCommencementOfProposedSaleToThePublic">From time to time after the effective date of this Registration Statement.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--DividendOrInterestReinvestmentPlanOnly_c20240415__20240415_zX4xmwJkj85"><ix:nonNumeric contextRef="AsOf2024-04-15" format="ixt:booleanfalse" id="Fact000038" name="dei:DividendOrInterestReinvestmentPlanOnly">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
    box if the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--DelayedOrContinuousOffering_c20240415__20240415_zbo5CDkSnkt"><ix:nonNumeric contextRef="AsOf2024-04-15" format="ixt:booleantrue" id="Fact000039" name="dei:DelayedOrContinuousOffering">&#9746;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
    box if any securities being registered on this Form will be offered on a delayed or continuous basis in reliance on Rule 415
    under the Securities Act of 1933 (&#8220;Securities Act&#8221;), other than securities offered in connection with a dividend
    reinvestment plan.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecef--PrimaryShelfFlag_c20240415__20240415_zAPMfLDQ36Kg"><ix:nonNumeric contextRef="AsOf2024-04-15" format="ixt:booleantrue" id="Fact000040" name="cef:PrimaryShelfFlag">&#9746;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
    box if this Form is a registration statement pursuant to General Instruction A.2 or a post-effective amendment thereto.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--EffectiveUponFiling462e_c20240415__20240415_zzMv5xN0dj8l"><ix:nonNumeric contextRef="AsOf2024-04-15" format="ixt:booleanfalse" id="Fact000041" name="dei:EffectiveUponFiling462e">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
    box if this Form is a registration statement pursuant to General Instruction B or a post-effective amendment thereto that
    will become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--AdditionalSecuritiesEffective413b_c20240415__20240415_z9WptAQeFU63"><ix:nonNumeric contextRef="AsOf2024-04-15" format="ixt:booleanfalse" id="Fact000042" name="dei:AdditionalSecuritiesEffective413b">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
    box if this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction B to register
    additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>It
is proposed that this filing will become effective (check appropriate box):</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--EffectiveWhenDeclaredSection8c_c20240415__20240415_zX9essgBIut5"><ix:nonNumeric contextRef="AsOf2024-04-15" format="ixt:booleanfalse" id="Fact000043" name="dei:EffectiveWhenDeclaredSection8c">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
    declared effective pursuant to Section 8(c) of the Securities Act.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
appropriate, check the following box:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--NewEffectiveDateForPreviousFiling_c20240415__20240415_zsWZ4jXQp0Af"><ix:nonNumeric contextRef="AsOf2024-04-15" format="ixt:booleanfalse" id="Fact000044" name="dei:NewEffectiveDateForPreviousFiling">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    [post-effective] amendment designates a new effective date for a previously filed [post-effective amendment] [registration
    statement].</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--AdditionalSecurities462b_c20240415__20240415_zqkRvQGlN6T8"><ix:nonNumeric contextRef="AsOf2024-04-15" format="ixt:booleanfalse" id="Fact000045" name="dei:AdditionalSecurities462b">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, and the
    Securities Act registration statement number of the earlier effective registration statement for the same offering is _________.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--NoSubstantiveChanges462c_c20240415__20240415_zDResSQjaZEd"><ix:nonNumeric contextRef="AsOf2024-04-15" format="ixt:booleanfalse" id="Fact000046" name="dei:NoSubstantiveChanges462c">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, and the Securities Act registration
    statement number of the earlier effective registration statement for the same offering is _________.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--ExhibitsOnly462d_c20240415__20240415_zA48Hw3lRZza"><ix:nonNumeric contextRef="AsOf2024-04-15" format="ixt:booleanfalse" id="Fact000047" name="dei:ExhibitsOnly462d">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, and the Securities Act registration
    statement number of the earlier effective registration statement for the same offering is _________.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Check
each box that appropriately characterizes the Registrant:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecef--RegisteredClosedEndFundFlag_c20240415__20240415_z6iA1PSrgjr3"><ix:nonNumeric contextRef="AsOf2024-04-15" format="ixt:booleantrue" id="Fact000048" name="cef:RegisteredClosedEndFundFlag">&#9746;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered
    Closed-End Fund (closed-end company that is registered under the Investment Company Act of 1940 (&#8220;Investment Company
    Act&#8221;)).</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecef--BusinessDevelopmentCompanyFlag_c20240415__20240415_zmVtBvOgUV45"><ix:nonNumeric contextRef="AsOf2024-04-15" format="ixt:booleanfalse" id="Fact000049" name="cef:BusinessDevelopmentCompanyFlag">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business
    Development Company (closed-end company that intends or has elected to be regulated as a business development company under
    the Investment Company Act).</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecef--IntervalFundFlag_c20240415__20240415_z412yPpOYlcl"><ix:nonNumeric contextRef="AsOf2024-04-15" format="ixt:booleanfalse" id="Fact000050" name="cef:IntervalFundFlag">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interval
    Fund (Registered Closed-End Fund or a Business Development Company that makes periodic repurchase offers under Rule 23c-3
    under the Investment Company Act).</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecef--PrimaryShelfQualifiedFlag_c20240415__20240415_zaDUs10rDCya"><ix:nonNumeric contextRef="AsOf2024-04-15" format="ixt:booleantrue" id="Fact000051" name="cef:PrimaryShelfQualifiedFlag">&#9746;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.2
    Qualified (qualified to register securities pursuant to General Instruction A.2 of this Form).</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--EntityWellKnownSeasonedIssuer_c20240415__20240415_ztgny1tQ64ic"><span style="-sec-ix-hidden: xdx2ixbrl0052">&#9744;</span></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Well-Known
    Seasoned Issuer (as defined by Rule 405 under the Securities Act).</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--EntityEmergingGrowthCompany_c20240415__20240415_zyE0KmLuNEv6"><ix:nonNumeric contextRef="AsOf2024-04-15" format="ixt:booleanfalse" id="Fact000053" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    Growth Company (as defined by Rule 12b-2 under the Securities Exchange Act of 1934 (&#8220;Exchange Act&#8221;)).</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    an Emerging Growth Company, indicate by check mark if the registrant has elected not to use the extended transition period
    for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of Securities
    Act.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecef--NewCefOrBdcRegistrantFlag_c20240415__20240415_zPPXEP40IrP3"><ix:nonNumeric contextRef="AsOf2024-04-15" format="ixt:booleanfalse" id="Fact000054" name="cef:NewCefOrBdcRegistrantFlag">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    Registrant (registered or regulated under the Investment Company Act for less than 12 calendar months preceding this filing).</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--AmendmentDescription_c20240415__20240415_zultjAhaWPRd"><ix:nonNumeric contextRef="AsOf2024-04-15" id="Fact000055" name="dei:AmendmentDescription">THE
REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL
THE REGISTRANT SHALL FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION STATEMENT SHALL THEREAFTER BECOME
EFFECTIVE IN ACCORDANCE WITH SECTION 8(a) OF THE SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME EFFECTIVE
ON SUCH DATE AS THE SECURITIES AND EXCHANGE COMMISSION, ACTING PURSUANT TO SAID SECTION 8(a), MAY DETERMINE.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Rule-Page --><div style="text-align: left"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement
filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it
is not soliciting an offer to buy these securities in any state where the offer and sale is not permitted.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: red"><b>Subject
to Completion<br/>
Preliminary Prospectus dated April 15, 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BASE</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROSPECTUS</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>dated&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GAMCO
Global Gold, Natural Resources &amp; Income Trust</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$500,000,000</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Shares of Beneficial Interest</b><br/>
<b>Preferred Shares of Beneficial Interest</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="text-align: left"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Investment
Objectives.</i> The GAMCO Global Gold, Natural Resources &amp; Income Trust is a non-diversified, closed-end management investment
company registered under the Investment Company Act of 1940, as amended. The Fund&#8217;s primary investment objective is to provide
a high level of current income. The Fund&#8217;s secondary investment objective is to seek capital appreciation consistent with
the Fund&#8217;s strategy and its primary objective. The Fund&#8217;s investment adviser is Gabelli Funds, LLC (the &#8220;Investment
Adviser&#8221;). We cannot assure you that the Fund will achieve its objectives. An investment in the Fund is not appropriate
for all investors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
normal market conditions, the Fund will attempt to achieve its objectives by investing at least 80% of its assets in equity securities
of companies principally engaged in the gold industry and the natural resources industries. The Fund will invest at least 25%
of its assets in the equity securities of companies principally engaged in the gold industry, which includes companies principally
engaged in the exploration, mining, fabrication, processing, distribution or trading of gold or the financing, managing, controlling
or operating of companies engaged in &#8220;gold-related&#8221; activities. In addition, the Fund will invest at least 25% of
its assets in the equity securities of companies principally engaged in the group of industries that constitute the natural resources
industries, which include companies principally engaged in the exploration, production or distribution of natural resources, such
as gas, oil, paper, food and agriculture, forestry products, metals (other than gold) and minerals as well as related transportation
companies and equipment manufacturers. The Fund may invest in the securities of companies located anywhere in the world and under
normal conditions will invest at least 40% of its assets in the securities of issuers located in at least three countries other
than the United States. The Fund may invest up to 10% of its total assets in securities rated below investment grade by recognized
statistical rating agencies or unrated securities of comparable quality, including securities of issuers in default, which are
likely to have the lowest rating. These securities, which may be preferred shares or debt, are predominantly speculative and involve
major risk exposure to adverse conditions. Securities that are rated lower than &#8220;BBB&#8221; by S&amp;P, or lower than &#8220;Baa&#8221;
by Moody&#8217;s or unrated securities considered by the Investment Adviser to be of comparable quality, are commonly referred
to as &#8220;junk bonds&#8221; or &#8220;high yield&#8221; securities. As part of its investment strategy, the Fund intends to
generate gains through an option strategy of writing (selling) covered call options on equity securities in its portfolio. When
the Fund sells a covered call option, it generates gains in the form of the premium paid by the buyer of the call option, but
the Fund forgoes the opportunity to participate in any increase in the value of the underlying equity security above the exercise
price of the option. See &#8220;Investment Objectives and Policies.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may offer, from time to time, in one or more offerings, our common shares or preferred shares, each having a par value of $0.001
per share (together, &#8220;shares&#8221;). Shares may be offered at prices and on terms to be set forth in one or more supplements
to this Prospectus (each a &#8220;Prospectus Supplement&#8221;). You should read this Prospectus and the applicable Prospectus
Supplement carefully before you invest in our shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
shares may be offered directly to one or more purchasers, through agents designated from time to time by us, or to or through underwriters
or dealers. The Prospectus Supplement relating to the offering will identify any agents or underwriters involved in the sale of our shares,
and will set forth any applicable purchase price, fee, commission or discount arrangement between us and our agents or underwriters,
or among our underwriters, or the basis upon which such amount may be calculated. The Prospectus Supplement relating to any sale of preferred
shares will set forth the liquidation preference and information about the dividend period, dividend rate, any call protection or non-call
period and other matters. We may not sell any of our shares through agents, underwriters or dealers without delivery of a Prospectus
Supplement describing the method and terms of the particular offering of our shares. Our common shares are listed on the NYSE American
LLC (&#8220;NYSE American&#8221;) under the symbol &#8220;GGN.&#8221; Our 5.00% Series B Cumulative Preferred Shares are listed on the
NYSE American under the symbol &#8220;GGN PrB.&#8221; On April 10</span>, 2024, the last reported sale price of our common shares was
$<span id="xdx_90B_eus-gaap--SharePrice_iI_c20240410__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember_zh2AlDRREGSl"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-04-10_custom_CommonStocksMember" id="Fact000056" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.11</ix:nonFraction></span>.
The net asset value of the Fund&#8217;s common shares at the close of business on April 10, 2024 was $<span id="xdx_900_eus-gaap--NetAssetValuePerShare_iI_c20240410__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember_zkCjvIPK70q"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2024-04-10_custom_CommonStocksMember" id="Fact000057" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.10</ix:nonFraction>
</span>per share. <b>Shares of closed-end funds can trade at a discount from net asset value. This creates a risk of loss for
an investor purchasing shares in a public offering.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investing
in the Fund&#8217;s shares involves risks. See &#8220;Risk Factors and Special Considerations&#8221; beginning on page 12 and
Additional Fund Information&#8212;Risk Factors and Special Considerations&#8221; in the Fund&#8217;s Annual Report for factors
that should be considered before investing in shares of the Fund, including risks related to a leveraged capital structure and
the Fund&#8217;s use of options and other derivatives.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved these securities or determined
if this Prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Prospectus may not be used to consummate sales of shares by us through agents, underwriters, or dealers unless accompanied by
a Prospectus Supplement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Prospectus, together with an applicable Prospectus Supplement, sets forth concisely the information about the Fund that a prospective
investor should know before investing. You should read this Prospectus, together with an applicable Prospectus Supplement, which
contains important information about the Fund, before deciding whether to invest in the shares, and retain it for future reference.
A Statement of Additional Information, dated , 2024 containing additional information about the Fund, has been filed with the
SEC and is incorporated by reference in its entirety into this Prospectus. You may request a free copy of our annual and semiannual
reports, request a free copy of the Statement of Additional Information, the table of contents of which is on page 43 of this
Prospectus, or request other information about us and make shareholder inquiries by calling (800) GABELLI (422-3554) or by writing
to the Fund. You may also obtain a copy of the Statement of Additional Information (and other information regarding the Fund)
from the SEC&#8217;s website (http://www.sec.gov). Our annual and semiannual reports are also available on our website (www.gabelli.com).
The Statement of Additional Information is only updated in connection with an offering and is therefore not available on the Fund&#8217;s
website. Information on, or accessible through, the Fund&#8217;s website is not a part of, and is not incorporated into, this
Prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
shares do not represent a deposit or obligation of, and are not guaranteed or endorsed by, any bank or other insured depository
institution, and are not federally insured by the Federal Deposit Insurance Corporation, the Federal Reserve Board or any other
government agency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>You
should rely only on the information contained or incorporated by reference in this Prospectus and any applicable Prospectus Supplement.
The Fund has not authorized anyone to provide you with different information. The Fund is not making an offer to sell these securities
in any state where the offer or sale is not permitted. You should not assume that the information contained in this Prospectus
and any applicable Prospectus Supplement is accurate as of any date other than the date of this Prospectus or the date of the
applicable Prospectus Supplement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-bottom: 1pt; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 91%; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a001">PROSPECTUS SUMMARY</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a002">SUMMARY OF FUND EXPENSES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a003">USE OF PROCEEDS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a004">THE FUND</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a005">INVESTMENT OBJECTIVES AND POLICIES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a006">RISK FACTORS AND SPECIAL CONSIDERATIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a007">MANAGEMENT OF THE FUND</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a008">PORTFOLIO TRANSACTIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a009">DIVIDENDS AND DISTRIBUTIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a010">ISSUANCE OF COMMON SHARES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a011">AUTOMATIC DIVIDEND REINVESTMENT AND VOLUNTARY CASH PURCHASE PLAN</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a012">DESCRIPTION OF THE SHARES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a013">ANTI-TAKEOVER PROVISIONS OF THE FUND&#8217;S GOVERNING DOCUMENTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a014">CLOSED-END FUND STRUCTURE</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a015">REPURCHASE OF COMMON SHARES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a016">NET ASSET VALUE</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a017">LIMITATION OF TRUSTEES&#8217; AND OFFICERS&#8217; LIABILITY</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a018">TAXATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a019">CUSTODIAN, TRANSFER AGENT AND DIVIDEND DISBURSING AGENT</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a020">PLAN OF DISTRIBUTION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a021">LEGAL MATTERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a022">INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a023">ADDITIONAL INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a024">INCORPORATION BY REFERENCE</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a028">PRIVACY PRINCIPLES OF THE FUND</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a025">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a026">TABLE OF CONTENTS OF STATEMENT OF ADDITIONAL INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2a027">CORPORATE BOND RATINGS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-1</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">- <!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --> -&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a001"></span>PROSPECTUS
SUMMARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>This
is only a summary. This summary may not contain all of the information that you should consider before investing in our securities.
You should review the more detailed information contained or incorporated by reference in this prospectus (this &#8220;Prospectus&#8221;),
including the sections titled &#8220;Risk Factors and Special Considerations&#8221; beginning on page 12 and in the Annual Report,
the applicable Prospectus Supplement and the Statement of Additional Information, dated , 2024 (the &#8220;SAI&#8221;).</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Fund</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
GAMCO Global Gold, Natural Resources &amp; Income Trust is a non-diversified, closed-end management investment company organized
under the laws of the State of Delaware. Throughout this Prospectus, we refer to the GAMCO Global Gold, Natural Resources &amp;
Income Trust as the &#8220;Fund&#8221; or as &#8220;we.&#8221; See &#8220;The Fund.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Offering</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may offer, from time to time, in one or more offerings, our common or preferred shares, $0.001 par value per share (together,
&#8220;shares&#8221;). The shares may be offered at prices and on terms to be set forth in one or more supplements to this Prospectus
(each a &#8220;Prospectus Supplement&#8221;). The offering price per share of our common shares will not be less than the net
asset value per share of our common shares at the time we make the offering, exclusive of any underwriting commissions or discounts.
You should read this Prospectus and the applicable Prospectus Supplement carefully before you invest in our shares. Our shares
may be offered directly to one or more purchasers, through agents designated from time to time by us or to or through underwriters
or dealers. The Prospectus Supplement relating to the offering will identify any agents, underwriters or dealers involved in the
sale of our shares, and will set forth any applicable purchase price, fee, commission or discount arrangement between us and our
agents or underwriters, or among our underwriters, or the basis upon which such amount may be calculated. The Prospectus Supplement
relating to any sale of preferred shares will set forth the liquidation preference and information about the dividend period,
dividend rate, any call protection or non-call period and other matters. While the aggregate number and amount of securities we
may issue pursuant to this registration statement is limited to $500,000,000 of shares, our Board of Trustees (each member a &#8220;Trustee&#8221;,
and collectively the &#8220;Board&#8221;) may, without any action by the shareholders, amend our Agreement and Declaration of
Trust from time to time to increase or decrease the aggregate number of shares or number of shares of any class or series that
we have authority to issue. We may not sell any of our shares through agents, underwriters or dealers without delivery of a Prospectus
Supplement describing the method and terms of the particular offering of our shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common shares are listed on the NYSE American under the symbol &#8220;GGN.&#8221; Our 5.00% Series B Cumulative Preferred Shares (&#8220;Series
B Preferred Shares&#8221;) are listed on the NYSE American under the symbol &#8220;GGN PrB.&#8221; On April 10, 2024, the last reported
sale price of our common shares was $<span id="xdx_903_eus-gaap--SharePrice_iI_c20240410__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember_zKTIG7ITDnQ8"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-04-10_custom_CommonStocksMember" id="Fact000058" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.11</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The net asset value of the Fund&#8217;s common shares at the close of business on April 10, 2024 was $<span id="xdx_900_eus-gaap--NetAssetValuePerShare_iI_c20240410__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember_zG6NBFampiVg"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2024-04-10_custom_CommonStocksMember" id="Fact000059" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.10</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share. As of April 10, 2024, the net
assets of the Fund attributable to its common shares were $632,782,431. As of April 10, 2024, the Fund had outstanding <span id="xdx_908_ecef--OutstandingSecurityNotHeldShares_c20240410__20240410__us-gaap--StatementClassOfStockAxis__custom--CommonStocksMember_zI9EwKJOQbuj"><ix:nonFraction name="cef:OutstandingSecurityNotHeldShares" contextRef="From2024-04-102024-04-10_custom_CommonStocksMember" id="Fact000060" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">154,296,778</ix:nonFraction></span> common
shares. As of April 10, 2024, the Fund had outstanding <span id="xdx_904_ecef--OutstandingSecurityNotHeldShares_c20240410__20240410__us-gaap--StatementClassOfStockAxis__custom--SeriesBCumulativePreferredStockMember_za2gFyh9a9V4"><ix:nonFraction name="cef:OutstandingSecurityNotHeldShares" contextRef="From2024-04-102024-04-10_custom_SeriesBCumulativePreferredStockMember" id="Fact000061" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,180,762</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series B Preferred at a liquidation value
of <span id="xdx_904_eus-gaap--PreferredStockLiquidationPreference_iI_c20240410__us-gaap--StatementClassOfStockAxis__custom--SeriesBCumulativePreferredStockMember_zwOK5ZyBjH0g">$<ix:nonFraction name="us-gaap:PreferredStockLiquidationPreference" contextRef="AsOf2024-04-10_custom_SeriesBCumulativePreferredStockMember" id="Fact000062" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">25</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share for a total liquidation value
of $<span id="xdx_901_ecef--SeniorSecuritiesAmt_iI_c20240410__us-gaap--StatementClassOfStockAxis__custom--SeriesBCumulativePreferredStockMember_zWuVAmc8m2be"><ix:nonFraction name="cef:SeniorSecuritiesAmt" contextRef="AsOf2024-04-10_custom_SeriesBCumulativePreferredStockMember" id="Fact000063" format="ixt:numdotdecimal" decimals="0" unitRef="USD">79,519,050</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment
Objectives and Policies</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s primary investment objective is to provide a high level of current income. The Fund&#8217;s secondary investment
objective is to seek capital appreciation consistent with the Fund&#8217;s strategy and its primary objective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
normal market conditions, the Fund will attempt to achieve its objectives by investing at least 80% of its assets in equity securities
of companies principally engaged in the gold and natural resources industries. The Fund will invest at least 25% of its assets
in the equity securities of companies principally engaged in the gold industry, which includes companies principal engaged in
the exploration, mining, fabrication, processing, distribution or trading of gold or the financing, managing, controlling or operating
of companies engaged in &#8220;gold-related&#8221; activities (&#8220;Gold Companies&#8221;). In addition, the Fund will invest
at least 25% of its assets in the equity securities of companies principally engaged in the group of industries that constitute
the natural resources industries, which include companies principally engaged in the exploration, production or distribution of
natural resources, such as gas, oil, paper, food and agriculture, forestry products, metals (other than gold) and minerals as
well as related transportation companies and equipment manufacturers (&#8220;Natural Resources Companies&#8221;). The Fund may
invest in the securities of companies located anywhere in the world and under normal market conditions will invest at least 40%
of its assets in the securities of issuers located in at least three countries other than the United States. For this purpose
an issuer will be treated as located outside the United States if it is either organized or headquartered outside the United States
and has a substantial portion of its operations or sales outside the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principally
engaged, as used in this Prospectus, means a company that derives at least 50% of its revenues or earnings or devotes at least
50% of its assets to gold or natural resources related activities, as the case may be. As part of its investment strategy, the
Fund intends to generate gains through an option strategy which will normally consist of writing (selling) call options on equity
securities in its portfolio (&#8220;covered calls&#8221;), but may, in amounts up to 15% of the Fund&#8217;s assets, consist of
writing uncovered call options on securities not held by the Fund, indices comprised of Gold Companies or Natural Resources Companies
or exchange traded funds comprised of such issuers and put options on securities in its portfolio. When the Fund sells a call
option, it generates gains in the form of the premium paid by the buyer of the call option, but the Fund forgoes the opportunity
to participate in any increase in the value of the underlying equity security above the exercise price of the option. When the
Fund sells a put option, it generates gains in the form of the premium paid by the buyer of the put option, but the Fund will
have the obligation to buy the underlying security at the exercise price if the price of the security decreases below the exercise
price of the option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
assurance can be given that the Fund&#8217;s investment objectives will be achieved. See &#8220;Investment Objectives and Policies&#8221;
in the Prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred
Shares and Borrowings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 7, 2013, the Fund completed the placement of $100 million of Cumulative Preferred Shares (&#8220;Preferred Shares&#8221;)
consisting of 4 million shares designated as Series B Preferred Shares and paying dividends of an annual rate equal to 5.00% of
liquidation preference. The Preferred Shares are senior to the common shares and result in the financial leveraging of the common
shares. Such leveraging tends to magnify both the risks and opportunities to common shareholders. Dividends on the Preferred Shares
are cumulative. The Fund is required by the Investment Company Act of 1940, as amended (the &#8220;1940 Act&#8221;) and by the
Statement of Preferences to meet certain asset coverage tests with respect to the Preferred Shares. If the Fund fails to meet
these requirements and does not correct such failure, the Fund may be required to redeem, in part or in full, the Preferred Shares
at the redemption price of $25 per share plus an amount equal to the accumulated and unpaid dividends whether or not declared
on such shares in order to meet the requirements. Additionally, failure to meet the foregoing asset coverage requirements could
restrict the Fund&#8217;s ability to pay dividends to common shareholders and could lead to sales of portfolio securities at inopportune
times. The income received on the Fund&#8217;s assets may vary in a manner unrelated to the fixed rate, which could have either
a beneficial or detrimental impact on net investment income and gains available to common shareholders. If the Fund has insufficient
investment income and gains, all or a portion of the distributions to preferred shareholders would come from the common shareholders&#8217;
capital. Such distributions reduce the net assets attributable to common shareholders since the liquidation value of the preferred
shareholders is constant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund may issue additional series of preferred shares or borrow money to leverage its investments. If the Fund&#8217;s Board determines
that it may be advantageous to the holders of the Fund&#8217;s common shares for the Fund to utilize such leverage, the Fund may
issue additional series of preferred shares or borrow money. Any preferred shares issued by the Fund will pay distributions either
at a fixed rate or at rates that will be reset frequently based on short term interest rates. Any borrowings may also be at fixed
or floating rates. Leverage creates a greater risk of loss as well as a potential for more gains for the common shares than if
leverage were not used. See &#8220;Additional Fund Information&#8212;Risk Factors and Special Considerations&#8212;Leverage Risks&#8221;
in the Annual Report. The Fund may also engage in investment management techniques which will not be considered senior securities
if the Fund complies with Rule 18f-4 under the 1940 Act. See &#8220;Additional Fund Information&#8212;Risk Factors and Special
Considerations&#8212;Special Risks of Derivative Transactions&#8221; in the Annual Report. These investment management techniques
principally consists of writing options as described under &#8220;Investment Objectives and Policies.&#8221; See &#8220;Additional
Fund Information&#8212;Risk Factors and Special Considerations&#8212;Risks Associated with Covered Calls and Other Option Transactions,&#8221;
&#8220;&#8212;Leverage Risk,&#8221; and &#8220;&#8212;Special Risks of Derivative Transactions&#8221; in the Annual Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividends
and Distributions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund intends to make regular monthly cash distributions of all or a portion of its investment company taxable income (which includes
ordinary income and realized net short term capital gains) to common shareholders. The Fund also intends to make annual distributions
of its realized net long term capital gains (which is the excess of net long term capital gains over net short term capital losses,
if any). The Fund, however, may make more than one capital gain distribution to avoid paying U.S. federal excise tax. See &#8220;Taxation.&#8221;
<b>A portion of the Fund&#8217;s common share distributions for the fiscal years ending 2014, 2015, 2016, 2017, 2018, 2019, 2020,
2021, 2022 and 2023 included a return of capital. During each of the fiscal years ended December 31, 2014, 2015, 2016, 2017, 2018,
2019, 2020, 2021, 2022 and 2023, the portion of the Fund&#8217;s common share distributions that included a return of capital
was approximately 100%, 98%, 95%, 92%, 95%, 100%, 94%, 84%, 84%, and 81%, respectively. When the Fund makes distributions consisting
of returns of capital, such distributions may further decrease the Fund&#8217;s total assets and, therefore have the likely effect
of increasing the Fund&#8217;s expense ratio as the Fund&#8217;s fixed expenses will become a larger percentage of the Fund&#8217;s
average net assets. In addition, in order to make such distributions, the Fund may have to sell a portion of its investment portfolio
at a time when independent investment judgment may not dictate such action. These effects could have a negative impact on the
prices investors receive when they sell shares of the Fund. A portion of the distributions to the preferred shareholders for the
fiscal years ending 2014, 2015 and 2016 included a return of capital. Shareholders who receive the payment of a distribution consisting
of a return of capital may be under the impression that they are receiving net profits when they are not. Shareholders should
not assume that the source of a distribution from the Fund is net profit. Any return of capital that is a component of a distribution
is not sourced from earnings and profits of the Fund and that portion should not be considered by investors as yield or total
return on their investment in the Fund. The Fund has capital loss carryforwards from prior years, which may cause a portion of
the Fund&#8217;s distributions to be recharacterized as a return of capital. Further, while any return of capital that is a component
of a distribution will not necessarily be taxed in the current period, it will have the effect of lowering the cost basis, which
may lead to higher taxes upon the sale of the securities.</b> Various factors will affect the level of the Fund&#8217;s income,
such as its asset mix and use of covered call strategies. To permit the Fund to maintain more stable monthly distributions, the
Fund may from time to time distribute less than the entire amount of income earned in a particular period, which would be available
to supplement future distributions. As a result, the distributions paid by the Fund for any particular monthly period may be more
or less than the amount of income actually earned by the Fund during that period. See &#8220;Dividends and Distributions&#8221;
in the Prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s distribution policy, including its policy to make regular monthly cash distributions, may be modified from time to
time by the Board as it deems appropriate, including in light of market and economic conditions and the Fund&#8217;s current,
expected, and historical earnings, and investment performance. Common shareholders are expected to be notified of any such modifications
by press release or in the Fund&#8217;s periodic shareholder reports. Because the Fund&#8217;s income will fluctuate and the Fund&#8217;s
distribution policy may be changed by the Board at any time, there can be no assurance that the Fund will pay distributions or
dividends at a particular rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
company taxable income (including dividend income) and capital gain distributions paid by the Fund are automatically reinvested
in additional shares of the Fund unless a shareholder elects to receive cash or the shareholder&#8217;s broker does not provide
reinvestment services. See &#8220;Automatic Dividend Reinvestment and Voluntary Cash Purchase Plan&#8221; in the Prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the Fund&#8217;s Governing Documents (as defined below) and as required by the 1940 Act, all preferred shares
of the Fund must have the same seniority with respect to distributions. Accordingly, no complete distribution due for a particular
dividend period will be declared or paid on any series of preferred shares of the Fund for any dividend period, or part thereof,
unless full cumulative dividends and distributions due through the most recent dividend payment dates for all series of outstanding
preferred shares of the Fund are declared and paid. If full cumulative distributions due have not been declared and made on all
outstanding preferred shares of the Fund, any distributions on such preferred shares will be made as nearly pro rata as possible
in proportion to the respective amounts of distributions accumulated but unmade on each such series of preferred shares on the
relevant dividend payment date. As used herein, &#8220;Governing Documents&#8221; means the Fund&#8217;s Agreement and Declaration
of Trust and By-Laws, together with any amendments or supplements thereto, including any Statement of Preferences establishing
a series of preferred shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use
of Proceeds</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund will use the net proceeds from the offering to purchase portfolio securities in accordance with its investment objectives
and policies as appropriate investment opportunities are identified, which is expected to substantially be completed within three
months however, changes in market conditions could result in the Fund&#8217;s anticipated investment period extending to as long
as six months. This could occur if market conditions are unstable to such an extent that the Investment Adviser believes market
risk is greater than the benefit of making additional investments at that time. Depending on market conditions and operations,
a position of the proceeds to be identified in any relevant Prospectus Supplement may be used to pay distributions in accordance
with the Fund&#8217;s distribution policy. See &#8220;Use of Proceeds&#8221; in the Prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exchange
Listing</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s common shares are listed on the NYSE American under the trading or &#8220;ticker&#8221; symbol &#8220;GGN.&#8221;
The Fund&#8217;s Preferred Shares are listed on the NYSE American under the ticker symbol &#8220;GGN PrB.&#8221; See &#8220;Description
of the Shares&#8221; in the Prospectus. The Fund&#8217;s common shares have historically traded at both a premium and discount
to NAV. Since the Fund commenced trading on the NYSE American, the Fund&#8217;s common shares have traded at a discount to net
asset value as low as (25.36)% and a premium as high as 56.07%. Any additional series of fixed rate preferred shares issued by
the Fund would also likely be listed on a stock exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market
Price of Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
shares of closed-end investment companies can trade at prices lower than their net asset value. Common shares of closed-end investment
companies may trade during some periods at prices higher than their net asset value and during other periods at prices lower than
their net asset value. The Fund cannot assure you that its common shares will trade at a price higher than or equal to net asset
value. The Fund&#8217;s net asset value will be reduced immediately following this offering by the sales load and the amount of
the offering expenses paid by the Fund. See &#8220;Use of Proceeds&#8221; in the Prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to net asset value, the market price of the Fund&#8217;s common shares may be affected by such factors as the Fund&#8217;s
dividend and distribution levels (which are affected by expenses) and stability, market liquidity, market supply and demand, unrealized
gains, general market and economic conditions and other factors. See &#8220;Risk Factors and Special Considerations,&#8221; &#8220;Description
of the Shares&#8221; and &#8220;Repurchase of Common Shares&#8221; in the Prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
common shares are designed primarily for long term investors, and you should not purchase common shares of the Fund if you intend
to sell them shortly after purchase.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fixed
rate preferred shares may also trade at premiums to or discounts from their liquidation preference for a variety of reasons, including
changes in interest rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk
Factors and Special Considerations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
is inherent in all investing and you could lose all or any portion of the amount you invest in our securities. Therefore, before
investing in our securities, you should consider the risks described in this Prospectus, the Fund&#8217;s Annual Report and any
Prospectus Supplement carefully. The following is only a summary of certain risks of investing in the Fund described in more detail
in the Annual Report and elsewhere in this Prospectus and any applicable Prospectus Supplement. Before you invest, you should
read the full summary of the risks of investing in the Fund, beginning on page 12 of this Prospectus under the heading &#8220;Risk
Factors and Special Considerations,&#8221; in any accompanying Prospectus Supplement and in the Fund&#8217;s Annual Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
related to the Fund&#8217;s portfolio investments include risks related to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">market risk;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">total return risk;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">industry risks relating
    to the Fund&#8217;s investments in the gold and natural resources industries;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">risks associated
    with covered calls and other option transactions and uncovered calls;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">investing in securities
    of foreign issuers;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">equity risk;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">investing in preferred
    shares, non-investment grade securities, and restricted and illiquid securities;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">use of financial
    leverage; and</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">derivative transactions.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Special
risks to investors in the Fund&#8217;s common shares include risks relating to the Fund&#8217;s common share distribution policy,
dividends and use of leverage, the common shares&#8217; market price and liquidity, dilution and portfolio turnover.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Special
risks to investors in the Fund&#8217;s preferred shares include risks relating to the preferred shares&#8217; market price and
liquidity, distributions on the preferred shares, redemption, reinvestment, subordination, common share repurchases, common share
distributions and credit quality ratings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
general risks include risks related to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Fund&#8217;s
    long term investment horizon, management and dependence on key personnel;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">equity risk, market
    disruptions and geopolitical events, economic events and market events, government intervention in the financial markets,
    and inflation;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the anti-takeover
    provisions in the Fund&#8217;s Governing Documents; and</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Fund&#8217;s
    status as a RIC for U.S. federal income tax purposes.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Management
and Fees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gabelli
Funds, LLC serves as the Fund&#8217;s Investment Adviser and is compensated for its services and its related expenses at an annual
rate of 1.00% of the Fund&#8217;s average weekly net assets, as defined in the Fund&#8217;s investment advisory agreement, with
no deduction for the liquidation preference of any outstanding preferred shares. Consequently, if the Fund has preferred shares
outstanding, the management fee as a percentage of net assets attributable to the common shares will be higher. The Investment
Adviser is responsible for administration of the Fund and currently utilizes and pays the fees of a third party sub-administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
the investment advisory fees are based on a percentage of managed assets, which includes assets attributable to the Fund&#8217;s
use of leverage, the Investment Adviser may have a conflict of interest in the input it provides to the Board regarding whether
to use or increase the Fund&#8217;s use of leverage. There may be cases in which the Fund determines to borrow or use other forms
of leverage. The Board bases its decision, with input from the Investment Adviser, regarding whether and how much leverage to
use for the Fund on its assessment of whether such use of leverage is in the best interests of the Fund. The Board seeks to manage
the Investment Adviser&#8217;s potential conflict of interest by retaining the final decision on these matters and by periodically
reviewing the Fund&#8217;s performance and use of leverage. See &#8220;Management of the Fund&#8221; in the Prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Repurchase
of Common Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s Board of Trustees has authorized the Fund (and the Fund accordingly reserves freedom of action) to repurchase its
common shares in the open market when the common shares are trading at a discount of 7.5% or more from net asset value (or such
other percentage as the Board of Trustees may determine from time to time). The Fund generally intends to finance common share
repurchases with cash on hand and, while the Fund may incur debt to finance common share repurchases, such debt financing would
require further approval of the Board, and the Fund does not currently intend to incur debt to finance common share repurchases.
The Fund has repurchased its common shares under this authorization. See &#8220;Description of the Shares&#8212;Common Shares&#8221;
in the Prospectus. Although the Board of Trustees has authorized such repurchases, the Fund is not required to repurchase its
common shares, and the Fund&#8217;s officers, in determining whether to repurchase Fund common shares pursuant to this authority,
take into account a variety of market and economic factors including, among other things, trading volume, the magnitude of discount,
bid/ask spreads, the Fund&#8217;s available cash position, leverage and expense ratios, and any applicable legal or contractual
restrictions on such repurchases that may be applicable at the time. The Board of Trustees has not established a limit on the
number of shares that could be purchased during such period. During the year ended December 31, 2023, the Fund did not repurchase
any common shares in the open market. Such repurchases are subject to certain notice and other requirements under the 1940 Act.
See &#8220;Repurchase of Common Shares&#8221; in the Prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Anti-Takeover
Provisions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
provisions of the Fund&#8217;s Agreement and Declaration of Trust and By-Laws (collectively, the &#8220;Governing Documents&#8221;)
may be regarded as &#8220;anti-takeover&#8221; provisions. Pursuant to these provisions, only one of three classes of Trustees
is elected each year, and the affirmative vote of the holders of 75% of the outstanding shares of the Fund are necessary to authorize
the conversion of the Fund from a closed-end to an open-end investment company or to authorize certain transactions between the
Fund and a beneficial owner of more than 5% of any class of the Fund&#8217;s capital stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund is organized as a Delaware statutory trust and thus is subject to the control share acquisition statute contained in Subchapter
III of the Delaware Statutory Trust Act (the &#8220;DSTA Control Share Statute&#8221;). The DSTA Control Share Statute applies
to any closed-end investment company organized as a Delaware statutory trust and listed on a national securities exchange, such
as the Fund. The DSTA Control Share Statute became automatically applicable to the Fund on August 1, 2022. The DSTA Control Share
Statute provides for a series of voting power thresholds above which shares are considered &#8220;control beneficial interests&#8221;
(referred to herein as &#8220;control shares&#8221;). Once a threshold is reached, an acquirer has no voting rights under the
DSTA or the governing documents of the Fund with respect to shares acquired in excess of that threshold (i.e., the &#8220;control
shares&#8221;) unless approved by shareholders of the Fund or exempted by the Board. Approval by the shareholders requires the
affirmative vote of two-thirds of all votes entitled to be cast on the matter, excluding shares held by the acquirer and its associates
as well as shares held by certain insiders of the Fund. Further approval by the Fund&#8217;s shareholders would be required with
respect to additional acquisitions of control shares above the next applicable threshold level. The Board is permitted, but not
obligated to, exempt specific acquisitions or classes of acquisitions of control shares, either in advance or retroactively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing is only a summary of the material terms of the DSTA Control Share Statute. Shareholders should consult their own counsel
with respect to the application of the DSTA Control Share Statute to any particular circumstance. Some uncertainty around the
general application under the 1940 Act of state control share statutes exists as a result of recent court decisions which have
held that control share acquisition provisions in funds&#8217; governing documents are not consistent with the 1940 Act. Additionally,
in some circumstances uncertainty may also exist in how to enforce the control share restrictions contained in state control share
statutes against beneficial owners who hold their shares through financial intermediaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
overall effect of these provisions is to render more difficult the accomplishment of a merger with, or the assumption of control
by, a principal shareholder. These provisions may have the effect of depriving Fund common shareholders of an opportunity to sell
their shares at a premium to the prevailing market price. The issuance of preferred shares could make it more difficult for the
holders of common shares to avoid the effect of these provisions. See &#8220;Anti-Takeover Provisions of the Fund&#8217;s Governing
Documents&#8221; in the Prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Custodian,
Transfer Agent and Dividend Disbursing Agent</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bank of New York Mellon, located at 240 Greenwich Street, New York, NY 10286, serves as the custodian (the &#8220;Custodian&#8221;)
of the Fund&#8217;s assets pursuant to a custody agreement. Under the custody agreement, the Custodian holds the Fund&#8217;s
assets in compliance with the 1940 Act. For its services, the Custodian will receive a monthly fee paid by the Fund based upon,
among other things, the average value of the total assets of the Fund, plus certain charges for securities transactions and out-of-pocket
expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">American
Stock Transfer &amp; Trust Company (&#8220;American Stock Transfer&#8221;), located at 6201 15th Avenue, Brooklyn, New York 11219,
serves as the Fund&#8217;s distribution disbursing agent, as agent under the Fund&#8217;s Automatic Dividend Reinvestment and
Voluntary Cash Purchase Plan and as transfer agent and registrar with respect to the common and preferred shares of the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a002"></span>SUMMARY
OF FUND EXPENSES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained under the heading &#8220;Additional Fund Information&#8212;Summary of Fund Expenses&#8221; in the Fund&#8217;s
Annual Report is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a003"></span>USE
OF PROCEEDS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investment Adviser expects that it will initially invest the proceeds of the offering in high quality short term debt securities
and instruments. The Investment Adviser anticipates that the investment of the proceeds will be made in accordance with the Fund&#8217;s
investment objectives and policies as appropriate investment opportunities are identified, which is expected to substantially
be completed within three months; however, changes in market conditions could result in the Fund&#8217;s anticipated investment
period extending to as long as six months. This could occur if market conditions are unstable to such an extent that the Investment
Adviser believes market risk is greater than the benefit of making additional investments at that time. Depending on market conditions
and operations, a portion of the cash held by the Fund, including any proceeds raised from the offering to be identified in any
relevant Prospectus Summary, may be used to pay distributions in accordance with the Fund&#8217;s distribution policy. Such distribution
may include a return of capital and should not be considered as dividend yield or the total return from an investment in the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
it does not currently expect to do so, the Fund may also use the net proceeds from the offering to call, redeem or repurchase
shares of its Series B Preferred Shares. The distribution rate on the Series B Preferred Shares is 5.00%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a004"></span>THE
FUND</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund is a non-diversified, closed-end management investment company registered under the 1940 Act. The Fund was organized as a
Delaware statutory trust on January 4, 2005, pursuant to an Agreement and Declaration of Trust governed by the laws of the State
of Delaware. The Fund commenced investment operations on March 31, 2005. The Fund&#8217;s principal office is located at One Corporate
Center, Rye, New York, 10580-1422 and its telephone number is (800) 422-3554.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="AsOf2024-04-15" escape="true" id="Fact000065" name="cef:InvestmentObjectivesAndPracticesTextBlock"><p id="xdx_80C_ecef--InvestmentObjectivesAndPracticesTextBlock_dU_zKXuIxU6QLW3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a005"></span>INVESTMENT
OBJECTIVES AND POLICIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment
Objectives</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s primary investment objective is to provide a high level of current income. The Fund&#8217;s secondary investment
objective is to seek capital appreciation consistent with the Fund&#8217;s strategy and its primary objective. Under normal market
conditions, the Fund will attempt to achieve its objectives by investing at least 80% of its assets in equity securities of companies
principally engaged in the gold industry and the natural resources industries. The Fund will invest at least 25% of its assets
in the equity securities of companies principally engaged in the gold industry, which includes companies principally engaged in
the exploration, mining, fabrication, processing, distribution or trading of gold or the financing, managing, controlling or operating
of companies engaged in &#8220;gold-related&#8221; activities. In addition, the Fund will invest at least 25% of its assets in
the equity securities of companies principally engaged in the group of industries that constitute the natural resources industries,
which include companies principally engaged in the exploration, production or distribution of natural resources, such as gas,
oil, paper, food and agriculture, forestry products, metals (other than gold) and minerals as well as related transportation companies
and equipment manufacturers. The Fund may invest in the securities of companies located anywhere in the world. Under normal market
conditions, the Fund will invest at least 40% of its assets in the securities of issuers located in at least three countries other
than the United States. For this purpose an issuer will be treated as located outside the United States if it is either organized
or headquartered outside the United States and has a substantial portion of its operations or sales outside the United States.
Equity securities may include common stocks, preferred stocks, convertible securities, warrants, depository receipts and equity
interests in trusts and other entities. Other Fund investments may include investment companies, securities of issuers subject
to reorganization or other risk arbitrage investments, certain derivative instruments, debt (including obligations of the United
States government) and money market instruments. The Fund may invest up to 10% of its total assets in securities rated below investment
grade by recognized statistical rating agencies or unrated securities of comparable quality, including securities of issuers in
default, which are likely to have the lowest rating. These securities, which may be preferred shares or debt, are predominantly
speculative and involve major risk exposure to adverse conditions. Securities that are rated lower than &#8220;BBB&#8221; by S&amp;P,
or lower than &#8220;Baa&#8221; by Moody&#8217;s or unrated securities considered by the Investment Adviser to be of comparable
quality, are commonly referred to as &#8220;junk bonds&#8221; or &#8220;high yield&#8221; securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principally
engaged, as used in this Prospectus, means a company that derives at least 50% of its revenues or earnings or devotes at least
50% of its assets to gold or natural resources related activities, as the case may be. As part of its investment strategy, the
Fund intends to generate gains through an option strategy of writing (selling) covered call options on equity securities in its
portfolio. When the Fund sells a covered call option, it generates gains in the form of the premium paid by the buyer of the call
option, but the Fund forgoes the opportunity to participate in any increase in the value of the underlying equity security above
the exercise price of the option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained under the headings &#8220;Additional Fund Information&#8212;Investment Objectives and Policies&#8221; in
the Fund&#8217;s Annual Report is incorporated herein by reference.</span></p>

</ix:nonNumeric><p id="xdx_81C_zPsJpKbEWVfi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:nonNumeric contextRef="AsOf2024-04-15" escape="true" id="Fact000067" name="cef:RiskFactorsTableTextBlock"><p id="xdx_807_ecef--RiskFactorsTableTextBlock_dU_z4nYaARZRjwf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a006"></span>RISK
FACTORS AND SPECIAL CONSIDERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained under the heading &#8220;Additional Fund Information&#8212;Risk Factors and Special Considerations&#8221;
in the Fund&#8217;s Annual Report is incorporated herein by reference.</span></p>

</ix:nonNumeric><p id="xdx_81D_zgbXdUT67KJg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a007"></span>MANAGEMENT
OF THE FUND</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained under the heading &#8220;Additional Fund Information&#8212;Management of the Fund&#8221; in the Fund&#8217;s
Annual Report is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a008"></span>PORTFOLIO
TRANSACTIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
transactions are not entered into with affiliates of the Fund. However, G.research, an affiliate of the Investment Adviser, may
execute portfolio transactions on stock exchanges and in the OTC markets on an agency basis and may be paid commissions. For a
more detailed discussion of the Fund&#8217;s brokerage allocation practices, see &#8220;Portfolio Transactions&#8221; in the SAI.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a009"></span>DIVIDENDS
AND DISTRIBUTIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund intends to make regular monthly cash distributions of all or a portion of its investment company taxable income (which includes
ordinary income and realized short term capital gains) to common shareholders. The Fund also intends to make annual distributions
of its realized net long term capital gains, if any (which is the excess of net long term capital gains over net short term capital
losses). As a RIC under the Code, the Fund will not be subject to U.S. federal income tax on any taxable income that it distributes
to shareholders, provided that at least 90% of its investment company taxable income for that taxable year is distributed to its
shareholders. The Fund, however, may make more than one capital gain distribution to avoid paying U.S. federal excise tax. See
&#8220;Taxation.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
portion of the Fund&#8217;s common share distributions for the fiscal years ending 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021,
2022 and 2023 included a return of capital. During each of the fiscal years ended December 31, 2014, 2015, 2016, 2017, 2018, 2019,
2020, 2021, 2022 and 2023, the portion of the Fund&#8217;s common share distributions that included a return of capital was approximately
100%, 98%, 95%, 92%, 95%, 100%, 94%, 84%, 80%, and 80%, respectively. When the Fund makes distributions consisting of returns
of capital, such distributions may further decrease the Fund&#8217;s total assets and, therefore have the likely effect of increasing
the Fund&#8217;s expense ratio as the Fund&#8217;s fixed expenses will become a larger percentage of the Fund&#8217;s average
net assets. In addition, in order to make such distributions, the Fund may have to sell a portion of its investment portfolio
at a time when independent investment judgment may not dictate such action. These effects could have a negative impact on the
prices investors receive when they sell shares of the Fund. A portion of the distributions to the preferred shareholders for the
fiscal years ending 2014, 2015 and 2016 included a return of capital. Shareholders who receive the payment of a distribution consisting
of a return of capital may be under the impression that they are receiving net profits when they are not.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
should not assume that the source of a distribution from the Fund is net profit. Any return of capital that is a component of
a distribution is not sourced from earnings and profits of the Fund and that portion should not be considered by investors as
yield or total return on their investment in the Fund. The Fund has capital loss carryforwards from prior years, which may cause
a portion of the Fund&#8217;s distributions to be recharacterized as a return of capital. Further, while any return of capital
that is a component of a distribution will not necessarily be taxed in the current period, it will have the effect of lowering
the cost basis, which may lead to higher taxes upon the sale of the securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund will pay common shareholders annually all, or at least 90%, of its investment company taxable income. Various factors will
affect the level of the Fund&#8217;s income, such as its asset mix and use of option strategies. To permit the Fund to maintain
more stable monthly distributions, the Fund may from time to time distribute less than the entire amount of income earned in a
particular period, which would be available to supplement future distributions. As a result, the distributions paid by the Fund
for any particular monthly period may be more or less than the amount of income actually earned by the Fund during that period.
However, as the Fund is entitled to rely on an exemption from the 1940 Act which allows the Board of Trustees to implement a managed
distribution policy, the Board of Trustees in the future may determine to cause the Fund to distribute a fixed percentage of the
Fund&#8217;s average net asset value or market price per common share over a specified period of time at or about the time of
distribution or to distribute a fixed dollar amount. The Board of Trustees has no present intention to implement such a policy.
See &#8220;Dividends and Distributions&#8221; in the SAI.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s distribution policy, including its policy to make regular monthly cash distributions, may be modified from time to
time by the Board as it deems appropriate, including in light of market and economic conditions and the Fund&#8217;s current,
expected, and historical earnings, and investment performance. Common shareholders are expected to be notified of any such modifications
by press release or in the Fund&#8217;s periodic shareholder reports. Because the Fund&#8217;s income will fluctuate and the Fund&#8217;s
distribution policy may be changed by the Board at any time, there can be no assurance that the Fund will pay distributions or
dividends at a particular rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
will automatically have all dividends and distributions reinvested in common shares of the Fund issued by the Fund or purchased
in the open market in accordance with the Fund&#8217;s dividend reinvestment plan unless an election is made to receive cash.
See &#8220;Automatic Dividend Reinvestment and Voluntary Cash Purchase Plan.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the Fund&#8217;s Governing Documents and as required by the 1940 Act, all preferred shares of the Fund must have
the same seniority with respect to distributions. Accordingly, no complete distribution due for a particular dividend period will
be declared or paid on any series of preferred shares of the Fund for any dividend period, or part thereof, unless full cumulative
dividends and distributions due through the most recent dividend payment dates for all series of outstanding preferred shares
of the Fund are declared and paid. If full cumulative distributions due have not been declared and made on all outstanding preferred
shares of the Fund, any distributions on such preferred shares will be made as nearly pro rata as possible in proportion to the
respective amounts of distributions accumulated but unmade on each such series of preferred shares on the relevant dividend payment
date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a010"></span>ISSUANCE
OF COMMON SHARES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2023, the Fund did not issue shares of beneficial interest through &#8220;at the market offerings.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a011"></span>AUTOMATIC
DIVIDEND REINVESTMENT AND VOLUNTARY CASH PURCHASE PLAN</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained under the heading &#8220;Additional Fund Information&#8212;Automatic Dividend Reinvestment and Voluntary
Cash Purchase Plan&#8221; in the Fund&#8217;s Annual Report is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="AsOf2024-04-15" escape="true" id="Fact000069" name="cef:CapitalStockTableTextBlock"><p id="xdx_800_ecef--CapitalStockTableTextBlock_dU_zjVW7v5Rkb3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a012"></span>DESCRIPTION
OF THE SHARES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following is a brief description of the terms of the Fund&#8217;s shares. This description does not purport to be complete and
is qualified by reference to the Fund&#8217;s Agreement and Declaration of Trust and its By-Laws. For complete terms of the shares,
please refer to the actual terms of each series, which are set forth in the Agreement and Declaration of Trust.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund is an unincorporated statutory trust organized under the laws of Delaware pursuant to a Certificate of Trust dated as of
January 4, 2005. The Fund is authorized to issue an unlimited number of common shares of beneficial interest, par value $0.001
per share. Each common share of beneficial interest has one vote and, when issued and paid for in accordance with the terms of
the applicable offering, will be fully paid and non-assessable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Though
the Fund expects to pay distributions monthly on the common shares of beneficial interest, it is not obligated to do so. All common
shares of beneficial interest are equal as to distributions, assets and voting privileges and have no conversion, preemptive or
other subscription rights. The Fund will send annual and semiannual reports, including financial statements, to all holders of
its shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offerings
of shares require approval by the Fund&#8217;s Board of Trustees. Any additional offering of common shares of beneficial interest
will be subject to the requirements of the 1940 Act, which provides that common stock may not be issued at a price below the then
current net asset value, exclusive of sales load, except in connection with an offering to existing holders of common shares or
with the consent of a majority of the Fund&#8217;s common shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s common shares of beneficial interest are listed on the NYSE American under the symbol &#8220;GGN.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s common shares have historically traded at both a premium and discount to NAV. Since the Fund commenced trading on
the NYSE American, the Fund&#8217;s common shares have traded at a discount to net asset value as low as (25.36)% and a premium
as high as 56.07%. Unlike open-end funds, closed-end funds like the Fund do not continuously offer shares and do not provide daily
redemptions. Rather, if a shareholder determines to buy additional common shares or sell shares already held, the shareholder
may do so by trading through a broker on the NYSE American or otherwise. The average weekly trading volume of common shares on
the NYSE American during the period from January 1, 2023 to December 31, 2023 was 2,276,588 shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
of closed-end investment companies often trade on an exchange at prices lower than net asset value. Because the market value of
the common shares may be influenced by such factors as dividend and distribution levels (which are in turn affected by expenses),
dividend and distribution stability, net asset value, market liquidity, relative demand for and supply of such shares in the market,
unrealized gains, general market and economic conditions and other factors beyond the control of the Fund, the Fund cannot assure
you that common shares will trade at a price equal to or higher than net asset value in the future. The common shares are designed
primarily for long term investors and you should not purchase the common shares if you intend to sell them soon after purchase.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the rights of the outstanding preferred shares, the Fund&#8217;s common shares vote as a single class on election of Trustees
and on additional matters with respect to which the 1940 Act, the Fund&#8217;s Agreement and Declaration of Trust, By-Laws or
resolutions adopted by the Trustees provide for a vote of the Fund&#8217;s common shares. See &#8220;Anti-Takeover Provisions
of the Fund&#8217;s Governing Documents.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund is a closed-end, non-diversified, management investment company and as such its shareholders do not, and will not, have the
right to require the Fund to repurchase their shares. The Fund, however, may repurchase its common shares from time to time as
and when it deems such a repurchase advisable, subject to maintaining required asset coverage for each series of outstanding preferred
shares. The Board has authorized such repurchases to be made when the Fund&#8217;s common shares are trading at a discount from
net asset value of 7.5% or more (or such other percentage as the Board of the Fund may determine from time to time). Pursuant
to the 1940 Act, the Fund may repurchase its common shares on a securities exchange (provided that the Fund has informed its shareholders
within the preceding six months of its intention to repurchase such shares) or pursuant to tenders and may also repurchase shares
privately if the Fund meets certain conditions regarding, among other things, distribution of net income for the preceding fiscal
year, status of the seller, price paid, brokerage commissions, prior notice to shareholders of an intention to purchase shares
and purchasing in a manner and on a basis that does not discriminate unfairly against the other shareholders through their interest
in the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_z4DPn305mLYc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the Fund repurchases its common shares for a price below net asset value, the net asset value of the common shares that remain
outstanding will be enhanced, but this does not necessarily mean that the market price of the outstanding common shares will be
affected, either positively or negatively. The repurchase of common shares will reduce the total assets of the Fund available
for investment and may increase the Fund&#8217;s expense ratio. In total through December 31, 2023, the Fund has repurchased and
retired 11,667,349 common shares in the open market at an average price of $3.58 per share and at an average discount of approximately
12.6% per share. During the year ended December 31, 2023, the Fund did not repurchase any common shares in the open market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Book
Entry</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
common shares sold through this offering will initially be held in the name of Cede &amp; Co. as nominee for the Depository Trust
Company (&#8220;DTC&#8221;). The Fund will treat Cede &amp; Co. as the holder of record of the common shares for all purposes.
In accordance with the procedures of DTC, however, purchasers of common shares will be deemed the beneficial owners of shares
purchased for purposes of distributions, voting and liquidation rights. Purchasers of common shares may obtain registered certificates
by contacting the transfer agent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred
Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
an unlimited number of the Fund&#8217;s shares have been classified by the Board of Trustees as preferred shares, par value $0.001
per share. The terms of such preferred shares may be fixed by the Board of Trustees and would materially limit and/or qualify
the rights of the holders of the Fund&#8217;s common shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 7, 2013, the Fund completed the placement of $100 million of preferred shares consisting of 4 million shares designated as
the Series B Preferred Shares and paying dividends of an annual rate equal to 5.00% of liquidation preference. The Series B Preferred
Shares are senior to the common shares and result in the financial leveraging of the common shares. Such leveraging tends to magnify
both the risks and opportunities to common shareholders. Dividends on the preferred shares are cumulative. The Fund is required
by the 1940 Act and by the Statement of Preferences to meet certain asset coverage tests with respect to the Series B Preferred
Shares. If the Fund fails to meet these requirements and does not correct such failure, the Fund may be required to redeem, in
part or in full, the Series B Preferred Shares at the redemption price of $25 per share plus an amount equal to the accumulated
and unpaid dividends whether or not declared on such shares in order to meet the requirements. Additionally, failure to meet the
foregoing asset coverage requirements could restrict the Fund&#8217;s ability to pay dividends to common shareholders or repurchase
common shares and could lead to sales of portfolio securities at inopportune times. The income received on the Fund&#8217;s assets
may vary in a manner unrelated to the fixed rate, which could have either a beneficial or detrimental impact on net investment
income and gains available to common shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series B Preferred Shares are listed on the NYSE American under the ticker symbol &#8220;GGN PrB.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
a liquidation, each holder of the preferred shares will be entitled to receive out of the assets of the Fund available for distribution
to shareholders (after payment of claims of the Fund&#8217;s creditors but before any distributions with respect to the Fund&#8217;s
common shares or any other shares of the Fund ranking junior to the preferred shares as to liquidation payments) an amount per
share equal to such share&#8217;s liquidation preference plus any accumulated but unpaid distributions (whether or not earned
or declared, excluding interest thereon) to the date of distribution, and such shareholders shall be entitled to no further participation
in any distribution or payment in connection with such liquidation. Each series of the preferred shares will rank on a parity
with any other series of preferred shares of the Fund as to the payment of distributions and the distribution of assets upon liquidation,
and will be junior to the Fund&#8217;s obligations with respect to any outstanding senior securities representing debt. If the
Fund has insufficient investment income and gains, all or a portion of the distributions to preferred shareholders would come
from the common shareholders&#8217; capital. Such distributions reduce the net assets attributable to common shareholders since
the liquidation preference of the preferred shareholders is constant. The preferred shares carry one vote per share on all matters
on which such shares are entitled to vote. The preferred shares will, upon issuance, be fully paid and nonassessable and will
have no preemptive, exchange or conversion rights. The Board of Trustees may by resolution classify or reclassify any authorized
but unissued capital shares of the Fund from time to time by setting or changing the preferences, conversion or other rights,
voting powers, restrictions, limitations as to distributions or terms or conditions of redemption. The Fund will not issue any
class of shares senior to the preferred shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_zcZZSDUj5y7a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption,
Purchase and Sale of Preferred Shares By the Fund.</i> The terms of any preferred shares are expected to provide that (i) they
are redeemable by the Fund at any time (either after the date of initial issuance, or after some period of time following initial
issuance) in whole or in part at the original purchase price per share plus accumulated dividends per share, (ii) the Fund may
tender for or purchase preferred shares and (iii) the Fund may subsequently resell any shares so tendered for or purchased. Any
redemption or purchase of preferred shares by the Fund will reduce the leverage applicable to the common shares, while any resale
of preferred shares by the Fund will increase that leverage.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Rating
Agency Guidelines.</i> The Series B Preferred Shares are rated A2 by Moody&#8217;s. Upon issuance, any new publicly issued series
of preferred shares may be rated by Moody&#8217;s or Fitch, in which case the following description of rating agency guidelines
would also be applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund expects that it would be required under any applicable rating agency guidelines to maintain assets having in the aggregate
a discounted value at least equal to a Basic Maintenance Amount (as defined in the applicable Statement of Preferences and summarized
below), for its outstanding preferred shares, including the Series B Preferred Shares. To the extent any particular portfolio
holding does not satisfy the applicable rating agency&#8217;s guidelines, all or a portion of such holding&#8217;s value will
not be included in the calculation of discounted value (as defined by such rating agency). The Moody&#8217;s and Fitch guidelines
would also impose certain diversification requirements and industry concentration limitations on the Fund&#8217;s overall portfolio,
and apply specified discounts to securities held by the Fund (except certain money market securities).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
&#8220;Basic Maintenance Amount&#8221; is generally equal to (a) the sum of (i) the aggregate liquidation preference of any preferred
shares then outstanding plus (to the extent not included in the liquidation preference of such preferred shares) an amount equal
to the aggregate accumulated but unpaid distributions (whether or not earned or declared) in respect of such preferred shares,
(ii) the Fund&#8217;s other liabilities (excluding dividends and other distributions payable on the Fund&#8217;s common shares),
(iii) any other current liabilities of the Fund (including amounts due and payable by the Fund pursuant to reverse repurchase
agreements and payables for assets purchased) less (b) the value of the Fund&#8217;s assets if such assets are either cash or
evidences of indebtedness which mature prior to or on the date of redemption or repurchase of preferred shares or payment of another
liability and are either U.S. government securities or evidences of indebtedness rated at least &#8220;Aaa,&#8221; &#8220;P-1&#8221;,
&#8220;VMIG-1&#8221; or &#8220;MIG-1&#8221; by Moody&#8217;s or &#8220;AAA&#8221;, &#8220;SP-1+&#8221; or &#8220;A-1+&#8221; by
S&amp;P and are held by the Fund for distributions, the redemption or repurchase of preferred shares or the Fund&#8217;s liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Fund does not cure in a timely manner a failure to maintain a discounted value of its portfolio equal to the Basic Maintenance
Amount in accordance with the requirements of any applicable rating agency or agencies then rating the preferred shares at the
request of the Fund, the Fund may, and in certain circumstances would be required to, mandatorily redeem preferred shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_z5z2vxb6A3x4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
rating agency providing a rating for the preferred shares, including the Series B Preferred Shares, at the request of the Fund
may, at any time, change or withdraw any such rating. The Board, without further action by the shareholders, may amend, alter,
add to or repeal certain of the definitions and related provisions of the applicable Statement of Preferences that have been adopted
by the Fund pursuant to the rating agency guidelines if the Board determines that such modification is necessary to prevent a
reduction in rating of the preferred shares, including the Series B Preferred Shares, by Moody&#8217;s or such other rating agency,
as the case may be, and any such amendment, alteration or repeal will be deemed not to affect the preferences, rights or powers
of the holders of preferred shares, provided that the Board shall have obtained confirmation from the rating agency that such
modification would not adversely affect its then current rating of the preferred shares, including the Series B Preferred Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described by Moody&#8217;s and Fitch, any ratings assigned to the preferred shares are assessments of the capacity and willingness
of the Fund to pay the obligations of each series of the preferred shares. Any ratings on the preferred shares are not recommendations
to purchase, hold or sell shares of any series, in as much as the ratings do not comment as to market price or suitability for
a particular investor. The rating agency guidelines also do not address the likelihood that an owner of preferred shares will
be able to sell such shares on an exchange, in an auction or otherwise. Any ratings would be based on current information furnished
to Moody&#8217;s and Fitch by the Fund and the Investment Adviser and information obtained from other sources. Any ratings may
be changed, suspended or withdrawn as a result of changes in, or the unavailability of, such information. The rating agency guidelines
would apply to the preferred shares, as the case may be, only so long as such rating agency is rating such shares at the request
of the Fund. The Fund expects that it would pay fees to Moody&#8217;s and Fitch for rating any preferred shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
rating agency guidelines will apply to the preferred shares, as the case may be, only so long as such rating agency is rating
such shares at the request of the Fund. The Fund will pay fees to the rating agencies for rating any series of the preferred shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Asset
Maintenance Requirements.</i> In addition to the requirements summarized under &#8220;&#8212;Rating Agency Guidelines&#8221; above,
the Fund must also satisfy asset maintenance requirements under the 1940 Act with respect to its preferred shares. Under the 1940
Act, such debt or preferred shares may be issued only if immediately after such issuance the value of the Fund&#8217;s total assets
(less ordinary course liabilities) is at least 300% of the amount of any debt outstanding and at least 200% of the amount of any
preferred stock and debt outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund will be required under the preferred shares&#8217; Statement of Preferences (the &#8220;Statement of Preferences&#8221;)
to determine whether it has, as of the last business day of each March, June, September and December of each year, an &#8220;asset
coverage&#8221; (as defined in the 1940 Act) of at least 200% (or such higher or lower percentage as may be required at the time
under the 1940 Act) with respect to all outstanding senior securities of the Fund that are debt or stock, including any outstanding
preferred shares. If the Fund fails to maintain the asset coverage required under the 1940 Act on such dates and such failure
is not cured within 60 calendar days, the Fund may, and in certain circumstances will be required to, mandatorily redeem the number
of preferred shares sufficient to satisfy such asset coverage. See &#8220;&#8212;Redemption&#8221; below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Distributions.
</i>Holders of any fixed rate preferred shares will be entitled to receive, when, as and if declared by the Board of Trustees,
out of funds legally available therefor, cumulative cash distributions, at an annual rate set forth in the applicable Prospectus
Supplement, payable with such frequency as set forth in the applicable Prospectus Supplement. Such distributions will accumulate
from the date on which such shares are issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zpKARao6cM68" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<ix:nonNumeric contextRef="From2024-04-152024-04-15_custom_PreferredStocksMember" escape="true" id="Fact000075" name="cef:PreferredStockRestrictionsOtherTextBlock"><p id="xdx_84A_ecef--PreferredStockRestrictionsOtherTextBlock_hus-gaap--StatementClassOfStockAxis__custom--PreferredStocksMember_dU_zvLNFVF0mmFc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restrictions
on Dividends and Other Distributions for the Preferred Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
long as any preferred shares are outstanding, the Fund may not pay any dividend or distribution (other than a dividend or distribution
paid in common shares or in options, warrants or rights to subscribe for or purchase common shares) in respect of the common shares
or call for redemption, redeem, purchase or otherwise acquire for consideration any common shares (except by conversion into or
exchange for shares of the Fund ranking junior to the preferred shares as to the payment of dividends and the distribution of
assets upon liquidation), unless:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Fund has declared
    and paid (or provided to the relevant dividend paying agent) all cumulative distributions on the Fund&#8217;s outstanding
    preferred shares due on or prior to the date of such common share dividend or distribution;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Fund has redeemed
    the full number of preferred shares to be redeemed pursuant to any mandatory redemption provision in the Fund&#8217;s Governing
    Documents; and</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">after making the
    distribution, the Fund meets applicable asset coverage requirements described under &#8220;&#8212;Rating Agency Guidelines&#8221;
    and &#8220;&#8212;Asset Maintenance Requirements.&#8221;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
complete distribution due for a particular dividend period will be declared or made on any series of the preferred shares for
any dividend period, or part thereof, unless full cumulative distributions due through the most recent dividend payment dates
therefor for all outstanding series of preferred shares of the Fund ranking on a parity with such series as to distributions have
been or contemporaneously are declared and made. If full cumulative distributions due have not been made on all outstanding preferred
shares of the Fund ranking on a parity with such series of preferred shares as to the payment of distributions, any distributions
being paid on the preferred shares will be paid as nearly pro rata as possible in proportion to the respective amounts of distributions
accumulated but unmade on each such series of preferred shares on the relevant dividend payment date. The Fund&#8217;s obligation
to make distributions on the preferred shares will be subordinate to its obligations to pay interest and principal, when due,
on any of the Fund&#8217;s senior securities representing debt.</span></p>

</ix:nonNumeric><p id="xdx_856_zWXSzbZxcbV4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redemption</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Mandatory
Redemption Relating to Asset Coverage Requirements.</i> The Fund may, at its option, consistent with its Governing Documents and
the 1940 Act, and in certain circumstances will be required to, mandatorily redeem preferred shares in the event that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Fund fails to
    maintain the asset coverage requirements specified under the 1940 Act on a quarterly valuation date (generally the last business
    day of March, June, September and December) and such failure is not cured on or before a stated period, following such failure
    (60 calendar days in the case of the Series B Preferred Shares); or</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Fund fails to
    maintain the asset coverage requirements as calculated in accordance with the applicable rating agency guidelines as of any
    monthly valuation date, and such failure is not cured on or before a stated period after such valuation date.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
redemption price for preferred shares subject to mandatory redemption will be the liquidation preference, as stated in the Prospectus
Supplement accompanying the issuance of such preferred shares, plus an amount equal to any accumulated but unpaid distributions
(whether or not earned or declared) to the date fixed for redemption, plus any applicable redemption premium determined by the
Board of Trustees and included in the Statement of Preferences.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zs8UVIAdfbr" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of preferred shares that will be redeemed in the case of a mandatory redemption will equal (and may, if the applicable
Statement of Preferences so provides, exceed) the minimum number of outstanding preferred shares, the redemption of which, if
such redemption had occurred immediately prior to the opening of business on the applicable cure date, would have resulted in
the relevant asset coverage requirement having been met or, if the required asset coverage cannot be so restored, all of the preferred
shares. In the event that preferred shares are redeemed due to a failure to satisfy the 1940 Act asset coverage requirements,
the Fund may, but is not required to, redeem a sufficient number of preferred shares so that the Fund&#8217;s assets exceed the
asset coverage requirements under the 1940 Act after the redemption by 10% (that is, 220% asset coverage) or some other amount
specified in the Statement of Preferences. In the event that preferred shares are redeemed due to a failure to satisfy applicable
rating agency guidelines, the Fund may, but is not required to, redeem a sufficient number of preferred shares so that the Fund&#8217;s
discounted portfolio value (as determined in accordance with the applicable rating agency guidelines) after redemption exceeds
the asset coverage requirements of each applicable rating agency by up to 10% (that is, 110% rating agency asset coverage) or
some other amount specified in the Statement of Preferences.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Fund does not have funds legally available for the redemption of, or is otherwise unable to redeem, all the preferred shares
to be redeemed on any redemption date, the Fund will redeem on such redemption date that number of shares for which it has legally
available funds, or is otherwise able to redeem, from the holders whose shares are to be redeemed ratably on the basis of the
redemption price of such shares, and the remainder of those shares to be redeemed will be redeemed on the earliest practicable
date on which the Fund will have funds legally available for the redemption of, or is otherwise able to redeem, such shares upon
written notice of redemption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
fewer than all of the Fund&#8217;s outstanding preferred shares are to be redeemed, the Fund, at its discretion and subject to
the limitations of its Governing Documents and the 1940 Act, will select the one or more series of preferred shares from which
shares will be redeemed and the amount of preferred shares to be redeemed from each such series. If less than all preferred shares
of a series are to be redeemed, such redemption will be made as among the holders of that series pro rata in accordance with the
respective number of shares of such series held by each such holder on the record date for such redemption (or by such other equitable
method as the Fund may determine). If fewer than all the preferred shares held by any holder are to be redeemed, the notice of
redemption mailed to such holder will specify the number of shares to be redeemed from such holder, which may be expressed as
a percentage of shares held on the applicable record date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Optional
Redemption of Fixed Rate Preferred Shares.</i> Fixed Rate Preferred Shares will not be subject to optional redemption by the Fund
until the date, if any, specified in the applicable Prospectus Supplement, unless such redemption is necessary, in the judgment
of the Fund, to maintain the Fund&#8217;s status as a RIC under the Code or as otherwise provided in the applicable Statement
of Preferences. Commencing on such date and thereafter, the Fund may at any time redeem such Fixed Rate Preferred Shares in whole
or in part for cash at a redemption price per share equal to the initial liquidation preference per share plus accumulated and
unpaid distributions (whether or not earned or declared) to the redemption date plus, if applicable, any redemption premium. Such
redemptions are subject to the notice requirements set forth under &#8220;&#8212;Redemption Procedures&#8221; and the limitations
of the Governing Documents and 1940 Act. The foregoing requirements may be modified in the case of any particular series of preferred
shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption
Procedures.</i> A notice of redemption with respect to an optional redemption will be given to the holders of record of fixed
rate preferred shares selected for redemption not less than 15 days (subject to NYSE American requirements) nor, more than 40
days prior to the date fixed for redemption. Preferred shareholders may receive shorter notice in the event of a mandatory redemption.
Each notice of redemption will state (i) the redemption date, (ii) the number or percentage of preferred shares to be redeemed
(which may be expressed as a percentage of such shares outstanding), (iii) the CUSIP number(s) of such shares, (iv) the redemption
price (specifying the amount of accumulated distributions to be included therein), (v) the place or places where such shares are
to be redeemed, (vi) that distributions on the shares to be redeemed will cease to accumulate on such redemption date, (vii) the
provision of the Statement of Preferences, as applicable, under which the redemption is being made and (viii) any conditions precedent
to such redemption. No defect in the notice of redemption or in the mailing thereof will affect the validity of the redemption
proceedings, except as required by applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_z4AYJzxeiPf9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of any preferred shares, whether subject to a variable or fixed rate, will not have the right to redeem any of their shares
at their option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-04-152024-04-15_custom_PreferredStocksMember" escape="true" id="Fact000079" name="cef:SecurityLiquidationRightsTextBlock"><p id="xdx_84D_ecef--SecurityLiquidationRightsTextBlock_hus-gaap--StatementClassOfStockAxis__custom--PreferredStocksMember_dU_zBGimj7jqjE" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation
Preference.</i> In the event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Fund,
the holders of preferred shares will be entitled to receive a preferential liquidating distribution, which is expected to equal
the original purchase price per preferred share plus accumulated and unpaid dividends, whether or not declared, before any distribution
of assets is made to holders of common shares. After payment of the full amount of the liquidating distribution to which they
are entitled, the holders of preferred shares will not be entitled to any further participation in any distribution of assets
by the Fund.</span></p>

</ix:nonNumeric><p id="xdx_855_ztVpl2lOdsK8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-04-152024-04-15_custom_PreferredStocksMember" escape="true" id="Fact000081" name="cef:SecurityVotingRightsTextBlock"><p id="xdx_84B_ecef--SecurityVotingRightsTextBlock_hus-gaap--StatementClassOfStockAxis__custom--PreferredStocksMember_dU_zW9tZD5HUJu9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting
Rights.</i> Except as otherwise stated in this Prospectus, specified in the Governing Documents or resolved by the Board or as
otherwise required by applicable law, holders of preferred shares shall be entitled to one vote per share held on each matter
submitted to a vote of the shareholders of the Fund and will vote together with holders of common shares and of any other preferred
shares then outstanding as a single class.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the election of the Fund&#8217;s Trustees, holders of the outstanding preferred shares, voting together as a single
class, will be entitled to elect two of the Fund&#8217;s Trustees, and the remaining Trustees will be elected by holders of common
shares and holders of preferred shares, voting together as a single class. In addition, if (i) at any time dividends and distributions
on outstanding preferred shares are unpaid in an amount equal to at least two full years&#8217; dividends and distributions thereon
and sufficient cash or specified securities have not been deposited with the applicable paying agent for the payment of such accumulated
dividends and distributions or (ii) at any time holders of any other series of preferred shares are entitled to elect a majority
of the Trustees of the Fund under the 1940 Act or the applicable Statement of Preferences creating such shares, then the number
of Trustees constituting the Board automatically will be increased by the smallest number that, when added to the two Trustees
elected exclusively by the holders of preferred shares as described above, would then constitute a simple majority of the Board
as so increased by such smallest number. Such additional Trustees will be elected by the holders of the outstanding preferred
shares, voting together as a single class, at a special meeting of shareholders which will be called as soon as practicable and
will be held not less than ten nor more than twenty days after the mailing date of the meeting notice. If the Fund fails to send
such meeting notice or to call such a special meeting, the meeting may be called by any preferred shareholder on like notice.
The terms of office of the persons who are Trustees at the time of that election will continue. If the Fund thereafter pays, or
declares and sets apart for payment in full, all dividends and distributions payable on all outstanding preferred shares for all
past dividend periods or the holders of other series of preferred shares are no longer entitled to elect such additional Trustees,
the additional voting rights of the holders of the preferred shares as described above will cease, and the terms of office of
all of the additional Trustees elected by the holders of the preferred shares (but not of the Trustees with respect to whose election
the holders of common shares were entitled to vote or the two Trustees the holders of preferred shares have the right to elect
as a separate class in any event) will terminate automatically.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
1940 Act requires that, in addition to any approval by shareholders that might otherwise be required, the approval of the holders
of a majority of any outstanding preferred shares (as defined in the 1940 Act), voting separately as a class, would be required
to (1) adopt any plan of reorganization that would adversely affect the preferred shares, and (2) take any action requiring a
vote of security holders under Section 13(a) of the 1940 Act, including, among other things, changes in the Fund&#8217;s classification
as a closed-end investment company or changes in its fundamental investment restrictions. As a result of these voting rights,
the Fund&#8217;s ability to take any such actions may be impeded to the extent that there are any preferred shares outstanding.
Additionally, the affirmative vote of the holders of a &#8220;majority of the outstanding&#8221; (as defined in the 1940 Act)
preferred shares of any series of the Fund&#8217;s preferred shares, voting separately from the holders of any other series of
the Fund&#8217;s preferred shares (to the extent its rights are affected differently), shall be required with respect to any matter
that materially and adversely affects the rights, preferences or powers of that series in a manner different from that of other
series or classes of the Fund&#8217;s shares. The affirmative vote of the holders of a &#8220;majority of the outstanding&#8221;
(as defined in the 1940 Act) preferred shares, voting separately as one class, shall be required to amend, alter or repeal the
provisions of  the Fund&#8217;s Agreement and Declaration of Trust or By-laws, whether by merger, consolidation or otherwise,
if such amendment, alteration or repeal would affect adversely the rights, preferences or powers expressly set forth in any statement
of preferences of the Fund&#8217;s preferred shares, unless, in each case, the Fund obtains written confirmation from any rating
agency then rating the preferred shares at the Fund&#8217;s request that such amendment, alteration or repeal would not impair
the rating then assigned by such rating agency to such preferred shares, in which case the vote or consent of the holders of the
preferred shares is not required. No matter shall be deemed to adversely affect any rights, preferences or powers of the preferred
shares unless such matter (i) adversely alters or abolishes any right or preference of such series; (ii) creates, adversely alters
or abolishes any right in respect of redemption of such series; or (iii) creates or adversely alters (other than to abolish) any
restriction on transfer applicable to such series. An increase in the number of authorized preferred shares of the Fund pursuant
to the Agreement and Declaration of Trust or the issuance of additional shares of any series of preferred shares of the Fund pursuant
to the Agreement and Declaration of Trust shall not in and of itself be considered to adversely affect the rights, preferences
or powers of a series of preferred shares. The class votes of holders of preferred shares described above will in each case be
in addition to any other vote required to authorize the action in question.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zbUGiWKLDJ7b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing voting provisions will not apply to any series of preferred shares if, at or prior to the time when the act with respect
to which such vote otherwise would be required will be effected, such shares will have been redeemed or called for redemption
and sufficient cash or cash equivalents provided to the applicable paying agent to effect such redemption. The holders of preferred
shares will have no preemptive rights or rights to cumulative voting.</span></p>

</ix:nonNumeric><p id="xdx_851_zNYbsrqLi0yk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Limitation
on Issuance of Preferred Shares.</i> So long as the Fund has preferred shares outstanding, subject to receipt of approval from
the rating agencies of each series of preferred shares outstanding, and subject to compliance with the Fund&#8217;s investment
objectives, policies and restrictions, the Fund may issue and sell shares of one or more other series of additional preferred
shares provided that the Fund will, immediately after giving effect to the issuance of such additional preferred shares and to
its receipt and application of the proceeds thereof (including, without limitation, to the redemption of preferred shares to be
redeemed out of such proceeds), have an &#8220;asset coverage&#8221; for all senior securities of the Fund which are stock, as
defined in the 1940 Act, of at least 200% of the sum of the liquidation preference of the preferred shares of the Fund then outstanding
and all indebtedness of the Fund constituting senior securities and no such additional preferred shares will have any preference
or priority over any other preferred shares of the Fund upon the distribution of the assets of the Fund or in respect of the payment
of dividends or distributions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund will consider from time to time whether to offer additional preferred shares or securities representing indebtedness and
may issue such additional securities if the Board concludes that such an offering would be consistent with the Fund&#8217;s Governing
Documents and applicable law, and in the best interest of existing common shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Book
Entry.</i> Fixed Rate Preferred Shares will initially be held in the name of Cede &amp; Co. as nominee for DTC. The Fund will
treat Cede &amp; Co. as the holder of record of preferred shares for all purposes. In accordance with the procedures of DTC, however,
purchasers of Fixed Rate Preferred Shares will be deemed the beneficial owners of stock purchased for purposes of dividends, voting
and liquidation rights.</span></p>

</ix:nonNumeric><p id="xdx_812_znWtvMijGfKb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a013"></span>ANTI-TAKEOVER
PROVISIONS OF THE FUND&#8217;S GOVERNING DOCUMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund presently has provisions in its Governing Documents which could have the effect of limiting, in each case, (i) the ability
of other entities or persons to acquire control of the Fund, (ii) the Fund&#8217;s freedom to engage in certain transactions or
(iii) the ability of the Fund&#8217;s Trustees or shareholders to amend the Governing Documents or effectuate changes in the Fund&#8217;s
management. These provisions of the Governing Documents of the Fund may be regarded as &#8220;anti-takeover&#8221; provisions.
The Board of Trustees of the Fund is divided into three classes, each having a term of no more than three years. Each year the
term of one class of Trustees will expire. Accordingly, only those Trustees in one class may be changed in any one year, and it
would require a minimum of two years to change a majority of the Board of Trustees. Such system of electing Trustees may have
the effect of maintaining the continuity of management and, thus, make it more difficult for the shareholders of the Fund to change
the majority of Trustees. A Trustee of the Fund may be removed with cause by a majority of the remaining Trustees and, without
cause, by two-thirds of the remaining Trustees or by no less than two-thirds of the aggregate number of votes entitled to be cast
for the election of such Trustee. Under the Fund&#8217;s By-Laws, advance notice to the Fund of any shareholder proposal is required,
potential nominees to the Board of Trustees must satisfy a series of requirements relating to, among other things, potential conflicts
of interest or relationships and fitness to be a Trustee of a closed-end fund in order to be nominated or elected as a Trustee
and any shareholder proposing the nomination or election of a person as a Trustee must supply significant amounts of information
designed to enable verification of whether such person satisfies such qualifications. Additionally, the Fund&#8217;s By-Laws provide
that, with respect to any election of Trustees in which the number of persons nominated for election as Trustees exceeds the number
of Trustees to be elected (i.e., a &#8220;contested election&#8221;), the affirmative vote of a majority of the shares outstanding
and entitled to vote for the election of Trustees at a meeting at which a quorum is present shall be required to elect such Trustees.
The Agreement and Declaration of Trust also requires any shareholder action by written consent to be unanimous. Special voting
requirements of 75% of the outstanding voting shares (in addition to any required class votes) apply to certain mergers or a sale
of all or substantially all of the Fund&#8217;s assets, liquidation, conversion of the Fund into an open-end fund or interval
fund and amendments to several provisions of the Agreement and Declaration of Trust, including the foregoing provisions. In addition,
80% of the holders of the outstanding voting securities of the Fund voting as a class is generally required in order to authorize
any of the following transactions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">merger or consolidation
    of the Fund with or into any other entity;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">issuance of any
    securities of the Fund to any person or entity for cash, other than pursuant to the Dividend and Reinvestment Plan or any
    offering if such person or entity acquires no greater percentage of the securities offered than the percentage beneficially
    owned by such person or entity immediately prior to such offering or, in the case of a class or series not then beneficially
    owned by such person or entity, the percentage of common shares beneficially owned by such person or entity immediately prior
    to such offering;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sale, lease or exchange
    of all or any substantial part of the assets of the Fund to any entity or person (except assets having an aggregate fair market
    value of less than $5,000,000);</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sale, lease or exchange
    to the Fund, in exchange for securities of the Fund, of any assets of any entity or person (except assets having an aggregate
    fair market value of less than $5,000,000); or</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the purchase of
    the Fund&#8217;s common shares by the Fund from any person or entity other than pursuant to a tender offer equally available
    to other shareholders in which such person or entity tenders no greater percentage of common shares than are tendered by all
    other shareholders; if such person or entity is directly, or indirectly through affiliates, the beneficial owner of more than
    5% of the outstanding shares of the Fund.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
such vote would not be required when, under certain conditions, the Board of Trustees approves the transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, shareholders have no authority to adopt, amend or repeal By-Laws. The Board of Trustees has authority to adopt, amend
and repeal By-Laws consistent with the Agreement and Declaration of Trust (including to require approval by the holders of a majority
of the outstanding shares for the election of Trustees). Reference is made to the Governing Documents of the Fund, on file with
the SEC, for the full text of these provisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provisions of the Governing Documents described above could have the effect of depriving the owners of shares in the Fund of opportunities
to sell their shares at a premium over prevailing market prices, by discouraging a third party from seeking to obtain control
of the Fund in a tender offer or similar transaction. The overall effect of these provisions is to render more difficult the accomplishment
of a merger or the assumption of control by a principal shareholder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing 75% and 80% voting requirements, which have been considered and determined to be in the best interests of shareholders
by the Trustees, are greater than the voting requirements imposed by the 1940 Act and applicable Delaware law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund is organized as a Delaware statutory trust and thus is subject to the control share acquisition statute contained in Subchapter
III of the Delaware Statutory Trust Act (the &#8220;DSTA Control Share Statute&#8221;). The DSTA Control Share Statute applies
to any closed-end investment company organized as a Delaware statutory trust and listed on a national securities exchange, such
as the Fund. The DSTA Control Share Statute became automatically applicable to the Fund on August 1, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
DSTA Control Share Statute defines &#8220;control beneficial interests&#8221; (referred to as &#8220;control shares&#8221; herein)
by reference to a series of voting power thresholds and provides that a holder of control shares acquired in a control share acquisition
has no voting rights under the Delaware Statutory Trust Act (&#8220;DSTA&#8221;) or the Fund&#8217;s Governing Documents (as used
herein, &#8220;Governing Documents&#8221; means the Fund&#8217;s Agreement and Declaration of Trust and By-Laws, together with
any amendments or supplements thereto, including any Statement of Preferences establishing a series of preferred shares) with
respect to the control shares acquired in the control share acquisition, except to the extent approved by the Fund&#8217;s shareholders
by the affirmative vote of two&#8211;thirds of all the votes entitled to be cast on the matter, excluding all interested shares
(generally, shares held by the acquiring person and their associates and shares held by Fund insiders).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
DSTA Control Share Statute provides for a series of voting power thresholds above which shares are considered control shares.
Whether one of these thresholds of voting power is met is determined by aggregating the holdings of the acquiring person as well
as those of his, her or its &#8220;associates.&#8221; These thresholds are:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10% or more, but
    less than 15% of all voting power;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15% or more, but
    less than 20% of all voting power;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20% or more, but
    less than 25% of all voting power;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25% or more, but
    less than 30% of all voting power;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30% or more, but
    less than a majority of all voting power; or</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a majority or more
    of all voting power.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the DSTA Control Share Statute, once a threshold is reached, an acquirer has no voting rights with respect to shares in excess
of that threshold (i.e., the &#8220;control shares&#8221;) until approved by a vote of shareholders, as described above, or otherwise
exempted by the Fund&#8217;s Board of Trustees. The DSTA Control Share Statute contains a statutory process for an acquiring person
to request a shareholder meeting for the purpose of considering the voting rights to be accorded control shares. An acquiring
person must repeat this process at each threshold level. The DSTA Control Share Statute effectively allows non-interested shareholders
to evaluate the intentions and plans of an acquiring person above each threshold level.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the DSTA Control Share Statute, an acquiring person&#8217;s &#8220;associates&#8221; are broadly defined to include, among others,
relatives of the acquiring person, anyone in a control relationship with the acquiring person, any investment fund or other collective
investment vehicle that has the same investment adviser as the acquiring person, any investment adviser of an acquiring person
that is an investment fund or other collective investment vehicle and any other person acting or intending to act jointly or in
concert with the acquiring person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting
power under the DSTA Control Share Statute is the power (whether such power is direct or indirect or through any contract, arrangement,
understanding, relationship or otherwise) to directly or indirectly exercise or direct the exercise of the voting power of shares
of the Fund in the election of the Fund&#8217;s Trustees (either generally or with respect to any subset, series or class of trustees,
including any Trustees elected solely by a particular series or class of shares, such as the preferred shares). Thus, Fund preferred
shares, including the Series B Preferred Shares, acquired in excess of the above thresholds would be considered control shares
with respect to the preferred share class vote for two Trustees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
control shares of the Fund acquired before August 1, 2022, are not subject to the DSTA Control Share Statute; however, any further
acquisitions on or after August 1, 2022, are considered control shares subject to the DSTA Control Share Statute.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
DSTA Control Share Statute requires shareholders to disclose to the Fund any control share acquisition within 10 days of such
acquisition, and also permits the Fund to require a shareholder or an associate of such person to disclose the number of shares
owned or with respect to which such person or an associate thereof can directly or indirectly exercise voting power. Further,
the DSTA Control Share Statute requires a shareholder or an associate of such person to provide to the Fund within 10 days of
receiving a request therefor from the Fund any information that the Fund&#8217;s Trustees reasonably believe is necessary or desirable
to determine whether a control share acquisition has occurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
DSTA Control Share Statute permits the Fund&#8217;s Board of Trustees, through a provision in the Fund&#8217;s Governing Documents
or by Board action alone, to eliminate the application of the DSTA Control Share Statute to the acquisition of control shares
in the Fund specifically, generally, or generally by types, as to specifically identified or unidentified existing or future beneficial
owners or their affiliates or associates or as to any series or classes of shares. The DSTA Control Share Statute does not provide
that the Fund can generally &#8220;opt out&#8221; of the application of the DSTA Control Share Statute; rather, specific acquisitions
or classes of acquisitions may be exempted by the Fund&#8217;s Board of Trustees, either in advance or retroactively, but other
aspects of the DSTA Control Share Statute, which are summarized above, would continue to apply. The DSTA Control Share Statute
further provides that the Board of Trustees is under no obligation to grant any such exemptions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Trustees has considered the DSTA Control Share Statute. As of the date hereof, the Board of Trustees has not received
notice of the occurrence of a control share acquisition nor has been requested to exempt any acquisition. Therefore, the Board
of Trustees has not determined whether the application of the DSTA Control Share Statute to an acquisition of Fund shares is in
the best interest of the Fund and its shareholders and has not exempted any acquisition or class of acquisitions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Board of Trustees receives a notice of a control share acquisition and/or a request to exempt any acquisition, it will consider
whether the application of the DSTA Control Share Statute or the granting of such an exemption would be in the best interest of
the Fund and its shareholders. The Fund should not be viewed as a vehicle for trading purposes. It is designed primarily for risk-tolerant
long-term investors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing is only a summary of the material terms of the DSTA Control Share Statute. Shareholders should consult their own counsel
with respect to the application of the DSTA Control Share Statute to any particular circumstance. Some uncertainty around the
general application under the 1940 Act of state control share statutes exists as a result of recent court decisions which have
held that control share acquisition provisions in funds&#8217; governing documents are not consistent with the 1940 Act. Additionally,
in some circumstances uncertainty may also exist in how to enforce the control share restrictions contained in state control share
statutes against beneficial owners who hold their shares through financial intermediaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ownership restrictions set forth in the Fund&#8217;s Governing Documents and the limitations of the DSTA Control Share Statute
described above could have the effect of depriving shareholders of an opportunity to sell their shares at a premium over prevailing
market prices by discouraging a third party from seeking to obtain control over the Fund and may reduce market demand for the
Fund&#8217;s common shares, which could have the effect of increasing the likelihood that the Fund&#8217;s common shares trade
at a discount to net asset value and increasing the amount of any such discount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Governing Documents of the Fund are on file with the SEC. For access to the full text of these provisions, see &#8220;Additional
Information.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a014"></span>CLOSED-END
FUND STRUCTURE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund is a non-diversified, closed-end management investment company (commonly referred to as a closed-end fund). Closed-end funds
differ from open-end funds (which are generally referred to as mutual funds) in that closed-end funds generally list their common
shares for trading on a stock exchange and do not redeem their common shares at the request of the shareholder. This means that
if you wish to sell your common shares of a closed-end fund you must trade them on the market like any other stock at the prevailing
market price at that time. In a mutual fund, if the shareholder wishes to sell shares of the fund, the mutual fund will redeem
or buy back the shares at &#8220;net asset value.&#8221; Also, mutual funds generally offer new shares on a continuous basis to
new investors, and closed-end funds generally do not. The continuous inflows and outflows of assets in a mutual fund can make
it difficult to manage the fund&#8217;s investments. By comparison, closed-end funds are generally able to stay more fully invested
in securities that are consistent with their investment objectives, to have greater flexibility to make certain types of investments
and to use certain investment strategies such as financial leverage and investments in illiquid securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
shares of closed-end funds often trade at a discount to their net asset value. Because of this possibility and the recognition
that any such discount may not be in the interest of shareholders, the Fund&#8217;s Board of Trustees might consider from time
to time engaging in open-market repurchases, tender offers for shares or other programs intended to reduce a discount. We cannot
guarantee or assure, however, that the Fund&#8217;s Board of Trustees will decide to engage in any of these actions. Nor is there
any guarantee or assurance that such actions, if undertaken, would result in the common shares trading at a price equal or close
to net asset value per share. We cannot assure you that the Fund&#8217;s common shares will not trade at a discount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a015"></span>REPURCHASE
OF COMMON SHARES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund is a non-diversified, closed-end management investment company and as such its shareholders do not, and will not, have the
right to require the Fund to repurchase their shares. The Fund, however, may repurchase its common shares from time to time as
and when it deems such a repurchase advisable. The Board of Trustees has authorized, but does not require, such repurchases to
be made when the Fund&#8217;s common shares are trading at a discount from net asset value of 7.5% or more (or such other percentage
as the Board of Trustees of the Fund may determine from time to time). This authorization is a standing authorization that may
be executed in the discretion of the Fund&#8217;s officers. The Fund&#8217;s officers are authorized to use the Fund&#8217;s general
corporate funds to repurchase common shares. The Fund generally intends to finance common share repurchases with cash on hand,
and while the Fund may incur debt to finance common share repurchases, such debt financing would require further approval of the
Board, and the Fund does not currently intend to incur debt to finance common share repurchases. The Fund has repurchased its
common shares under this authorization. See &#8220;Description of the Shares&#8212;Common Shares.&#8221; Although the Board of
Trustees has authorized such repurchases, the Fund is not required to repurchase its common shares, and the Fund&#8217;s officers,
in determining whether to repurchase Fund common shares pursuant to this authority, take into account a variety of market and
economic factors including, among other things, trading volume, the magnitude of discount, bid/ask spreads, the Fund&#8217;s available
cash position, leverage and expense ratios and any applicable legal or contractual restrictions on such repurchases that may be
applicable at the time. The Board of Trustees has not established a limit on the number of shares that could be purchased during
such period. Pursuant to the 1940 Act, the Fund may repurchase its common shares on a securities exchange (provided that the Fund
has informed its shareholders within the preceding six months of its intention to repurchase such shares) or pursuant to tenders
and may also repurchase shares privately if the Fund meets certain conditions regarding, among other things, distribution of net
income for the preceding fiscal year, status of the seller, price paid, brokerage commissions, prior notice to shareholders of
an intention to purchase shares and purchasing in a manner and on a basis that does not discriminate unfairly against the other
shareholders through their interest in the Fund. The Fund has not and will not, unless otherwise set forth in a Prospectus Supplement
and accomplished in accordance with applicable law and positions of the SEC&#8217;s staff, repurchase common shares (i) immediately
after the completion of an offering of common shares (i.e., within sixty days of an overallotment option period) or (ii) at a
price that is tied to the initial offering price. See &#8220;Plan of Distribution.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the Fund repurchases its common shares for a price below net asset value, the net asset value of the common shares that remain
outstanding shares will be enhanced, but this does not necessarily mean that the market price of the outstanding common shares
will be affected, either positively or negatively. The repurchase of common shares will reduce the total assets of the Fund available
for investment and may increase the Fund&#8217;s expense ratio.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a016"></span>NET
ASSET VALUE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained under the heading &#8220;Additional Fund Information&#8212;Net Asset Value&#8221; in the Fund&#8217;s Annual
Report is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a017"></span>LIMITATION
OF TRUSTEES&#8217; AND OFFICERS&#8217; LIABILITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Governing Documents provide that the Fund will indemnify its Trustees and officers and may indemnify its employees or agents against
liabilities and expenses incurred in connection with litigation in which they may be involved because of their positions with
the Fund, to the fullest extent permitted by applicable law. However, nothing in the Governing Documents protects or indemnifies
a Trustee, officer, employee or agent of the Fund against any liability to which such person would otherwise be subject in the
event of such person&#8217;s willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in
the conduct of his or her position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a018"></span>TAXATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion is a brief summary of certain U.S. federal income tax considerations affecting the Fund and the ownership
and disposition of the Fund&#8217;s common and preferred shares. A more complete discussion of the tax rules applicable to the
Fund and its shareholders can be found in the SAI that is incorporated by reference into this Prospectus. This discussion assumes
you are a taxable U.S. person (as defined for U.S. federal income tax purposes) and that you hold your shares as capital assets
(generally assets held for investment purposes). This discussion is based upon current provisions of the Code, the regulations
promulgated thereunder and judicial and administrative authorities, all of which are subject to change or differing interpretations
by the courts or the Internal Revenue Service (the &#8220;IRS&#8221;), possibly with retroactive effect. No ruling has been or
will be sought from the IRS regarding any matter discussed herein. No assurance can be given that the IRS would not assert, or
that a court would not sustain, a position contrary to those set forth below. No attempt is made to present a detailed explanation
of all U.S. federal tax concerns affecting the Fund and its shareholders (including shareholders owning large positions in the
Fund or shareholders who are subject to special rules under the Code), nor does this discussion address any state, local or foreign
tax concerns.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
discussion set forth herein does not constitute tax advice and potential investors are urged to consult their own tax advisers
to determine the tax consequences to them of investing in the Fund.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Taxation
of the Fund</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund has elected to be treated and has qualified, and intends to continue to qualify annually, as a RIC under Subchapter M of
the Code. Accordingly, the Fund must, among other things, meet the following requirements regarding the source of its income and
the diversification of its assets:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund must derive
    in each taxable year at least 90% of its gross income from the following sources, which are referred to herein as &#8220;Qualifying
    Income&#8221;: (a) dividends, interest (including tax-exempt interest), payments with respect to certain securities loans,
    and gains from the sale or other disposition of stock, securities or foreign currencies, or other income (including but not
    limited to gain from options, futures and forward contracts) derived with respect to its business of investing in such stock,
    securities or foreign currencies; and (b) net income derived from interests in publicly traded partnerships that are treated
    as partnerships for U.S. federal income tax purposes and that derive less than 90% of their gross income from the items described
    in clause (a) above (each a &#8220;Qualified Publicly Traded Partnership&#8221;).</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund must diversify
    its holdings so that, at the end of each quarter of each taxable year (a) at least 50% of the market value of the Fund&#8217;s
    total assets is represented by cash and cash items (including receivables), U.S. government securities, the securities of
    other regulated investment companies and other securities, with such other securities limited, in respect of any one issuer,
    to an amount not greater than 5% of the value of the Fund&#8217;s total assets and not more than 10% of the outstanding voting
    securities of such issuer and (b) not more than 25% of the market value of the Fund&#8217;s total assets is invested in the
    securities of (I) any one issuer (other than U.S. government securities and the securities of other regulated investment companies),
    (II) any two or more issuers (other than regulated investment companies) that the Fund controls and that are determined to
    be engaged in the same business or similar or related trades or businesses or (III) any one or more Qualified Publicly Traded
    Partnerships.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
from the Fund&#8217;s investments in grantor trusts and equity interests of MLPs that are not Qualified Publicly Traded Partnerships
(if any) will be Qualifying Income only to the extent it is attributable to items of income of such trust or MLP that would be
Qualifying Income if earned directly by the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
in general the passive loss rules of the Code do not apply to regulated investment companies, such rules do apply to a RIC with
respect to items attributable to an interest in a Qualified Publicly Traded Partnership. The Fund&#8217;s investments in partnerships,
including in Qualified Publicly Traded Partnerships, may result in the Fund being subject to state, local or foreign income, franchise
or withholding tax liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a RIC, the Fund generally will not be subject to U.S. federal income tax on income and gains that the Fund distributes to its
shareholders, provided that it distributes each taxable year at least the sum of (i) 90% of the Fund&#8217;s investment company
taxable income (which includes, among other items, dividends, interest and the excess of any net short term capital gain over
net long term capital loss and other taxable income (other than any net capital gain, which is the excess of net long term capital
gain over net short term capital loss) reduced by deductible expenses) determined without regard to the deduction for dividends
paid and (ii) 90% of the Fund&#8217;s net tax-exempt interest income (the excess of its gross tax-exempt interest over certain
disallowed deductions). The Fund intends to distribute substantially all of such income at least annually. The Fund will be subject
to income tax at regular corporate rates on any taxable income or gains that it does not distribute to its shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Code imposes a 4% nondeductible federal excise tax on the Fund to the extent the Fund does not distribute by the end of any calendar
year an amount at least equal to the sum of (i) 98% of its ordinary income (not taking into account any capital gain or loss)
for the calendar year, (ii) 98.2% of its capital gain in excess of its capital loss (adjusted for certain ordinary losses) for
a one-year period generally ending on October 31 of the calendar year (unless an election is made to use the Fund&#8217;s fiscal
year), and (iii) certain undistributed amounts from previous years on which the Fund paid no U.S. federal income tax. In addition,
the minimum amounts that must be distributed in any year to avoid the federal excise tax will be increased or decreased to reflect
any under-distribution or over-distribution, as the case may be, from the previous year. While the Fund intends to distribute
any income and capital gain in the manner necessary to minimize imposition of the 4% federal excise tax, there can be no assurance
that sufficient amounts of the Fund&#8217;s taxable income and capital gain will be distributed to entirely avoid the imposition
of the federal excise tax. In that event, the Fund will be liable for the federal excise tax only on the amount by which it does
not meet the foregoing distribution requirement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
for any taxable year the Fund does not qualify as a RIC, all of its taxable income (including its net capital gain) will be subject
to tax at regular corporate rates without any deduction for distributions to shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Taxation
of Shareholders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund expects to take the position that under present law any preferred shares that it issues will constitute equity rather than
debt of the Fund for U.S. federal income tax purposes. It is possible, however, that the IRS could take a contrary position asserting,
for example, that such preferred shares constitute debt of the Fund. If that position were upheld, distributions on the Fund&#8217;s
preferred shares would be considered interest, taxable as ordinary income regardless of the taxable income of the Fund, and other
adverse consequences could result for the Fund or shareholders. The following discussion and the discussion in the SAI assume
that any preferred shares issued by the Fund will be treated as equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions
paid to you by the Fund from its net capital gain, if any, that the Fund reports as capital gains dividends (&#8220;capital gain
dividends&#8221;) are taxable at rates applicable to long term capital gain, regardless of how long you have held your shares.
All other dividends paid to you by the Fund (including dividends from short term capital gains) from its current or accumulated
earnings and profits (&#8220;ordinary income dividends&#8221;) are generally subject to tax as ordinary income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
distributions you receive that are in excess of the Fund&#8217;s current or accumulated earnings and profits will be treated as
a tax-free return of capital to the extent of your adjusted tax basis in your shares, and thereafter as capital gain from the
sale of your shares. The amount of any Fund distribution that is treated as a tax-free return of capital will reduce your adjusted
tax basis in your shares, thereby increasing your potential gain or reducing your potential loss on any subsequent sale or other
disposition of your shares. In determining the extent to which a distribution will be treated as being made from the Fund&#8217;s
earnings and profits, earnings and profits will be allocated on a pro rata basis first to distributions with respect to the Fund&#8217;s
preferred shares, and then to the Fund&#8217;s common shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
and other taxable distributions are taxable to you even though they are reinvested in additional shares of the Fund. Dividends
and other distributions paid by the Fund are generally treated under the Code as received by you at the time the dividend or distribution
is made. If, however, the Fund pays you a dividend in January that was declared in the previous October, November or December
and you were the shareholder of record on a specified date in one of such months, then such dividend will be treated for tax purposes
as being paid by the Fund and received by you on December 31 of the year in which the dividend was declared.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund will send you information after the end of each year setting forth the amount and tax status of any distributions paid to
you by the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as discussed in the SAI with respect to redemptions and repurchases, the sale or other disposition of shares of the Fund will
generally result in capital gain or loss to you, and will be long-term capital gain or loss if you have held such shares for more
than one year at the time of sale. Any loss upon the sale or exchange of shares held for six months or less will be treated as
long term capital loss to the extent of any capital gain dividends received (including amounts credited as an undistributed capital
gain dividend) by you with respect to such shares. Any loss you realize on a sale or exchange of shares will be disallowed if
you acquire other shares (whether through the automatic reinvestment of dividends or otherwise) within a 61-day period beginning
30 days before and ending 30 days after your sale or exchange of the shares. In such a case, your tax basis in the shares acquired
will be adjusted to reflect the disallowed loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund may be required to withhold, for U.S. federal backup withholding tax purposes, a portion of the dividends, distributions
and redemption proceeds payable to shareholders who fail to provide the Fund (or its agent) with their correct taxpayer identification
number (in the case of individuals, generally, their social security number) or to make required certifications, or who have been
notified by the IRS that they are subject to backup withholding. Certain shareholders are exempt from backup withholding. Backup
withholding is not an additional tax and any amount withheld may be refunded or credited against your U.S. federal income tax
liability, if any, provided that you timely furnish the required information to the IRS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a019"></span>CUSTODIAN,
TRANSFER AGENT AND DIVIDEND DISBURSING AGENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Bank of New York Mellon, located at 240 Greenwich Street, New York, NY 10286, serves as the Custodian of the Fund&#8217;s assets
pursuant to a custody agreement. Under the custody agreement, the Custodian holds the Fund&#8217;s assets in compliance with the
1940 Act. For its services, the Custodian will receive a monthly fee paid by the Fund based upon, among other things, the average
value of the total assets of the Fund, plus certain charges for securities transactions and out-of-pocket expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">American
Stock Transfer, located at 6201 15th Avenue, Brooklyn, New York 11219, serves as the Fund&#8217;s dividend disbursing agent, as
agent under the Fund&#8217;s Plan and as transfer agent and registrar for the common shares of the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a020"></span>PLAN
OF DISTRIBUTION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may sell the shares, being offered hereby in one or more of the following ways from time to time:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to underwriters
    or dealers for resale to the public or to institutional investors;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">directly to institutional
    investors;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">directly to a limited
    number of purchasers or to a single purchaser;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">through agents to
    the public or to institutional investors; or</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">through a combination
    of any of these methods of sale.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Prospectus Supplement with respect to each series of securities will state the terms of the offering of the securities, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the offering terms,
    including the name or names of any underwriters, dealers or agents;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the purchase price
    of the securities and the net proceeds to be received by us from the sale;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any underwriting
    discounts or agency fees and other items constituting underwriters&#8217; or agents&#8217; compensation, which compensation
    for any sale will in no event exceed 8% of the sales price;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any initial public
    offering price;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any discounts or
    concessions allowed or reallowed or paid to dealers; and</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any securities exchange
    on which the securities may be listed.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we use underwriters or dealers in the sale, the securities will be acquired by the underwriters or dealers for their own account
and may be resold from time to time in one or more transactions, including;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">negotiated transactions;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at a fixed public
    offering price or prices, which may be changed;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at market prices
    prevailing at the time of sale;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at prices related
    to prevailing market prices; or</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at negotiated prices.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
initial public offering price and any discounts or concessions allowed or reallowed or paid to dealers may be changed from time
to time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
underwriters are used in the sale of any securities, the securities may be either offered to the public through underwriting syndicates
represented by managing underwriters, or directly by underwriters. Generally, the underwriters&#8217; obligations to purchase
the securities will be subject to certain conditions precedent. The underwriters will be obligated to purchase all of the securities
if they purchase any of the securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
indicated in an applicable Prospectus Supplement, we may sell the securities through agents from time to time. The applicable
Prospectus Supplement will name any agent involved in the offer or sale of the securities and any commissions we pay to them.
In compliance with the guidelines of the Financial Industry Regulatory Authority, Inc., the maximum compensation to any agent
in connection with the sale of our securities pursuant to this Prospectus and any accompanying Prospectus Supplement may not exceed
8% of the aggregate offering price of the securities as set forth on the cover page of the supplement to this Prospectus. Generally,
any agent will be acting on a best efforts basis for the period of its appointment. We may authorize underwriters, dealers or
agents to solicit offers by certain purchasers to purchase the securities from us at the public offering price set forth in the
applicable Prospectus Supplement pursuant to delayed delivery contracts providing for payment and delivery on a specified date
in the future. The delayed delivery contracts will be subject only to those conditions set forth in the applicable Prospectus
Supplement, and the applicable Prospectus Supplement will set forth any commissions we pay for solicitation of these delayed delivery
contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offered
securities may also be offered and sold, if so indicated in the applicable Prospectus Supplement, in connection with a remarketing
upon their purchase, in accordance with a redemption or repayment pursuant to their terms, or otherwise, by one or more remarketing
firms, acting as principals for their own accounts or as agents for us. Any remarketing firm will be identified and the terms
of its agreements, if any, with us and its compensation will be described in the applicable Prospectus Supplement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agents,
underwriters and other third parties described above may be entitled to indemnification by us against certain civil liabilities
under the Securities Act, or to contribution with respect to payments which the agents or underwriters may be required to make
in respect thereof. Agents, underwriters and such other third parties may be customers of, engage in transactions with, or perform
services for us in the ordinary course of business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
series of securities will be a new issue of securities and will have no established trading market other than our common shares
and Preferred Shares, which are listed on the NYSE American. Any common shares sold will be listed on NYSE American, upon official
notice of issuance. The securities, other than the common shares, may or may not be listed on a national securities exchange.
Any underwriters to whom securities are sold by us for public offering and sale may make a market in the securities, but such
underwriters will not be obligated to do so and may discontinue any market making at any time without notice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a021"></span>LEGAL
MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
legal matters will be passed on by Skadden, Arps, Slate, Meagher &amp; Flom LLP, Boston, Massachusetts, counsel to the Fund in
connection with the offering of the Fund&#8217;s shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a022"></span>INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PricewaterhouseCoopers
LLP serves as the independent registered public accounting firm of the Fund, audits the financial statements of the Fund and provides
tax return preparation services in connection with the Fund. PricewaterhouseCoopers LLP is located at 300 Madison Avenue, New
York, New York 10017.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="gg2a023"></span>ADDITIONAL
INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund is subject to the informational requirements of the Securities Exchange Act of 1934, as amended, and the 1940 Act, and in
accordance therewith files reports and other information with the SEC. Reports, proxy statements and other information filed by
the Fund with the SEC pursuant to the informational requirements of such Acts can be inspected and copied at the public reference
facilities maintained by the SEC, 100 F Street, N.E., Washington, D.C. 20549. The SEC maintains a web site at http://www.sec.gov
containing reports, proxy and information statements and other information regarding registrants, including the Fund, that file
electronically with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
common shares are listed on the NYSE American under the symbol &#8220;GGN.&#8221; The Preferred Shares are listed on the NYSE
American under the symbol &#8220;GGN PrB.&#8221; Reports, proxy statements and other information concerning the Fund and filed
with the SEC by the Fund will be available for inspection at the NYSE American, 11 Wall Street, New York, New York, 10005.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Prospectus constitutes part of a Registration Statement filed by the Fund with the SEC under the Securities Act and the 1940 Act.
This Prospectus omits certain of the information contained in the Registration Statement, and reference is hereby made to the
Registration Statement and related exhibits for further information with respect to the Fund and the shares offered hereby. Any
statements contained herein concerning the provisions of any document are not necessarily complete, and, in each instance, reference
is made to the copy of such document filed as an exhibit to the Registration Statement or otherwise filed with the SEC. Each such
statement is qualified in its entirety by such reference. The complete Registration Statement may be obtained from the SEC upon
payment of the fee prescribed by its rules and regulations or free of charge through the SEC&#8217;s web site (http://www.sec.gov).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a024"></span>INCORPORATION
BY REFERENCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Prospectus is part of a registration statement that we have filed with the SEC. We are allowed to &#8220;incorporate by reference&#8221;
the information that we file with the SEC, which means that we can disclose important information to you by referring you to those
documents. We incorporate by reference into this Prospectus the documents listed below and any future filings we make with the
SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, including any filings on or after the date of this Prospectus
from the date of filing (excluding any information furnished, rather than filed), until we have sold all of the offered securities
to which this Prospectus and any accompanying prospectus supplement relates or the offering is otherwise terminated. The information
incorporated by reference is an important part of this Prospectus. Any statement in a document incorporated by reference into
this Prospectus will be deemed to be automatically modified or superseded to the extent a statement contained in (1) this Prospectus
or (2) any other subsequently filed document that is incorporated by reference into this Prospectus modifies or supersedes such
statement. The documents incorporated by reference herein include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1313510/000182912624001451/ggn_ncsr.htm">our annual report on Form N-CSR for the fiscal year ended December 31, 2023, filed with the SEC on March 8, 2024 (the &#8220;Annual Report&#8221;);</a></span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1313510/000113322823001751/ggn-html6182_def14a.htm">our definitive proxy statement on Schedule 14A for our 2023 annual meeting of shareholders, filed with the SEC on April 5, 2023 (the &#8220;Proxy Statement&#8221;);</a></span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1313510/000119312513202359/d533150d8a12b.htm">the
    description of our Series B Preferred Shares contained in our Registration Statement on Form 8-A (File No. 001-32464) filed
    with the SEC on May 7, 2013, including any amendment or report filed for the purpose of updating such description prior to
    the termination of the offering registered hereby;</a></span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1313510/000112528205001546/b405605_8a12b.txt">the
    description of our common shares contained in our Registration Statement on Form 8-A (File No. 001-32464) filed with the SEC
    on March 24, 2005, including any amendment or report filed for the purpose of updating such description prior to the termination
    of the offering registered hereby; and</a></span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1313510/000182912624001451/ggn_ncsr.htm">the
    report of PricewaterhouseCoopers LLP included in our annual report on Form N-CSR for the fiscal year ended December 31, 2023.</a></span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
obtain copies of these filings, see &#8220;Additional Information&#8221; in this Prospectus. We will also provide without charge
to each person, including any beneficial owner, to whom this Prospectus is delivered, upon written or oral request, a copy of
any and all of the documents that have been or may be incorporated by reference in this Prospectus or the accompanying Prospectus
Supplement. You should direct requests for documents by writing to: Investor Relations</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GAMCO
Global Gold, Natural Resources &amp; Income Trust<br/>
One Corporate Center<br/>
Rye, NY 10580-1422<br/>
(914) 921-5070</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Prospectus is also available on our website at http://www.gabelli.com. Information contained on our website is not incorporated
by reference into this prospectus supplement or the accompanying prospectus and should not be considered to be part of this prospectus
supplement or accompanying prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a028"></span>PRIVACY
PRINCIPLES OF THE FUND</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund is committed to maintaining the privacy of its shareholders and to safeguarding their non-public personal information. The
following information is provided to help you understand what personal information the Fund collects, how the Fund protects that
information and why, in certain cases, the Fund may share information with select other parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
the Fund does not receive any non-public personal information relating to its shareholders, although certain non-public personal
information of its shareholders may become available to the Fund. The Fund does not disclose any non-public personal information
about its shareholders or former shareholders to anyone, except as permitted by law or as is necessary in order to service shareholder
accounts (for example, to a transfer agent or third party administrator).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund restricts access to non-public personal information about its shareholders to employees of the Fund, the Investment Adviser,
and its affiliates with a legitimate business need for the information. The Fund maintains physical, electronic and procedural
safeguards designed to protect the non-public personal information of its shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a025"></span>SPECIAL
NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
projections, forecasts and estimates contained or incorporated by reference herein are forward looking statements and are based
upon certain assumptions. Projections, forecasts and estimates are necessarily speculative in nature, and it can be expected that
some or all of the assumptions underlying any projections, forecasts or estimates will not materialize or will vary significantly
from actual results. Actual results may vary from any projections, forecasts and estimates and the variations may be material.
Some important factors that could cause actual results to differ materially from those in any forward looking statements include
changes in interest rates, market, financial or legal uncertainties, including changes in tax law, and the timing and frequency
of defaults on underlying investments. Consequently, the inclusion of any projections, forecasts and estimates herein should not
be regarded as a representation by the Fund or any of its affiliates or any other person or entity of the results that will actually
be achieved by the Fund. Neither the Fund nor its affiliates has any obligation to update or otherwise revise any projections,
forecasts and estimates including any revisions to reflect changes in economic conditions or other circumstances arising after
the date hereof or to reflect the occurrence of unanticipated events, even if the underlying assumptions do not come to fruition.
The Fund acknowledges that, notwithstanding the foregoing, the safe harbor for forward-looking statements under the Private Securities
Litigation Reform Act of 1995 does not apply to investment companies such as the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="a026"></span><span id="gg2a026"></span>TABLE
OF CONTENTS OF STATEMENT OF ADDITIONAL INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
SAI dated as of , 2024 has been filed with the SEC and is incorporated by reference in this Prospectus. An SAI may be obtained
without charge by writing to the Fund at its address at One Corporate Center, Rye, New York 10580-1422 or by calling the Fund
toll-free at (800) GABELLI (422-3554).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Table of Contents of the SAI is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-bottom: 1pt; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 91%; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2b001">THE FUND</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2b002">INVESTMENT OBJECTIVES AND POLICIES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2b003">INVESTMENT RESTRICTIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2b004">MANAGEMENT OF THE FUND</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2b005">DIVIDENDS AND DISTRIBUTIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2b006">PORTFOLIO TRANSACTIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2b007">PORTFOLIO TURNOVER</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2b008">TAXATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2b009">BENEFICIAL OWNERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#gg2b010">GENERAL INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">No
dealer, sales person or other person has been authorized to give any information or to make any representations in connection
with this offering other than those contained in this Prospectus in connection with the offer contained herein, and, if given
or made, such other information or representations must not be relied upon as having been authorized by the Fund, the Investment
Adviser or the underwriters. Neither the delivery of this Prospectus nor any sale made hereunder will, under any circumstances,
create any implication that there has been no change in the affairs of the Fund since the date hereof or that the information
contained herein is correct as of any time subsequent to its date. This Prospectus does not constitute an offer to sell or a solicitation
of an offer to buy any securities other than the securities to which it relates. This Prospectus does not constitute an offer
to sell or the solicitation of an offer to buy such securities in any circumstance in which such an offer or solicitation is unlawful.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 48; Options: NewSection; Value: 43 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->





<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Appendix
A</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a027"></span>CORPORATE
BOND RATINGS</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MOODY&#8217;S
INVESTORS SERVICE, INC.</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 90px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aaa</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obligations rated
    Aaa are judged to be of the highest quality, subject to the lowest level of credit risk.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aa</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obligations rated
    Aa are judged to be of high quality and are subject to very low credit risk.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obligations rated
    A are judged to be upper-medium grade and are subject to low credit risk.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Baa</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obligations rated
    Baa are judged to be medium-grade and subject to moderate credit risk and as such may possess certain speculative characteristics.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ba</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obligations rated
    Ba are judged to be speculative and are subject to substantial credit risk.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obligations rated
    B are considered speculative and are subject to high credit risk.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Caa</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obligations rated
    Caa are judged to be speculative of poor standing and are subject to very high credit risk.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ca</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obligations rated
    Ca are highly speculative and are likely in, or very near, default, with some prospect of recovery of principal and interest.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obligations rated
    C are the lowest rated and are typically in default, with little prospect for recovery of principal or interest.</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>S&amp;P
GLOBAL RATINGS</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 90px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AAA</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An obligation rated
    &#8216;AAA&#8217; has the highest rating assigned by S&amp;P Global Ratings. The obligor&#8217;s capacity to meet its financial
    commitments on the obligation is extremely strong.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AA</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An obligation rated
    &#8216;AA&#8217; differs from the highest-rated obligations only to a small degree. The obligor&#8217;s capacity to meet its
    financial commitments on the obligation is very strong.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An obligation rated
    &#8216;A&#8217; is somewhat more susceptible to the adverse effects of changes in circumstances and economic conditions than
    obligations in higher-rated categories. However, the obligor&#8217;s capacity to meet its financial commitments on the obligation
    is still strong.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BBB</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An obligation rated
    &#8216;BBB&#8217; exhibits adequate protection parameters. However, adverse economic conditions or changing circumstances
    are more likely to weaken the obligor&#8217;s capacity to meet its financial commitments on the obligation.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BB;
B;&#160;</span></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CCC;
CC; <br/>
and C&#160;</span></p></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obligations rated
    &#8216;BB&#8217;, &#8216;B&#8217;, &#8216;CCC&#8217;, &#8216;CC&#8217;, and &#8216;C&#8217; are regarded as having significant
    speculative characteristics. &#8216;BB&#8217; indicates the least degree of speculation and &#8216;C&#8217; the highest. While
    such obligations will likely have some quality and protective characteristics, these may be outweighed by large uncertainties
    or major exposure to adverse conditions.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BB</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An obligation rated
    &#8216;BB&#8217; is less vulnerable to nonpayment than other speculative issues. However, it faces major ongoing uncertainties
    or exposure to adverse business, financial, or economic conditions that could lead to the obligor&#8217;s inadequate capacity
    to meet its financial commitments on the obligation.</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 90px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An obligation rated
    &#8216;B&#8217; is more vulnerable to nonpayment than obligations rated &#8216;BB&#8217;, but the obligor currently has the
    capacity to meet its financial commitments on the obligation. Adverse business, financial, or economic conditions will likely
    impair the obligor&#8217;s capacity or willingness to meet its financial commitments on the obligation.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CCC</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An obligation rated
    &#8216;CCC&#8217; is currently vulnerable to nonpayment and is dependent upon favorable business, financial, and economic
    conditions for the obligor to meet its financial commitments on the obligation. In the event of adverse business, financial,
    or economic conditions, the obligor is not likely to have the capacity to meet its financial commitments on the obligation.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CC</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An obligation rated
    &#8216;CC&#8217; is currently highly vulnerable to nonpayment. The &#8216;CC&#8217; rating is used when a default has not
    yet occurred but S&amp;P Global Ratings expects default to be a virtual certainty, regardless of the anticipated time to default.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An obligation rated
    &#8216;C&#8217; is currently highly vulnerable to nonpayment, and the obligation is expected to have lower relative seniority
    or lower ultimate recovery compared with obligations that are rated higher.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An obligation rated
    &#8216;D&#8217; is in default or in breach of an imputed promise. For non-hybrid capital instruments, the &#8216;D&#8217;
    rating category is used when payments on an obligation are not made on the date due, unless S&amp;P Global Ratings believes
    that such payments will be made within five business days in the absence of a stated grace period or within the earlier of
    the stated grace period or 30 calendar days. The &#8216;D&#8217; rating also will be used upon the filing of a bankruptcy
    petition or the taking of similar action and where default on an obligation is a virtual certainty, for example due to automatic
    stay provisions. A rating on an obligation is lowered to &#8216;D&#8217; if it is subject to a distressed debt restructuring.</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 1px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 30px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ratings from &#8216;AA&#8217;
    to &#8216;CCC&#8217; may be modified by the addition of a plus (+) or minus (-) sign to show relative standing within the
    rating categories.</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GAMCO
Global Gold, Natural Resources &amp; Income Trust</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Shares</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred
Shares</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROSPECTUS</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
2024</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 3; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subject
to Completion, Dated April 15, 2024</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GAMCO
Global Gold, Natural Resources &amp; Income Trust</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>STATEMENT
OF ADDITIONAL INFORMATION</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
INFORMATION IN THIS STATEMENT OF ADDITIONAL INFORMATION IS NOT COMPLETE AND MAY BE CHANGED. THE FUND MAY NOT SELL THESE SECURITIES
UNTIL THE REGISTRATION STATEMENT FILED WITH THE SECURITIES AND EXCHANGE COMMISSION IS EFFECTIVE. THIS STATEMENT OF ADDITIONAL
INFORMATION IS NOT AN OFFER TO SELL THESE SECURITIES AND IT IS NOT SOLICITING AN OFFER TO BUY THESE SECURITIES IN ANY STATE WHERE
THE OFFER OR SALE IS NOT PERMITTED.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
GAMCO Global Gold, Natural Resources &amp; Income Trust, or the &#8220;Fund,&#8221; is a non-diversified, closed-end management
investment company registered under the Investment Company Act of 1940, as amended (the &#8220;1940 Act&#8221;). The Fund commenced
investment operations on March&#160;31, 2005. Gabelli Funds, LLC (the &#8220;Investment Adviser&#8221;) serves as Investment Adviser
to the Fund.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Statement of Additional Information (the &#8220;SAI&#8221;) does not constitute a prospectus, but should be read in conjunction
with the Fund&#8217;s prospectus relating thereto dated&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2024, and as it may be supplemented.
This SAI does not include all information that a prospective investor should consider before investing in the Fund&#8217;s common
shares, and investors should obtain and read the Fund&#8217;s prospectus prior to purchasing such shares. This SAI incorporates
by reference the entire Prospectus. You may request a free copy of the Prospectus by calling (800) GABELLI (422-3554) or by writing
to the Fund. A copy of the Fund&#8217;s Registration Statement, including the Prospectus and any supplement, may be obtained from
the Securities and Exchange Commission (the &#8220;SEC&#8221;) upon payment of the fee prescribed, or inspected at the SEC&#8217;s
office or via its website (www.sec.gov) at no charge. Capitalized terms used but not defined in this SAI have the meanings ascribed
to them in the Prospectus.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Statement of Additional Information is dated&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2024.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr>
    <td style="vertical-align: top; padding-bottom: 1pt; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; width: 91%; padding-left: 9pt; text-indent: -9pt"><a href="#gg2c001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE FUND</span></a></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><a href="#gg2c002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INVESTMENT OBJECTIVES AND POLICIES</span></a></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><a href="#gg2c003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INVESTMENT RESTRICTIONS</span></a></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><a href="#gg2c004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MANAGEMENT OF THE FUND</span></a></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><a href="#gg2c005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIVIDENDS AND DISTRIBUTIONS</span></a></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><a href="#gg2c006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PORTFOLIO TRANSACTIONS</span></a></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><a href="#gg2c007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PORTFOLIO TURNOVER</span></a></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><a href="#gg2c008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TAXATION</span></a></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><a href="#gg2c009"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BENEFICIAL OWNERS</span></a></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><a href="#gg2c010"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GENERAL INFORMATION</span></a></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">- <!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2b001"></span><span id="gg2c001"></span>THE
FUND</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
GAMCO Global Gold, Natural Resources &amp; Income Trust is a non-diversified, closed-end management investment company organized
under the laws of the State of Delaware. The Fund&#8217;s common shares of beneficial interest, par value $0.001 per share, are
listed on the NYSE American LLC (the &#8220;NYSE American&#8221;) under the symbol &#8220;GGN.&#8221; Our 5.00% Series B Cumulative
Preferred Shares (&#8220;Series B Preferred&#8221;) are listed on the NYSE American under the symbol &#8220;GGN PrB.&#8221;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2c002"></span><span id="gg2b002"></span>INVESTMENT
OBJECTIVES AND POLICIES</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained under the heading &#8220;Additional Fund Information&#8212;Risk Factors and Special Considerations&#8212;Additional
Investment Policies&#8221; in the Fund&#8217;s Annual Report is incorporated herein by reference.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2b003"></span><span id="gg2c003"></span>INVESTMENT
RESTRICTIONS</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained under the heading &#8220;Additional Fund Information&#8212;Investment Restrictions&#8221; in the Fund&#8217;s
Annual Report is incorporated herein by reference.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2c004"></span><span id="gg2b004"></span>MANAGEMENT
OF THE FUND</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained under the heading &#8220;Proposal: To Elect Four (4) Trustees of the Fund&#8212;Information about the Trustees
and Officers&#8221; in the Fund&#8217;s Proxy Statement is incorporated herein by reference.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Indemnification
of Officers and Trustees; Limitations on Liability</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Agreement and Declaration of Trust of the Fund provides that the Fund will indemnify its Trustees and officers and may indemnify
its employees or agents against liabilities and expenses incurred in connection with litigation in which they may be involved
because of their positions with the Fund to the fullest extent permitted by applicable law. However, nothing in the Agreement
and Declaration of Trust of the Fund protects or indemnifies a Trustee, officer, employee or agent of the Fund against any liability
to which such person would otherwise be subject in the event of such person&#8217;s willful misfeasance, bad faith, gross negligence
or reckless disregard of the duties involved in the conduct of his or her position.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment
Advisory and Administrative Arrangements</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investment Adviser is a New York limited liability company which serves as an investment adviser to registered investment companies
as well as one fund that trades on the London Stock Exchange and Luxembourg SICAV, with combined aggregate net assets of approximately
$20.3 billion as of December&#160;31, 2023. The Investment Adviser is a registered adviser under the Investment Advisers Act of
1940, as amended, and is a wholly owned subsidiary of GBL. Mr.&#160;Mario J. Gabelli may be deemed a &#8220;controlling person&#8221;
of the Investment Adviser on the basis of his controlling interest in GBL. Mr.&#160;Gabelli owns a majority of the stock of GGCP,
which holds a majority of the capital stock and voting power of GBL. The Investment Adviser has several affiliates that provide
investment advisory services: GAMCO Asset Management Inc., a wholly owned subsidiary of GBL, acts as investment adviser for individuals,
pension trusts, profit sharing trusts, and endowments, and as a sub-adviser to certain third party investment funds, which include
registered investment companies having assets under management of approximately $10.7 billion as of December&#160;31, 2023; Teton
Advisors, Inc., and its wholly owned investment adviser, Keeley Teton Advisers, LLC, with assets under management of approximately
$1.3 billion as of September&#160;30, 2023, acts as investment adviser to The TETON Westwood Funds, the KEELEY Funds, and separately
managed accounts; and Gabelli &amp; Company Investment Advisers, Inc. (formerly, Gabelli Securities, Inc.), a wholly owned subsidiary
of Associated Capital, acts as investment adviser for certain alternative investment products, consisting primarily of risk arbitrage
and merchant banking limited partnerships and offshore companies, with assets under management of approximately $1.6 billion as
of December&#160;31, 2023. Teton Advisors, Inc. was spun off by GBL in March&#160;2009 and is an affiliate of GBL by virtue of
Mr.&#160;Gabelli&#8217;s ownership of GGCP, the principal shareholder of Teton Advisors, Inc. as of December&#160;31, 2023. Associated
Capital was spun off from GBL on November&#160;30, 2015, and is an affiliate of GBL by virtue of Mr.&#160;Gabelli&#8217;s ownership
of GGCP, the principal shareholder of Associated Capital.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Affiliates
of the Investment Adviser may, in the ordinary course of their business, acquire for their own account or for the accounts of
their investment advisory clients, significant (and possibly controlling) positions in the securities of companies that may also
be suitable for investment by the Fund. The securities in which the Fund might invest may thereby be limited to some extent. For
instance, many companies in the past several years have adopted so-called &#8220;poison pill&#8221; or other defensive measures
designed to discourage or prevent the completion of non-negotiated offers for control of the company. Such defensive measures
may have the effect of limiting the shares of the company which might otherwise be acquired by the Fund if the affiliates of the
Investment Adviser or their investment advisory accounts have or acquire a significant position in the same securities. However,
the Investment Adviser does not believe that the investment activities of its affiliates will have a material adverse effect upon
the Fund in seeking to achieve its investment objectives. Securities purchased or sold pursuant to contemporaneous orders entered
on behalf of the investment company accounts of the Investment Adviser or the investment advisory accounts managed by its affiliates
for their unaffiliated clients are allocated pursuant to procedures, approved by the Board of Trustees, believed to be fair and
not disadvantageous to any such accounts. In addition, all such orders are accorded priority of execution over orders entered
on behalf of accounts in which the Investment Adviser or its affiliates have a substantial pecuniary interest. The Investment
Adviser may on occasion give advice or take action with respect to other clients that differs from the actions taken with respect
to the Fund. The Fund may invest in the securities of companies that are investment management clients of GAMCO Asset Management
Inc. In addition, portfolio companies or their officers or directors may be minority shareholders of the Investment Adviser or
its affiliates.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the Investment Advisory Agreement, the Investment Adviser manages the portfolio of the Fund in accordance with its
stated investment objectives and policies, makes investment decisions for the Fund, places orders to purchase and sell securities
on behalf of the Fund and manages its other business and affairs, all subject to the supervision and direction of the Fund&#8217;s
Board of Trustees. In addition, under the Investment Advisory Agreement, the Investment Adviser oversees the administration of
all aspects of the Fund&#8217;s business and affairs and provides, or arranges for others to provide, at the Investment Adviser&#8217;s
expense, certain enumerated services, including maintaining the Fund&#8217;s books and records, preparing reports to the Fund&#8217;s
shareholders and supervising the calculation of the net asset value of the Fund&#8217;s shares. Expenses of computing the net
asset value of the Fund, including any equipment or services obtained solely for the purpose of pricing shares or valuing its
investment portfolio, underwriting compensation and reimbursements in connection with sales of its securities, the costs of utilizing
a third party to monitor and collect class action settlements on behalf of the Fund, compensation to an administrator for certain
SEC filings on behalf of the Fund, the fees and expenses of Trustees who are not officers or employees of the Investment Adviser
of its affiliates, compensation and other expenses of employees of the Fund as approved by the Trustees, the pro rata costs of
the Fund&#8217;s Chief Compliance Officer, charges of the custodian, any sub-custodian and transfer agent and dividend paying
agent, expenses in connection with the Automatic Dividend Reinvestment and Voluntary Cash Purchase Plan, accounting and pricing
costs, membership fees in trade associations, expenses for legal and independent accountants&#8217; services, costs of printing
proxies, share certificates and shareholder reports, fidelity bond coverage for Fund officers and employees, Trustee and officers&#8217;
errors and omissions insurance coverage, and stock exchange listing fees will be an expense of the Fund unless the Investment
Adviser voluntarily assumes responsibility for such expenses.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investment Advisory Agreement combines investment advisory and certain administrative responsibilities into one agreement. For
services rendered by the Investment Adviser on behalf of the Fund under the Fund&#8217;s Investment Advisory Agreement, the Fund
pays the Investment Adviser a fee computed weekly and paid monthly at the annual rate of 1.00% of the average weekly net assets
of the Fund. The Fund&#8217;s average weekly net assets will be deemed to be the average weekly value of the Fund&#8217;s total
assets minus the sum of the Fund&#8217;s liabilities (such liabilities exclude the aggregate liquidation preference of outstanding
preferred shares and accumulated dividends, if any, on those shares and the outstanding principal amount of any debt securities
the proceeds of which were used for investment purposes, plus accrued and unpaid interest thereon). For purposes of the calculation
of the fees payable to the Investment Adviser by the Fund, average weekly net assets of the Fund are determined at the end of
each month on the basis of its average net assets for each week during the month. The assets for each weekly period are determined
by averaging the net assets at the end of a week with the net assets at the end of the prior week.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Investment Advisory Agreement, for the fiscal years ended December&#160;31, 2021, 2022 and 2023, the Investment Adviser
earned $6,968,768, $6,746,062 and $6,881,876, respectively, for advisory and administrative services rendered to the Fund.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the Investment Adviser has entered into a sub-administration agreement (the &#8220;Sub-Administration Agreement&#8221;) with BNY
Mellon Investment Servicing (US) Inc. (the &#8220;Sub-Administrator&#8221;) pursuant to which the Sub-Administrator provides certain
administrative services necessary for the Fund&#8217;s operations which do not include the investment and portfolio management
services provided by the Investment Adviser. For these services and the related expenses borne by the Sub-Administrator, the Investment
Adviser pays a prorated monthly fee at the annual rate of 0.0275% of the first $10 billion of the aggregate average net assets
of the Fund and all other funds advised by the Investment Adviser and Teton Advisors, Inc. and administered by the Sub-Administrator,
0.0125% of the aggregate average net assets exceeding $10 billion but less than $15 billion, 0.01% of the aggregate average net
assets in excess of $15 billion and 0.008% of the aggregate average net assets in excess of $20 billion.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investment Advisory Agreement provides that, in the absence of willful misfeasance, bad faith, gross negligence or reckless disregard
for its obligations and duties thereunder, the Investment Adviser is not liable for any error of judgment or mistake of law or
for any loss suffered by the Fund. As part of the Investment Advisory Agreement, the Fund has agreed that the name &#8220;Gabelli&#8221;
is the Investment Adviser&#8217;s property, and that in the event the Investment Adviser ceases to act as an investment adviser
to the Fund, the Fund will change its name to one not including &#8220;Gabelli.&#8221;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to its terms, the Investment Advisory Agreement will remain in effect with respect to the Fund from year to year if approved annually
(i) by the Fund&#8217;s Board of Trustees or by the holders of a majority of its outstanding voting securities and (ii) by a majority
of the Trustees who are not &#8220;interested persons&#8221; (as defined in the 1940 Act) of any party to the Investment Advisory
Agreement, by vote cast in person at a meeting called for the purpose of voting on such approval.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investment Advisory Agreement was most recently approved by a majority of the Fund&#8217;s Board of Trustees, including a majority
of the Trustees who are not interested persons as that term is defined in the 1940 Act, at an in person meeting of the Board of
Trustees held on February&#160;15, 2023. A discussion regarding the basis for the most recent approval of the Investment Advisory
Agreement by the Board is available in the Fund&#8217;s semiannual report to shareholders for the period ending June&#160;30,
2023.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investment Advisory Agreement terminates automatically on its assignment and may be terminated without penalty on 60 days&#8217;
written notice at the option of either party thereto or by a vote of a majority (as defined in the 1940 Act) of the Fund&#8217;s
outstanding voting securities.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Portfolio
Holdings Information</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees
of the Investment Adviser and its affiliates will often have access to information concerning the portfolio holdings of the Fund.
The Fund and the Investment Adviser have adopted policies and procedures that require all employees to safeguard proprietary information
of the Fund, which includes information relating to the Fund&#8217;s portfolio holdings as well as portfolio trading activity
of the Investment Adviser with respect to the Fund (collectively, &#8220;Portfolio Holdings Information&#8221;). In addition,
the Fund and the Investment Adviser have adopted policies and procedures providing that Portfolio Holdings Information may not
be disclosed except to the extent that it is (a) made available to the general public by posting on the Fund&#8217;s website or
filed as part of a required filing on Form N-PORT or N-CSR or (b) provided to a third party for legitimate business purposes or
regulatory purposes, that has agreed to keep such data confidential under terms approved by the Investment Adviser&#8217;s legal
department or outside counsel, as described below. The Investment Adviser will examine each situation under (b) with a view to
determine that release of the information is in the best interest of the Fund and their shareholders and, if a potential conflict
between the Investment Adviser&#8217;s interests and the Fund&#8217;s interests arises, to have such conflict resolved by the
Chief Compliance Officer or those Trustees who are not considered to be &#8220;interested persons&#8221;, as defined in the 1940
Act. These policies further provide that no officer of the Fund or employee of the Investment Adviser shall communicate with the
media about the Fund without obtaining the advance consent of the Chief Executive Officer, Chief Operating Officer, or General
Counsel of the Investment Adviser.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the foregoing policies, the Fund currently may disclose Portfolio Holdings Information in the circumstances outlined below. Disclosure
generally may be either on a monthly or quarterly basis with no time lag in some cases and with a time lag of up to 60 days in
other cases (with the exception of proxy voting services which require a regular download of data):</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To regulatory authorities
    in response to requests for such information and with the approval of the Chief Compliance Officer of the Fund;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To mutual fund rating
    and statistical agencies and to persons performing similar functions where there is a legitimate business purpose for such
    disclosure and such entity has agreed to keep such data confidential until at least it has been made public by the Investment
    Adviser;</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To service providers
    of the Fund, as necessary for the performance of their services to the Fund and to the Board of Trustees, where such entity
    has agreed to keep such data confidential until at least it has been made public by the Investment Adviser. The Fund&#8217;s
    current service providers that may receive such information are its administrator, sub-administrator, custodian, independent
    registered public accounting firm, legal counsel, and financial printers;</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To firms providing
    proxy voting and other proxy services provided such entity has agreed to keep such data confidential until at least it has
    been made public by the Investment Adviser;</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To certain broker
    dealers, investment advisers, and other financial intermediaries for purposes of their performing due diligence on the Fund
    and not for dissemination of this information to their clients or use of this information to conduct trading for their clients.
    Disclosure of Portfolio Holdings Information in these circumstances requires the broker, dealer, investment adviser, or financial
    intermediary to agree to keep such information confidential until it has been made public by the Investment Adviser and is
    further subject to prior approval of the Chief Compliance Officer of the Fund and shall be reported to the Board of Trustees
    at the next quarterly meeting; and</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To consultants for
    purposes of performing analysis of the Fund, which analysis may be used by the consultant with its clients or disseminated
    to the public, provided that such entity shall have agreed to keep such information confidential until at least it has been
    made public by the Investment Adviser.</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this SAI, the Fund makes information about portfolio securities available to its administrator, sub-administrator,
custodian, and proxy voting services on a daily basis, with no time lag, to its typesetter on a quarterly basis with a ten day
time lag, to its financial printers on a quarterly basis with a forty-five day time lag, and its independent registered public
accounting firm and legal counsel on an as needed basis with no time lag. The names of the Fund&#8217;s administrator, custodian,
independent registered public accounting firm, and legal counsel are set forth in this SAI. The Fund&#8217;s proxy voting service
is Broadridge Financial Solutions, Inc. Donnelley Financial Solutions and Appatura provide typesetting services for the Fund and
the Fund selects from a number of financial printers who have agreed to keep such information confidential until at least it has
been made public by the Investment Adviser. Other than those arrangements with the Fund&#8217;s service providers and proxy voting
service, the Fund has no ongoing arrangements to make available information about the Fund&#8217;s portfolio securities prior
to such information being disclosed in a publicly available filing with the SEC that is required to include the information.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosures
made pursuant to a confidentiality agreement are subject to periodic confirmation by the Chief Compliance Officer of the Fund
that the recipient has utilized such information solely in accordance with the terms of the agreement. Neither the Fund, nor the
Investment Adviser, nor any of the Investment Adviser&#8217;s affiliates will accept on behalf of itself, its affiliates, or the
Fund any compensation or other consideration in connection with the disclosure of portfolio holdings of the Fund. The Board of
Trustees will review such arrangements annually with the Fund&#8217;s Chief Compliance Officer.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2b005"></span><span id="gg2c005"></span>DIVIDENDS
AND DISTRIBUTIONS</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund is subject to Section&#160;19(b) of the 1940 Act and Rule&#160;19b-1 thereunder which restricts the ability of the Fund to
make distributions of long term capital gains.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent the Fund&#8217;s total distributions for a year exceed its net investment company taxable income (interest, dividends
and net short term capital gains in excess of expenses) and net realized long term capital gains for that year, the excess would
generally constitute a tax-free return of capital up to the amount of a shareholder&#8217;s tax basis in the common shares. Any
distributions which (based upon the Fund&#8217;s full year performance) constitute a tax-free return of capital would reduce a
shareholder&#8217;s tax basis in the common shares, thereby increasing such shareholder&#8217;s potential gain or reducing his
or her potential loss on the sale of the common shares. The Fund has capital loss carryforwards from prior years, which may cause
a portion of the Fund&#8217;s distributions to be recharacterized as a return of capital. Any such amounts distributed to a shareholder
in excess of the basis in the common shares would generally be taxable to the shareholder as capital gain. See &#8220;Taxation.&#8221;
Distribution notices provided by the Fund to its shareholders will clearly indicate what portion of each distribution would constitute
net income, net capital gains, and return of capital based on information available to the Fund for the relevant period at the
time the distribution is declared. The final determination of the source of such distributions for federal income tax purposes
will be made shortly after year end based on the Fund&#8217;s actual net investment company taxable income and net capital gain
for that year and would be communicated to shareholders promptly. In the event that the Fund distributes amounts in excess of
its investment company taxable income and net capital gain, such distributions will decrease the Fund&#8217;s total assets and,
therefore, have the likely effect of increasing the Fund&#8217;s expense ratio, as the Fund&#8217;s fixed expenses will become
a larger percentage of the Fund&#8217;s average net assets. In addition, in order to make such distributions, the Fund may have
to sell a portion of its investment portfolio at a time when independent investment judgment may not dictate such action. These
effects would have a negative impact on the prices investors receive when they sell shares of the Fund.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2c006"></span><span id="gg2b006"></span>PORTFOLIO
TRANSACTIONS</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to policies established by the Board of Trustees of the Fund, the Investment Adviser is responsible for placing purchase and sale
orders and the allocation of brokerage on behalf of the Fund. Transactions in equity securities are in most cases effected on
U.S. stock exchanges and involve the payment of negotiated brokerage commissions. There may be no stated commission in the case
of securities traded in OTC markets, but the prices of those securities may include undisclosed commissions or mark-ups. Principal
transactions are not entered into with affiliates of the Fund. However, G.research, may execute transactions in the OTC markets
on an agency basis and receive a stated commission therefrom. To the extent consistent with applicable provisions of the 1940
Act and the rules and exemptions adopted by the SEC thereunder, as well as other regulatory requirements, the Fund&#8217;s Board
of Trustees has determined that portfolio transactions may be executed through G.research, and its broker-dealer affiliates if,
in the judgment of the Investment Adviser, the use of those broker-dealers is likely to result in price and execution at least
as favorable as those of other qualified broker-dealers, and if, in particular transactions, the affiliated broker-dealers charge
the Fund a rate consistent with that charged to comparable unaffiliated customers in similar transactions and comparable to rates
charged by other broker-dealers for similar transactions. The Fund has no obligations to deal with any broker or group of brokers
in executing transactions in portfolio securities. In executing transactions, the Investment Adviser seeks to obtain the best
price and execution for the Fund, taking into account such factors as price, size of order, difficulty of execution and operational
facilities of the firm involved and the firm&#8217;s risk in positioning a block of securities. While the Investment Adviser generally
seeks reasonably competitive commission rates, the Fund does not necessarily pay the lowest commission available.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the fiscal years ended December&#160;31, 2021, December&#160;31, 2022 and December&#160;31, 2023, the Fund paid aggregate brokerage
commissions of $1,387,193, $981,833 and $933,314, respectively, of which G.research received $0, $0 and $0, respectively.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to obtaining the best price and execution, brokers who provide supplemental research, market and statistical information, or other
services (e.g., wire services) to the Investment Adviser or its affiliates may receive orders for transactions by the Fund. The
term &#8220;research, market and statistical information&#8221; includes advice as to the value of securities, and advisability
of investing in, purchasing or selling securities, and the availability of securities or purchasers or sellers of securities,
and furnishing analyses and reports concerning issues, industries, securities, economic factors and trends, portfolio strategy
and the performance of accounts. Information so received will be in addition to and not in lieu of the services required to be
performed by the Investment Adviser under the Investment Advisory Agreement and the expenses of the Investment Adviser will not
necessarily be reduced as a result of the receipt of such supplemental information. Such information may be useful to the Investment
Adviser and its affiliates in providing services to clients other than the Fund, and not all such information is used by the Investment
Adviser in connection with the Fund. Conversely, such information provided to the Investment Adviser and its affiliates by brokers
and dealers through whom other clients of the Investment Adviser and its affiliates effect securities transactions may be useful
to the Investment Adviser in providing services to the Fund.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
investment decisions for the Fund are made independently from those for the other accounts managed by the Investment Adviser and
its affiliates, investments of the kind made by the Fund may also be made for those other accounts. When the same securities are
purchased for or sold by the Fund and any of such other accounts, it is the policy of the Investment Adviser and its affiliates
to allocate such purchases and sales in a manner deemed fair and equitable over time to all of the accounts, including the Fund.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2b007"></span><span id="gg2c007"></span>PORTFOLIO
TURNOVER</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained under the heading &#8220;Additional Fund Information&#8212;Investment Objective and Policies&#8212;Portfolio
Turnover&#8221; in the Fund&#8217;s Annual Report is incorporated herein by reference.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2c008"></span><span id="gg2b008"></span>TAXATION</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion is a brief summary of certain U.S. federal income tax considerations affecting the Fund and the ownership
and disposition of the Fund&#8217;s common and preferred shares. Except as otherwise provided below, this discussion assumes you
are a taxable U.S. person (as defined for U.S. federal income tax purposes) and that you hold your shares as capital assets. This
discussion is based upon current provisions of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), the regulations
promulgated thereunder and judicial and administrative authorities, all of which are subject to change or differing interpretations
by the courts or the Internal Revenue Service (the &#8220;IRS&#8221;), possibly with retroactive effect. No ruling has been or
will be sought from the IRS regarding any matter discussed herein. No assurance can be given that the IRS would not assert, or
that a court would not sustain, a position contrary to those set forth below. No attempt is made to present a detailed explanation
of all U.S. federal tax concerns affecting the Fund and its shareholders (including shareholders owning large positions in the
Fund or shareholders who are subject to special rules under the Code), nor does this discussion address any state, local or foreign
tax concerns.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
discussions set forth herein and in the prospectus do not constitute tax advice and potential investors are urged to consult their
own tax advisers to determine the tax consequences to them of investing in the Fund.</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Taxation
of the Fund</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund has elected to be treated and has qualified, and intends to continue to qualify annually, as a RIC under Subchapter M of
the Code. Accordingly, the Fund must, among other things, meet the following requirements regarding the source of its income and
the diversification of its assets:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund must derive
    in each taxable year at least 90% of its gross income from the following sources, which are referred to herein as &#8220;Qualifying
    Income&#8221;: (a) dividends, interest (including tax-exempt interest), payments with respect to certain securities loans,
    and gains from the sale or other disposition of stock, securities or foreign currencies, or other income (including but not
    limited to gain from options, futures and forward contracts) derived with respect to its business of investing in such stock,
    securities or foreign currencies; and (b) net income derived from interests in publicly traded partnerships that are treated
    as partnerships for U.S. federal income tax purposes and that derive less than 90% of their gross income from the items described
    in clause (a) above (each a &#8220;Qualified Publicly Traded Partnership&#8221;).</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund must diversify
    its holdings so that, at the end of each quarter of each taxable year (a) at least 50% of the market value of the Fund&#8217;s
    total assets is represented by cash and cash items (including receivables), U.S. government securities, the securities of
    other regulated investment companies and other securities, with such other securities limited, in respect of any one issuer,
    to an amount not greater than 5% of the value of the Fund&#8217;s total assets and not more than 10% of the outstanding voting
    securities of such issuer and (b) not more than 25% of the market value of the Fund&#8217;s total assets is invested in the
    securities of (I) any one issuer (other than U.S. government securities and the securities of other regulated investment companies),
    (II) any two or more issuers (other than regulated investment companies) that the Fund controls and that are determined to
    be engaged in the same business or similar or related trades or businesses or (III) any one or more Qualified Publicly Traded
    Partnerships.</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
from the Fund&#8217;s investments in grantor trusts and equity interests of MLPs that are not Qualified Publicly Traded Partnerships
(if any) will be Qualifying Income only to the extent it is attributable to items of income of such trust or MLP that would be
Qualifying Income if earned directly by the Fund.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
in general the passive loss rules of the Code do not apply to regulated investment companies, such rules do apply to a RIC with
respect to items attributable to an interest in a Qualified Publicly Traded Partnership. The Fund&#8217;s investments in partnerships,
including in Qualified Publicly Traded Partnerships, may result in the Fund being subject to state, local or foreign income, franchise
or withholding tax liabilities.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a RIC, the Fund generally will not be subject to U.S. federal income tax on income and gains that the Fund distributes to its
shareholders, provided that it distributes each taxable year at least the sum of (i) 90% of the Fund&#8217;s investment company
taxable income (which includes, among other items, dividends, interest and the excess of any net short term capital gain over
net long term capital loss and other taxable income, other than any net capital gain (which is the excess of net long term capital
gain over net short term capital gain), reduced by deductible expenses) determined without regard to the deduction for dividends
paid and (ii) 90% of the Fund&#8217;s net tax-exempt interest income (the excess of its gross tax-exempt interest over certain
disallowed deductions). The Fund intends to distribute substantially all of such income at least annually. The Fund will be subject
to income tax at regular corporate rates on any taxable income or gains that it does not distribute to its shareholders.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Code imposes a 4% nondeductible federal excise tax on the Fund to the extent the Fund does not distribute by the end of any calendar
year an amount at least equal to the sum of (i) 98% of its ordinary income (not taking into account any capital gain or loss)
for the calendar year, (ii) 98.2% of its capital gain in excess of its capital loss (adjusted for certain ordinary losses) for
a one year period generally ending on October&#160;31 of the calendar year (unless an election is made to use the Fund&#8217;s
fiscal year), and (iii) certain undistributed amounts from previous years on which the Fund paid no U.S. federal income tax. In
addition, the minimum amounts that must be distributed in any year to avoid the federal excise tax will be increased or decreased
to reflect any under-distribution or over-distribution, as the case may be, from the previous year. While the Fund intends to
distribute any income and capital gain in the manner necessary to minimize imposition of the 4% federal excise tax, there can
be no assurance that sufficient amounts of the Fund&#8217;s taxable income and capital gain will be distributed to entirely avoid
the imposition of the federal excise tax. In that event, the Fund will be liable for the federal excise tax only on the amount
by which it does not meet the foregoing distribution requirement.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
distribution will be treated as paid during the calendar year if it is paid during the calendar year or declared by the Fund in
October, November or December of the year, payable to shareholders of record on a date during such a month and paid by the Fund
during January of the following year. Any such distributions paid during January of the following year will be deemed to be received
by the Fund&#8217;s shareholders on December&#160;31 of the year the distributions are declared, rather than when the distributions
are actually received.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
for any taxable year the Fund does not qualify as a RIC, all of its taxable income (including its net capital gain) will be subject
to tax at regular corporate rates without any deduction for distributions to shareholders, and such distributions will be taxable
to the shareholders as ordinary dividends to the extent of the Fund&#8217;s current or accumulated earnings and profits. Provided
that certain holding period and other requirements are met, such dividends, however, would be eligible (i) to be treated as qualified
dividend income in the case of shareholders taxed as individuals and (ii) for the dividends received deduction in the case of
corporate shareholders. The Fund could be required to recognize unrealized gains, pay taxes and make distributions (which could
be subject to interest charges) before requalifying for taxation as a RIC. If the Fund fails to qualify as a RIC in any year,
it must pay out its earnings and profits accumulated in that year in order to qualify again as a RIC. If the Fund failed to qualify
as a RIC for a period greater than two taxable years, the Fund may be required to elect to recognize and pay tax on any net built-in
gains with respect to certain of its assets (i.e., the excess of the aggregate gains, including items of income, over aggregate
losses that would have been realized with respect to such assets if the Fund had been liquidated) or, alternatively, to elect
to be subject to taxation on such built-in gain recognized for a period of five years, in order to qualify as a RIC in a subsequent
year. The remainder of this discussion assumes that the Fund qualifies for taxation as a RIC.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
of the Fund&#8217;s investment practices are subject to special and complex U.S. federal income tax provisions that may, among
other things, (i) disallow, suspend or otherwise limit the allowance of certain losses or deductions, (ii) convert lower taxed
long term capital gains and qualified dividend income into higher taxed short term capital gains or ordinary income, (iii) convert
ordinary loss or a deduction into capital loss (the deductibility of which is more limited), (iv) cause the Fund to recognize
income or gain without a corresponding receipt of cash, (v) adversely affect the time as to when a purchase or sale of stock or
securities is deemed to occur, (vi) adversely alter the characterization of certain complex financial transactions and (vii) produce
income that will not qualify as good income for purposes of the 90% annual gross income requirement described above. These U.S.
federal income tax provisions could therefore affect the amount, timing and character of distributions to shareholders. The Fund
will monitor its transactions and may make certain tax elections and may be required to borrow money or dispose of securities
to mitigate the effect of these rules and prevent disqualification of the Fund as a RIC.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
MLPs in which the Fund intends to invest are expected to be treated as partnerships for U.S. federal income tax purposes. The
cash distributions received by the Fund from an MLP may not correspond to the amount of income allocated to the Fund by the MLP
in any given taxable year. If the amount of income allocated by an MLP to the Fund exceeds the amount of cash received by the
Fund from such MLP, the Fund may have difficulty making distributions to its shareholders in the amounts necessary to satisfy
the requirements for maintaining its status as a RIC or avoiding U.S. federal income or excise taxes. Accordingly, the Fund may
have to dispose of securities under disadvantageous circumstances in order to generate sufficient cash to satisfy the distribution
requirements.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund expects that the income derived by the Fund from the MLPs in which it invests will be Qualifying Income. If, however, a partnership
in which the Fund invests is not a Qualified Publicly Traded Partnership, the income derived by the Fund from such investment
may not be Qualifying Income and, therefore, could adversely affect the Fund&#8217;s status as a RIC. The Fund intends to monitor
its investments in MLPs and other partnerships to prevent the disqualification of the Fund as a RIC.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
U.S. tax classification of the Canadian Royalty Trusts in which the Fund invests and the types of income that the Fund receives
may have an impact on the Fund&#8217;s ability to qualify as a RIC. In particular, securities issued by certain Canadian Royalty
Trusts (such as Canadian Royalty Trusts which are grantor trusts for U.S. federal income tax purposes) may not produce &#8220;qualified&#8221;
income for purposes of determining the Fund&#8217;s compliance with the tax rules applicable to RICs. Additionally, the Fund may
be deemed to directly own the assets of each Canadian Royalty Trust, and would need to look to such assets when determining the
Fund&#8217;s compliance with the asset diversification rules applicable to regulated investment companies. To the extent that
the Fund holds such securities indirectly through investments in a taxable subsidiary formed by the Fund, those securities may
produce &#8220;qualified&#8221; income. However, the net return to the Fund on such investments would be reduced to the extent
that the subsidiary is subject to corporate income taxes. The Fund intends to monitor its investments in the Canadian Royalty
Trusts with the objective of maintaining its continued qualification as a RIC.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gain
or loss on the sales of securities by the Fund will generally be long-term capital gain or loss if the securities have been held
by the Fund for more than one year. Gain or loss on the sale of securities held for one year or less will be short term capital
gain or loss.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
premium received by the Fund for writing a call option is not included in income at the time of receipt. If the option expires,
the premium is short term capital gain to the Fund. If the Fund enters into a closing transaction, the difference between the
amount paid to close out its position and the premium received is short term capital gain or loss. If a call option written by
the Fund is exercised, thereby requiring the Fund to sell the underlying security, the premium will increase the amount realized
upon the sale of the security and any resulting gain or loss will be long term or short term, depending upon the holding period
of the security. With respect to a put or call option that is purchased by the Fund, if the option is sold, any resulting gain
or loss will be a capital gain or loss, and will be short term or long term, depending upon the holding period for the option.
If the option expires, the resulting loss is a capital loss and is short term or long term, depending upon the holding period
for the option. If the option is exercised, the cost of the option, in the case of a call option, is added to the basis of the
purchased security and, in the case of a put option, reduces the amount realized on the underlying security in determining gain
or loss. Because the Fund does not have control over the exercise of the call options it writes, such exercises or other required
sales of the underlying securities may cause the Fund to realize capital gains or losses at inopportune times.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s transactions in foreign currencies, forward contracts, options, futures contracts (including options and futures
contracts on foreign currencies) and short sales, to the extent permitted, will be subject to special provisions of the Code (including
provisions relating to &#8220;hedging transactions,&#8221; &#8220;straddles&#8221; and &#8220;constructive sales&#8221;) that
may, among other things, affect the character of gains and losses realized by the Fund (i.e., may affect whether gains or losses
are ordinary or capital), accelerate recognition of income to the Fund and defer Fund losses. These rules could therefore affect
the character, amount and timing of distributions to shareholders. Certain of these provisions may also (a) require the Fund to
mark-to-market certain types of the positions in its portfolio (i.e., treat them as if they were closed out at the end of each
year), (b) cause the Fund to recognize income without receiving cash with which to pay dividends or make distributions in amounts
necessary to satisfy the distribution requirements for avoiding income and excise taxes, (c) treat dividends that would otherwise
constitute qualified dividend income as non-qualified dividend income and/or (d) treat dividends that would otherwise be eligible
for the corporate dividends-received deduction as ineligible for such treatment.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s investment in so-called &#8220;section&#160;1256 contracts,&#8221; such as regulated futures contracts, most foreign
currency forward contracts traded in the interbank market, options on most stock indices and any non-equity options, are subject
to special tax rules. All section&#160;1256 contracts held by the Fund at the end of its taxable year are required to be marked
to their market value, and any unrealized gain or loss on those positions will be included in the Fund&#8217;s income as if each
position had been sold for its fair market value at the end of the taxable year. The resulting gain or loss will be combined with
any gain or loss realized by the Fund from positions in section&#160;1256 contracts closed during the taxable year. Provided such
positions were held as capital assets and were not part of a &#8220;hedging transaction&#8221; or a &#8220;straddle,&#8221; 60%
of the resulting net gain or loss will be treated as long term capital gain or loss, and 40% of such net gain or loss will be
treated as short term capital gain or loss, regardless of the period of time the positions were actually held by the Fund.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Fund purchases shares in certain foreign investment entities, called passive foreign investment companies (&#8220;PFICs&#8221;),
the Fund may be subject to U.S. federal income tax on a portion of any &#8220;excess distribution&#8221; or gain from the disposition
of such shares even if such income is distributed as a taxable dividend by the Fund to the shareholders. Additional charges in
the nature of interest may be imposed on the Fund in respect of deferred taxes arising from such distributions or gains. Elections
may be available to the Fund to mitigate the effect of this tax and the additional charges, but such elections generally accelerate
the recognition of income without the receipt of cash. Dividends paid by PFICs are not treated as qualified dividend income, as
discussed below under &#8220;Taxation of Shareholders.&#8221;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Fund invests in the stock of a PFIC, or any other investment that produces income that is not matched by a corresponding cash
distribution to the Fund, the Fund could be required to recognize income that it has not yet received in cash. Any such income
would be treated as income earned by the Fund and therefore would be subject to the distribution requirements of the Code. In
addition, if the Fund does not meet the asset coverage requirements of the 1940 Act or the terms of its preferred shares, the
Fund may be required to suspend distributions to the holders of the common shares until the asset coverage is restored. This might
prevent the Fund from distributing 90% of its net investment company taxable income as is required in order to avoid Fund-level
U.S. federal income taxation on all of its income, or might prevent the Fund from distributing enough ordinary income and capital
gain net income to avoid completely the imposition of the income or excise tax. To avoid this result, the Fund may be required
to borrow money or dispose of securities in unfavorable circumstances, forgo favorable investments, or take other actions that
it would otherwise not take to be able to make required distributions to the shareholders.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund may invest in debt obligations purchased at a discount, with the result that the Fund may be required to accrue income for
U.S. federal income tax purposes before amounts due under the obligations are paid (with such accrued income increasing the amount
the Fund must distribute in order to qualify as a RIC or avoid the 4% excise tax). The Fund may also invest in securities rated
in the medium to lower rating categories of nationally recognized rating organizations, and in unrated securities (&#8220;high
yield securities&#8221;). A portion of the interest payments on such high yield securities may be treated as dividends for certain
U.S. federal income tax purposes.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gains
or losses attributable to fluctuations in exchange rates between the time the Fund accrues income or receivables or expenses or
other liabilities denominated in a foreign currency and the time the Fund actually collects such income or receivables or pays
such liabilities or expenses are generally treated as ordinary income or loss. Similarly, gains or losses on foreign currency
forward contracts and the disposition of debt securities denominated in a foreign currency, to the extent attributable to fluctuations
in exchange rates between the acquisition and disposition dates, are also treated as ordinary income or loss.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
or other income (including, in some cases, capital gains) received by the Fund from investments in foreign securities may be subject
to withholding and other taxes imposed by foreign countries. Tax conventions between certain countries and the U.S. may reduce
or eliminate such taxes in some cases. If more than 50% of the Fund&#8217;s total assets at the close of its taxable year consists
of stock or securities of foreign corporations, the Fund may elect for U.S. federal income tax purposes to treat foreign income
taxes paid by it as paid by its shareholders. The Fund may qualify for and make this election in some, but not necessarily all,
of its taxable years. If the Fund were to make such an election, shareholders of the Fund would be required to take into account
an amount equal to their pro rata portions of such foreign taxes in computing their taxable income and then treat an amount equal
to those foreign taxes as a U.S. federal income tax deduction (subject to limitations, which may be significant) or as a foreign
tax credit (subject to limitations, which may be significant) against their U.S. federal income liability. Shortly after any year
for which it makes such an election, the Fund will report to its shareholders the amount per share of such foreign income tax
that must be included in each shareholder&#8217;s gross income and the amount that may be available for the deduction or credit.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Taxation
of Shareholders</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund will either distribute or retain for reinvestment all or part of its net capital gain, which is the excess of net long term
capital gains over net short term capital losses. If any such gain is retained, the Fund will be subject to a corporate tax on
such retained amount. In that event, the Fund may designate the retained amount as undistributed capital gain in a notice to its
shareholders, each of whom (i) will be required to include in income for tax purposes as long term capital gain its share of such
undistributed amounts, (ii) will be entitled to credit its proportionate share of the tax paid by the Fund against its U.S. federal
income tax liability and to claim refunds to the extent that the credit exceeds such liability and (iii) will increase its basis
in its shares of the Fund by an amount equal to the amount of undistributed capital gain included in the shareholder&#8217;s income
less the tax deemed paid by the shareholders under clause (ii).</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions
paid by the Fund from its investment company taxable income generally are taxable as ordinary income to the extent of the Fund&#8217;s
current or accumulated earnings and profits. Such distributions (if reported by the Fund) may, however, qualify (provided holding
period and other requirements are met by both the Fund and the shareholder) (i) for the dividends received deduction available
to corporations, but only to the extent that the Fund&#8217;s income consists of dividend income from U.S. corporations and (ii)
in the case of individual shareholders, as qualified dividend income (eligible to be taxed at long term capital gains rates) to
the extent that the Fund receives qualified dividend income. If the Fund&#8217;s qualified dividend income is less than 95% of
its gross income, a shareholder of the Fund may only include as qualified dividend income that portion of the dividends that may
be and are so designated by the Fund as qualified dividend income. There can be no assurance as to what portion of the Fund&#8217;s
distributions will qualify for favorable treatment as qualified dividend income.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qualified
dividend income is, in general, dividend income from taxable domestic corporations and certain qualified foreign corporations
(e.g., generally, foreign corporations incorporated in a possession of the United States or in certain countries with a qualifying
comprehensive tax treaty with the United States, or whose stock with respect to which such dividend is paid is readily tradable
on an established securities market in the United States). A qualified foreign corporation does not include a foreign corporation
that for the taxable year of the corporation in which the dividend was paid, or the preceding taxable year, is a PFIC. If the
Fund lends portfolio securities, the amount received by the Fund that is the equivalent of the dividends paid by the issuer on
the securities loaned will not be eligible for qualified dividend income treatment.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Properly
reported distributions of net capital gain reported as capital gain distributions, if any, are taxable to shareholders at rates
applicable to long term capital gain, whether paid in cash or in stock, and regardless of how long the shareholder has held the
Fund&#8217;s shares. Capital gain distributions are not eligible for the dividends received deduction. Unrecaptured Section&#160;1250
gain distributions, if any, will be subject to a 25% tax. For non-corporate taxpayers, investment company taxable income (other
than qualified dividend income) will currently be taxed at ordinary income rates, while net capital gain generally will be taxed
at long term capital gains rates. For corporate taxpayers, both investment company taxable income and net capital gain are taxed
at ordinary income rates.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
IRS currently requires that a RIC that has two or more classes of stock allocate to each such class proportionate amounts of each
type of its income (such as ordinary income, net capital gain and qualified dividend income) based upon the percentage of total
dividends paid to each class for the tax year. Accordingly, because the Fund issues preferred shares, the Fund will allocate its
ordinary income, net capital gain, qualified dividend income and other relevant items (if any) between its common shares and preferred
shares in proportion to the total dividends paid to each class with respect to such tax year.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Properly
reported dividends paid by the Fund that are attributable to the Fund&#8217;s &#8220;qualified REIT dividends&#8221; (generally,
ordinary income dividends paid by a REIT, not including capital gain dividends or dividends treated as qualified dividend income)
are eligible for the 20% deduction described in Section&#160;199A of the Code in the case of non-corporate U.S. shareholders,
provided that certain holding period and other requirements are met by the Fund shareholder and the Fund. There can be no assurance
as to what portion, if any, of the Fund&#8217;s distributions will qualify for such deduction. Subject to any future regulatory
guidance to the contrary, any distribution of income attributable to income from the Fund&#8217;s investment in an MLP will not
qualify for the 20% deduction for &#8220;qualified PTP income&#8221; that would generally be available to a non-corporate U.S.
shareholder were the shareholder to own such MLP directly. As a result, it is possible that a non-corporate U.S. shareholder will
be subject to a higher effective tax rate on any such distributions received from the Fund compared to the effective rate applicable
to any income the U.S. shareholder would receive if the shareholder invested directly in an MLP.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
for any calendar year, the total distributions exceed both current earnings and profits and accumulated earnings and profits,
the excess will generally be treated as a tax-free return of capital up to the amount of a shareholder&#8217;s tax basis in the
common shares. The amount treated as a tax-free return of capital will reduce a shareholder&#8217;s tax basis in the common shares,
thereby increasing such shareholder&#8217;s potential gain or reducing his or her potential loss on the sale of the common shares.
Any amounts distributed to a shareholder in excess of his or her basis in the common shares will be taxable to the shareholder
as capital gain (assuming your common shares are held as a capital asset). In determining the extent to which a distribution will
be treated as being made from the Fund&#8217;s earnings and profits, the Fund&#8217;s earnings and profits will be allocated on
a pro rata basis, first to distributions with respect to the Fund&#8217;s preferred shares, and then to its common shares.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
may be entitled to offset their capital gain distributions (but not distributions eligible for qualified dividend income treatment)
with capital losses. There are a number of statutory provisions affecting when capital losses may be offset against capital gain,
and limiting the use of losses from certain investments and activities. Accordingly, shareholders with capital loss are urged
to consult their tax advisers.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
types of income received by the Fund from REITs, real estate mortgage investment conduits (&#8220;REMICs&#8221;), taxable mortgage
pools or other investments may cause the Fund to designate some or all of its distributions as &#8220;excess inclusion income.&#8221;
To Fund shareholders, such excess inclusion income will (i) constitute taxable income, as &#8220;unrelated business taxable income&#8221;
(&#8220;UBTI&#8221;) for those shareholders who would otherwise be tax-exempt such as individual retirement accounts, 401(k) accounts,
Keogh plans, pension plans and certain charitable entities; (ii) not be offset against net operating losses for tax purposes;
(iii) not be eligible for reduced U.S. withholding for non-U.S. shareholders even from tax treaty countries; and (iv) cause the
Fund to be subject to tax if certain &#8220;disqualified organizations,&#8221; as defined by the Code (such as certain governments
or governmental agencies and charitable remainder trusts), are Fund shareholders.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the discussion of repurchases and redemptions below, upon a sale, exchange or other disposition of shares, a shareholder will
generally realize a taxable gain or loss equal to the difference between the amount of cash and the fair market value of other
property received and the shareholder&#8217;s adjusted tax basis in the shares. Such gain or loss will be treated as long term
capital gain or loss if the shares have been held for more than one year. Any loss realized on a sale or exchange of shares of
the Fund will be disallowed to the extent the shares disposed of are replaced by substantially identical shares within a 61-day
period beginning 30 days before and ending 30 days after the date that the shares are disposed of. In such a case, the basis of
the shares acquired will be adjusted to reflect the disallowed loss.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
loss realized by a shareholder on the sale or exchange of Fund common shares held by the shareholder for six months or less will
be treated for tax purposes as a long term capital loss to the extent of any capital gain distributions received by the shareholder
(or amounts credited to the shareholder as an undistributed capital gain) with respect to such common shares.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
repurchase or a redemption of shares by the Fund will be taxable transactions for U.S. federal income tax purposes, either as
a &#8220;sale or exchange,&#8221; or under certain circumstances, as a &#8220;dividend.&#8221; In general, the transaction should
be treated as a sale or exchange of shares if the receipt of cash (a) is &#8220;substantially disproportionate&#8221; with respect
to the shareholder, (b) results in a &#8220;complete redemption&#8221; of the shareholder&#8217;s interest, or (c) is &#8220;not
essentially equivalent to a dividend&#8221; with respect to the shareholder. A &#8220;substantially disproportionate&#8221; distribution
generally requires a reduction of at least 20% in the shareholder&#8217;s proportionate interest in the Fund and also requires
the shareholder to own less than 50% of the voting power of all classes of the Fund entitled to vote immediately after the repurchase
or redemption. A &#8220;complete redemption&#8221; of a shareholder&#8217;s interest generally requires that all shares of the
Fund owned by such shareholder be disposed of. A distribution &#8220;not essentially equivalent to a dividend&#8221; requires
that there be a &#8220;meaningful reduction&#8221; in the shareholder&#8217;s proportionate interest in the Fund, which should
result if the shareholder has a minimal interest in the Fund, exercises no control over Fund affairs and suffers a reduction in
his proportionate interest in the Fund. In determining whether any of these tests has been met, any Fund shares actually owned,
as well as shares considered to be owned by the shareholder by reason of certain constructive ownership rules set forth in section&#160;318
of the Code, generally must be taken into account.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the repurchase or the redemption of your shares meets any of these three tests for &#8220;sale or exchange&#8221; treatment, you
will recognize gain or loss equal to the difference between the amount of cash and the fair market value of other property received
pursuant to the repurchase or redemption and the adjusted tax basis of the shares sold. If none of the tests described above are
met with respect to a repurchase or redemption, you may be treated as having received, in whole or in part, a dividend, return
of capital or capital gain, depending on (i) whether there are sufficient earnings and profits to support a dividend and (ii)
your tax basis in the relevant class of shares. The tax basis in the shares tendered to the Fund will be transferred to any remaining
shares held by you in the Fund. In addition, if the sale of shares pursuant to the applicable repurchase or redemption is treated
as a &#8220;dividend&#8221; to a tendering stockholder, a constructive dividend under certain provisions of the Code may result
to a non-tendering shareholder whose proportionate interest in the earnings and assets of the Fund has been increased as a result
of such tender.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
U.S. shareholders who are individuals, estates or trusts and whose income exceeds certain thresholds will be required to pay a
3.8% Medicare tax on all or a part of their &#8220;net investment income,&#8221; which includes dividends received from the Fund
and capital gains from the sale or other disposition of the Fund&#8217;s stock.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary
income distributions, capital gain distributions, and gain from the disposition of shares of the Fund also may be subject to state
and local, and foreign taxes. Shareholders are urged to consult their own tax advisers regarding specific questions about U.S.
federal (including the application of the alternative minimum tax), state, local or foreign tax consequences to them of investing
in the Fund.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as provided below, a holder of shares that is a nonresident alien individual or a foreign corporation (a &#8220;foreign investor&#8221;)
generally will be subject to U.S. withholding tax at the rate of 30% (or possibly a lower rate provided by an applicable tax treaty)
on ordinary income dividends. Assuming applicable disclosure and certification requirements are met, U.S. federal income or withholding
tax will not generally apply to any gain or realized by a foreign investor in respect of any distributions of net capital gain
(including net capital gain retained by the Fund but deemed distributed to shareholders) or upon the sale or other disposition
of shares. Different tax consequences may result (i) if the foreign investor is engaged in a trade or business in the United States,
or (ii) in the case of an individual, if the foreign investor is present in the United States for 183 days or more during a taxable
year and certain other conditions are met. Foreign investors should consult their tax advisers regarding the tax consequences
of investing in the Fund&#8217;s shares.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Properly
reported ordinary income dividends are generally exempt from U.S. federal income or withholding tax where they (i) are paid in
respect of the Fund&#8217;s &#8220;qualified net interest income&#8221; (generally, the Fund&#8217;s U.S.-source interest income,
other than certain contingent interest and interest from obligations of a corporation or partnership in which the Fund is at least
a 10% shareholder, reduced by expenses that are allocable to such income) or (ii) are paid in respect of the Fund&#8217;s &#8220;qualified
short term capital gains&#8221; (generally, the excess of the Fund&#8217;s net short term capital gain over the Fund&#8217;s long
term capital loss for such taxable year). Depending on its circumstances, the Fund may report all, some or none of its potentially
eligible dividends as such qualified net interest income or as qualified short term capital gains, and/or treat such dividends,
in whole or in part, as ineligible for this exemption from withholding. In order to qualify for the exemption from withholding,
a foreign investor needs to comply with applicable certification requirements relating to its non-U.S. status (including, in general,
furnishing an IRS Form W-8BEN or W-8BEN-E or substitute form). In the case of shares held through an intermediary, the intermediary
may withhold even if the Fund reports the payment as qualified net interest income or qualified short term capital gains. Foreign
investors should contact their intermediaries with respect to the application of these rules to their accounts. There can be no
assurance as to what portion of the Fund&#8217;s distributions will qualify for favorable treatment as qualified net interest
income or qualified short term capital gains.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Withholding
at a rate of 30% will be required on dividends in respect of our stock held by or through certain foreign financial institutions
(including investment funds), unless such institution enters into an agreement with the Treasury to report, on an annual basis,
information with respect to interests in, and accounts maintained by, the institution to the extent such interests or accounts
are held by certain U.S. persons and by certain non-U.S. entities that are wholly or partially owned by U.S. persons and to withhold
on certain payments. Accordingly, the entity through which our stock is held will affect the determination of whether such withholding
is required. Similarly, dividends in respect of our stock held by an investor that is a non-financial non-U.S. entity that does
not qualify under certain exemptions will be subject to withholding at a rate of 30%, unless such entity either (i) certifies
that such entity does not have any &#8220;substantial United States owners&#8221; or (ii) provides certain information regarding
the entity&#8217;s &#8220;substantial United States owners,&#8221; which the applicable withholding agent will in turn provide
to the Internal Revenue Service. An intergovernmental agreement between the United States and an applicable foreign country, or
future Treasury regulations or other guidance, may modify these requirements. We will not pay any additional amounts to stockholders
in respect of any amounts withheld. Stockholders are encouraged to consult their tax advisors regarding the possible implications
of the legislation on their investment in our stock.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Backup
Withholding</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund may be required to withhold U.S. federal income tax on all taxable distributions and redemption proceeds payable to certain
non-exempt shareholders who fail to provide the Fund (or its agent) with their correct taxpayer identification number or to make
required certifications, or who have been notified by the IRS that they are subject to backup withholding. Backup withholding
is not an additional tax. Any amounts withheld may be refunded or credited against such shareholder&#8217;s U.S. federal income
tax liability, if any, provided that the required information is timely furnished to the IRS.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
foregoing is a general and abbreviated summary of the applicable provisions of the Code and Treasury regulations presently in
effect. For the complete provisions, reference should be made to the pertinent Code sections and the Treasury regulations promulgated
thereunder. The Code and the Treasury regulations are subject to change by legislative, judicial or administrative action, either
prospectively or retroactively. Persons considering an investment in shares of the Fund should consult their own tax advisers
regarding the purchase, ownership and disposition of Fund shares.</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2b009"></span><span id="gg2c009"></span>BENEFICIAL
OWNERS</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below is information as to those shareholders to the Fund&#8217;s knowledge that beneficially own 5% or more of a class
of the Fund&#8217;s outstanding equity securities as of March 31, 2024.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    and Address of Beneficial Owner</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of Class</b></span></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount
                                         of Shares</b>&#160;</span></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and
        Nature of</b><br/>
        <b>Ownership</b>&#160;</span></p></td>
    <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percent
    of Class</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 52%"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Americo
                           Financial Life &amp; Annuity&#160;</span></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">P.O.
        Box 410288&#160;</span></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kansas
        City, MO 64141&#160;</span></p></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series
    B Preferred Shares</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">479,000
    (beneficial)</span></td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.1%</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Louisiana
        Workers Compensation&#160;</span></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2237
        S Acadian Thruway&#160;</span></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Baton
        Rouge, LA 70808&#160;</span></p></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series B Preferred
    Shares</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">223,258 (beneficial)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.0%</span></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
        &amp; Investment Management Group</span></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111 Cass Street</span></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Traverse
        City, MI 49684&#160;</span></p></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series B Preferred
    Shares</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">182,284 (beneficial)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7%</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2024, the Trustees and officers of the Fund as a group beneficially owned less than 1% of the Fund&#8217;s
outstanding common shares and less than 1% of the outstanding Series B Preferred Shares.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2b010"></span><span id="gg2c010"></span>GENERAL
INFORMATION</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Book-Entry-Only
Issuance</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Depository Trust Company (&#8220;DTC&#8221;) will act as securities depository for the common shares offered pursuant to the prospectus.
The information in this section concerning DTC and DTC&#8217;s book-entry system is based upon information obtained from DTC.
The securities offered hereby initially will be issued only as fully registered securities registered in the name of Cede &amp;
Co. (as nominee for DTC). One or more fully-registered global security certificates initially will be issued, representing in
the aggregate the total number of securities, and deposited with DTC.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DTC
is a limited-purpose trust company organized under the New York Banking Law, a &#8220;banking organization&#8221; within the meaning
of the New York Banking Law, a member of the Federal Reserve System, a &#8220;clearing corporation&#8221; within the meaning of
the New York Uniform Commercial Code and a &#8220;clearing agency&#8221; registered pursuant to the provisions of Section&#160;17A
of the Securities Exchange Act of 1934. DTC holds securities that its participants deposit with DTC. DTC also facilities the settlement
among participants of securities transactions, such as transfers and pledges, in deposited securities through electronic computerized
book-entry changes in participants&#8217; accounts, thereby eliminating the need for physical movement of securities certificates.
Direct DTC participants include securities brokers and dealers, banks, trust companies, clearing corporations and certain other
organizations. Access to the DTC system is also available to others such as securities brokers and dealers, banks and trust companies
that clear through or maintain a custodial relationship with a direct participant, either directly or indirectly through other
entities.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchases
of securities within the DTC system must be made by or through direct participants, which will receive a credit for the securities
on DTC&#8217;s records. The ownership interest of each actual purchaser of a security, a beneficial owner, is in turn to be recorded
on the direct or indirect participants&#8217; records. Beneficial owners will not receive written confirmation from DTC of their
purchases, but beneficial owners are expected to receive written confirmations providing details of the transactions, as well
as periodic statements of their holdings, from the direct or indirect participants through which the beneficial owners purchased
securities. Transfers of ownership interests in securities are to be accomplished by entries made on the books of participants
acting on behalf of beneficial owners. Beneficial owners will not receive certificates representing their ownership interests
in securities, except as provided herein.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DTC
has no knowledge of the actual beneficial owners of the securities being offered pursuant to the prospectus; DTC&#8217;s records
reflect only the identity of the direct participants to whose accounts such securities are credited, which may or may not be the
beneficial owners. The participants will remain responsible for keeping account of their holdings on behalf of their customers.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conveyance
of notices and other communications by DTC to direct participants, by direct participants to indirect participants, and by direct
participants and indirect participants to beneficial owners will be governed by arrangements among them, subject to any statutory
or regulatory requirements as may be in effect from time to time.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments
on the securities will be made to DTC. DTC&#8217;s practice is to credit direct participants&#8217; accounts on the relevant payment
date in accordance with their respective holdings shown on DTC&#8217;s records unless DTC has reason to believe that it will not
receive payments on such payment date. Payments by participants to beneficial owners will be governed by standing instructions
and customary practices and will be the responsibility of such participant and not of DTC or the Fund, subject to any statutory
or regulatory requirements as may be in effect from time to time. Payment of distributions to DTC is the responsibility of the
Fund, disbursement of such payments to direct participants is the responsibility of DTC, and disbursement of such payments to
the beneficial owners is the responsibility of direct and indirect participants. Furthermore each beneficial owner must rely on
the procedures of DTC to exercise any rights under the securities.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DTC
may discontinue providing its services as securities depository with respect to the securities at any time by giving reasonable
notice to the Fund. Under such circumstances, in the event that a successor securities depository is not obtained, certificates
representing the securities will be printed and delivered.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proxy
Voting Procedures</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund has adopted the proxy voting procedures of the Investment Adviser and has directed the Investment Adviser to vote all proxies
relating to the Fund&#8217;s voting securities in accordance with such procedures. The proxy voting procedures are attached as
Appendix A. They are also on file with the SEC and can be reviewed and copied at the SEC&#8217;s Public Reference Room in Washington,
D.C., and information on the operation of the Public Reference Room may be obtained by calling the SEC at (202) 551-8090. The
proxy voting procedures are also available on the EDGAR Database on the SEC&#8217;s internet site (http://www.sec.gov) and copies
of the proxy voting procedures may be obtained, after paying a duplicating fee, by electronic request at the following E-mail
address: publicinfo@sec.gov, or by writing the SEC&#8217;s Public Reference Section, Washington, D.C. 20549-0102.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Code
of Ethics</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund and the Investment Adviser have adopted a code of ethics. This code of ethics sets forth restrictions on the trading activities
of trustees/directors, officers and employees of the Fund, the Investment Adviser and their affiliates. For example, such persons
may not purchase any security for which the Fund has a purchase or sale order pending, or for which such trade is under consideration.
In addition, those trustees/directors, officers and employees that are principally involved in investment decisions for client
accounts are prohibited from purchasing or selling for their own account for a period of seven days a security that has been traded
for a client&#8217;s account, unless such trade is executed on more favorable terms for the client&#8217;s account and it is determined
that such trade will not adversely affect the client&#8217;s account. Short term trading by such trustee/directors, officers and
employees for their own accounts in securities held by the Fund client&#8217;s account is also restricted. The above examples
are subject to certain exceptions and they do not represent all of the trading restrictions and policies set forth by the code
of ethics. The code of ethics is on file with the SEC and can be reviewed and copied at the SEC&#8217;s Public Reference Room
in Washington, D.C., and information on the operation of the Public Reference Room may be obtained by calling the SEC at (202)
551-8090. The code of ethics is also available on the EDGAR Database on the SEC&#8217;s Internet site at http://www.sec.gov, and
copies of the code of ethics may be obtained, after paying a duplicating fee, by electronic request at the following E-mail address:
publicinfo@sec.gov, or by writing the SEC&#8217;s Public Reference Section, Washington, D.C. 20549-0102.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Joint
Code of Ethics for Chief Executive and Senior Financial Officers</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund and the Investment Adviser have adopted a joint Code of Ethics that serves as a code of conduct. The Code of Ethics sets
forth policies to guide the chief executive and senior financial officers in the performance of their duties. The code of ethics
is on file with the SEC and can be reviewed and copied at the SEC&#8217;s Public Reference Room in Washington, D.C., and information
on the operation of the Public Reference Room may be obtained by calling the SEC at (202) 551-8090. The Code of Ethics is also
available on the EDGAR Database on the SEC&#8217;s Internet site (http://www.sec.gov), and copies of the Code of Ethics may be
obtained, after paying a duplicating fee, by electronic request at the following E-mail address: publicinfo@sec.gov, or by writing
the SEC&#8217;s Public Reference Section, Washington, D.C. 20549-0102.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --> -</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART
C</b>&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OTHER
INFORMATION</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
25. <i>Financial Statements and Exhibits</i></b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b>Part A</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1313510/000182912624001451/ggn_ncsr.htm">The
audited financial statements included in the annual report to the Fund&#8217;s shareholders for the fiscal year ended December
31, 2023&#160;(the &#8220;2023 Annual Report&#8221;), together with the report of&#160;PricewaterhouseCoopers LLP&#160;thereon,
are incorporated by reference to the 2023 Annual Report in Part A.</a></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1313510/000182912623005963/ggn_ncsrs.htm">The
unaudited financial statements included in the semi-annual report to the Fund&#8217;s shareholders for the six months ended June&#160;30,
2023 are incorporated by reference to the Fund&#8217;s semi-annual report to shareholders in Part A.</a></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b>Part B</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">None</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 48px; font-size: 10pt"><span style="font-size: 10pt">(2)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Exhibits</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 96px; font-size: 10pt; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px; font-size: 10pt; text-align: justify"><span style="font-size: 10pt">(a)</span></td>
    <td style="vertical-align: top; width: 48px; font-size: 10pt"><span style="font-size: 10pt">(i)</span></td>
    <td style="vertical-align: top; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1313510/000094040011000103/gggnr77q11.txt"><span style="font-size: 10pt">Third Amended and Restated Agreement and Declaration of Trust of Registrant (1)</span></a></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 144px; text-align: justify"><p style="margin-top: 0; margin-bottom: 0">&#160;&#160;</p></td>
    <td style="vertical-align: top; width: 48px"><span style="font-size: 10pt">(ii)</span></td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1313510/000119312513202289/d532603dex99aiv.htm"><span style="font-size: 10pt">Statement of Preferences of Series B Cumulative Preferred Shares (2)</span></a></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 96px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px; text-align: justify"><span style="font-size: 10pt">(b)</span></td>
    <td style="vertical-align: top; width: 48px"><span style="font-size: 10pt">(i)</span></td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1313510/000119312516564005/d180690dex99b.htm"><span style="font-size: 10pt">Third Amended and Restated&#160;By-Laws&#160;of the Registrant dated as of March&#160;28, 2014 (3)</span></a></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 96px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px"><span style="font-size: 10pt">(ii)</span></td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/0001313510/000119312522228908/d287619dex99bii.htm"><span style="font-size: 10pt">Amendment No. 1 to Third Amended and Restated By-Laws of the Registrant (4)</span></a></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 96px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px; text-align: justify"><span style="font-size: 10pt">(c)</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Not applicable</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 96px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px; text-align: justify"><span style="font-size: 10pt">(d)</span></td>
    <td style="vertical-align: top; width: 48px"><span style="font-size: 10pt">(i)</span></td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1313510/000095011605001103/b404784_ex99-d.txt"><span style="font-size: 10pt">Form of Specimen Common Share Certificate (5)</span></a></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 96px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px"><span style="font-size: 10pt">(ii)</span></td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1313510/000119312513202289/d532603dex99diii.htm"><span style="font-size: 10pt">Form of Specimen Preferred Share Certificate for the Series B Cumulative Preferred Shares (2)</span></a></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 96px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px; text-align: justify"><span style="font-size: 10pt">(e)</span></td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1313510/000119312521173759/d171093dn2a.htm#pro171093_11"><span style="font-size: 10pt">Automatic Dividend Reinvestment and Voluntary Cash Purchase Plan (6)</span></a></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 96px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px; text-align: justify"><span style="font-size: 10pt">(f)</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Not applicable</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 96px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px; text-align: justify"><span style="font-size: 10pt">(g)</span></td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1313510/000112528205001596/b404784_ex99-g.txt"><span style="font-size: 10pt">Investment Advisory Agreement between Registrant and Gabelli Funds, LLC (7)</span></a></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 96px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px; text-align: justify"><span style="font-size: 10pt">(h)</span></td>
    <td style="vertical-align: top; width: 48px"><span style="font-size: 10pt">(i)</span></td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1313510/000119312521193318/d140151dex99hi.htm"><span style="font-size: 10pt">Sales Agreement, dated June 16, 2021 (10)</span></a></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 96px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px"><span style="font-size: 10pt">(ii)</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Underwriting Agreement &#8224;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 96px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px; text-align: justify"><span style="font-size: 10pt">(i)</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Not applicable</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 96px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px; text-align: justify"><span style="font-size: 10pt">(j)</span></td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1313510/000112528205001596/b404784_ex99-j.txt"><span style="font-size: 10pt">Custodian Agreement (7)</span></a></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 96px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px; text-align: justify"><span style="font-size: 10pt">(k)</span></td>
    <td style="vertical-align: top"><a href="http://www.sec.gov/Archives/edgar/data/1313510/000095011605001103/b404784_ex99-k.txt"><span style="font-size: 10pt">Form of Registrar, Transfer Agency and Service Agreement (5)</span></a></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 96px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px; text-align: justify"><span style="font-size: 10pt">(l)</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Opinion and Consent of Skadden, Arps, Slate, Meagher&#160;&amp;
    Flom LLP with respect to legality*</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 27; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 96px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px; text-align: justify"><span style="font-size: 10pt">(m)</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Not applicable</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 96px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px; text-align: justify"><span style="font-size: 10pt">(n)</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Consent of Independent Registered Public Accounting Firm*</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 96px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px; text-align: justify"><span style="font-size: 10pt">(o)</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Not applicable</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 96px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px; text-align: justify"><span style="font-size: 10pt">(p)</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1313510/000112528205001545/b404784_ex99-p.txt">Form
    of Initial Subscription Agreement (8)</a></span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 96px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px; text-align: justify"><span style="font-size: 10pt">(q)</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Not applicable</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 96px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px; text-align: justify"><span style="font-size: 10pt">(r)</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/0001313510/000119312521110297/d42368dex99r.htm">Code
    of Ethics of the Fund and the Investment Adviser (9)</a></span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 96px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px; text-align: justify"><span style="font-size: 10pt">(s)</span></td>
    <td style="vertical-align: top; width: 48px"><span style="font-size: 10pt">(i) </span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Powers of Attorney (12)</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 96px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px"><span style="font-size: 10pt">(ii)</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Form of Prospectus Supplement Relating to Common Shares (12)</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 96px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px; text-align: justify">&#160;</td>
    <td style="vertical-align: top; width: 48px"><span style="font-size: 10pt">(iii)</span></td>
    <td style="vertical-align: top"><span style="font-size: 10pt">Form of Prospectus Supplement Relating to Preferred Shares
    (12)</span></td></tr>
<tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td colspan="2" style="vertical-align: top">&#160;</td></tr>
<tr>
    <td style="text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="vertical-align: top"><span style="font-size: 10pt">(iv)</span></td>
    <td style="vertical-align: top"><a href="ex99-siv.htm"><span style="font-size: 10pt">Calculation of Filing Fee Table*</span></a></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 1pt; margin-bottom: 1pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 100%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">*</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Filed herewith</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 24px"><span style="font-size: 10pt">&#8224;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">To be filed by amendment</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 34px"><span style="font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Previously filed with the Registrant&#8217;s Annual Report for Management Companies on Form NSAR filed on March&#160;1, 2011 (811-21698).</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 34px"><span style="font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Previously filed with Post-Effective Amendment No. 2 to the Registration Statement on Form N-2 filed on May&#160;7, 2013 (333-186097).</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 34px"><span style="font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Previously filed with Post-Effective Amendment No. 3 to the Registration Statement on Form N-2 filed on April&#160;28, 2016 (333-198978).</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 34px"><span style="font-size: 10pt">(4)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Previously filed with Post-Effective Amendment No. 2 to the Registration Statement on Form N-2 filed on August&#160;24, 2022 (333-255130).</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 34px"><span style="font-size: 10pt">(5)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Previously filed with Pre-Effective Amendment No. 2 to the Registration Statement on Form N-2 filed on March&#160;23, 2005 (333-121998).</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 34px"><span style="font-size: 10pt">(6)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Included in Prospectus.</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 34px"><span style="font-size: 10pt">(7)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Previously filed with Pre-Effective Amendment No. 4 to the Registration Statement on Form N-2 filed on March&#160;28, 2005 (333-121998).</span></td></tr>
</table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 34px"><span style="font-size: 10pt">(8)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Previously filed with Pre-Effective Amendment No. 3 to the Registration Statement on Form N-2 filed on March&#160;24, 2005 (333-121998).</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 34px"><span style="font-size: 10pt">(9)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Previously filed with the Registrant&#8217;s Registration Statement on Form N-2 filed on April&#160;8, 2021 (333-255130).</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 34px"><span style="font-size: 10pt">(10)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to the Registrant&#8217;s Post-Effective Amendment No. 1 to the Registration Statement on Form N-2, File Nos. 333-255130 and 811-21698, as filed with the Securities and Exchange Commission on June&#160;17, 2021.</span></td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 0px">&#160;</td>
    <td style="width: 34px"><span style="font-size: 10pt">(11)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to the Registrant&#8217;s Annual Report on Form N-CSR for the year ended December&#160;31, 2021, as filed with the Securities and Exchange Commission on March&#160;9, 2022.</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">(12)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Incorporated by reference to the Registrant&#8217;s Registration
    Statement on Form N-2, File No. 333-277179, as filed with the Securities and Exchange Commission on February 20, 2024.</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
26. <i>Marketing Arrangements</i></b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained under the heading &#8220;Plan of Distribution&#8221; in the Prospectus is incorporated by reference, and
any information concerning any underwriters will be contained in the accompanying Prospectus Supplement, if any.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
27. <i>Other Expenses of Issuance and Distribution</i></b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the estimated expenses to be incurred in connection with the offering described in this Registration
Statement:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; width: 89%; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SEC
    registration fees</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73,800</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NYSE
    American listing fee</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rating
    Agency fees</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Printing/engraving
    expenses</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">310,000</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Auditing
    fees and expenses</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72,500</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
    fees and expenses</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">525,000</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; padding-bottom: 1pt; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous</span></td>
    <td style="vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">303,700</span></td>
    <td style="vertical-align: bottom; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 27pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,345,000</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
28. <i>Persons Controlled by or Under Common Control with Registrant</i></b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
29. <i>Number of Holders of Securities as of March 31, 2024</i></b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of Class</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of</b><br/>
    <b>Record Holders</b></span></td></tr>
<tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; width: 89%; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Shares of Beneficial Interest</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</span></td></tr>
<tr style="background-color: white">
    <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series
    B Cumulative Preferred Shares</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
30. <i>Indemnification</i></b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Article
IV of the Registrant&#8217;s Third Amended and Restated Agreement and Declaration of Trust provides as follows:</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
No Personal Liability of Shareholders, Trustees, etc. No Shareholder of the Trust shall be subject in such capacity to any personal
liability whatsoever to any Person in connection with Trust Property or the acts, obligations or affairs of the Trust. Shareholders
shall have the same limitation of personal liability as is extended to stockholders of a private corporation for profit incorporated
under the general corporation law of the State of Delaware. No Trustee or officer of the Trust shall be subject in such capacity
to any personal liability whatsoever to any Person, other than the Trust or its Shareholders, in connection with Trust Property
or the affairs of the Trust, save only liability to the Trust or its Shareholders arising from bad faith, willful misfeasance,
gross negligence or reckless disregard for his duty to such Person; and, subject to the foregoing exception, all such Persons
shall look solely to the Trust Property for satisfaction of claims of any nature arising in connection with the affairs of the
Trust. If any Shareholder, Trustee or officer, as such, of the Trust, is made a party to any suit or proceeding to enforce any
such liability, subject to the foregoing exception, he shall not, on account thereof, be held to any personal liability.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
Mandatory Indemnification. (a) The Trust shall indemnify the Trustees and officers of the Trust (each such person being an &#8220;indemnitee&#8221;)
against any liabilities and expenses, including amounts paid in satisfaction of judgments, in compromise or as fines and penalties,
and reasonable counsel fees reasonably incurred by such indemnitee in connection with the defense or disposition of any action,
suit or other proceeding, whether civil or criminal, before any court or administrative or investigative body in which he may
be or may have been involved as a party or otherwise (other than, except as authorized by the Trustees, as the plaintiff or complainant)
or with which he may be or may have been threatened, while acting in any capacity set forth above in this Section&#160;4.2 by
reason of his having acted in any such capacity, except with respect to any matter as to which he shall not have acted in good
faith in the reasonable belief that his action was in the best interest of the Trust or, in the case of any criminal proceeding,
as to which he shall have had reasonable cause to believe that the conduct was unlawful, provided, however, that no indemnitee
shall be indemnified hereunder against any liability to any person or any expense of such indemnitee arising by reason of (i)
willful misfeasance, (ii) bad faith, (iii) gross negligence (negligence in the case of Affiliated Indemnitees), or (iv) reckless
disregard of the duties involved in the conduct of his position (the conduct referred to in such clauses (i) through (iv) being
sometimes referred to herein as &#8220;disabling conduct&#8221;). Notwithstanding the foregoing, with respect to any action, suit
or other proceeding voluntarily prosecuted by any indemnitee as plaintiff, indemnification shall be mandatory only if the prosecution
of such action, suit or other proceeding by such indemnitee was authorized by a majority of the Trustees.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Notwithstanding the foregoing, no indemnification shall be made hereunder unless there has been a determination (1) by a final
decision on the merits by a court or other body of competent jurisdiction before whom the issue of entitlement to indemnification
hereunder was brought that such indemnitee is entitled to indemnification hereunder or, (2) in the absence of such a decision,
by (i) a majority vote of a quorum of those Trustees who are neither Interested Persons of the Trust nor parties to the proceeding
(&#8220;Disinterested Non-Party Trustees&#8221;), that the indemnitee is entitled to indemnification hereunder, or (ii) if such
quorum is not obtainable or even if obtainable, if such majority so directs, independent legal counsel in a written opinion conclude
that the indemnitee should be entitled to indemnification hereunder. All determinations to make advance payments in connection
with the expense of defending any proceeding shall be authorized and made in accordance with the immediately succeeding paragraph
(c) below.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Trust shall make advance payments in connection with the expenses of defending any action with respect to which indemnification
might be sought hereunder if the Trust receives a written affirmation by the indemnitee of the indemnitee&#8217;s good faith belief
that the standards of conduct necessary for indemnification have been met and a written undertaking to reimburse the Trust unless
it is subsequently determined that he is entitled to such indemnification and if a majority of the Trustees determine that the
applicable standards of conduct necessary for indemnification appear to have been met. In addition, at least one of the following
conditions must be met: (1) the indemnitee shall provide adequate security for his undertaking, (2) the Trust shall be insured
against losses arising by reason of any lawful advances, or (3) a majority of a quorum of the Disinterested Non-Party Trustees,
or if a majority vote of such quorum so direct, independent legal counsel in a written opinion, shall conclude, based on a review
of readily available facts (as opposed to a full trial-type inquiry), that there is substantial reason to believe that the indemnitee
ultimately will be found entitled to indemnification.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The rights accruing to any indemnitee under these provisions shall not exclude any other right to which he may be lawfully entitled.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Notwithstanding the foregoing, subject to any limitations provided by the 1940 Act and this Declaration, the Trust shall have
the power and authority to indemnify Persons providing services to the Trust to the full extent provided by law as if the Trust
were a corporation organized under the Delaware General Corporation Law provided that such indemnification has been approved by
a majority of the Trustees.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
No Duty of Investigation; Notice in Trust Instruments, etc. No purchaser, lender, transfer agent or other person dealing with
the Trustees or with any officer, employee or agent of the Trust shall be bound to make any inquiry concerning the validity of
any transaction purporting to be made by the Trustees or by said officer, employee or agent or be liable for the application of
money or property paid, loaned, or delivered to or on the order of the Trustees or of said officer, employee or agent. Every obligation,
contract, undertaking, instrument, certificate, Share, other security of the Trust, and every other act or thing whatsoever executed
in connection with the Trust shall be conclusively taken to have been executed or done by the executors thereof only in their
capacity as Trustees under this Declaration or in their capacity as officers, employees or agents of the Trust. The Trustees may
maintain insurance for the protection of the Trust Property, its Shareholders, Trustees, officers, employees and agents in such
amount as the Trustees shall deem adequate to cover possible liability, and such other insurance as the Trustees in their sole
judgment shall deem advisable or is required by the 1940 Act.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
Reliance on Experts, etc. Each Trustee and officer or employee of the Trust shall, in the performance of its duties, be fully
and completely justified and protected with regard to any act or any failure to act resulting from reliance in good faith upon
the books of account or other records of the Trust, upon an opinion of counsel, or upon reports made to the Trust by any of the
Trust&#8217;s officers or employees or by any advisor, administrator, manager, distributor, selected dealer, accountant, appraiser
or other expert or consultant selected with reasonable care by the Trustees, officers or employees of the Trust, regardless of
whether such counsel or other person may also be a Trustee.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Section&#160;9
of the Registrant&#8217;s Investment Advisory Agreement provides as follows:</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
Indemnity</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Fund hereby agrees to indemnify the Adviser and each of the Adviser&#8217;s trustees, officers, employees, and agents (including
any individual who serves at the Adviser&#8217;s request as director, officer, partner, trustee or the like of another corporation)
and controlling persons (each such person being an &#8220;indemnitee&#8221;) against any liabilities and expenses, including amounts
paid in satisfaction of judgments, in compromise or as fines and penalties, and counsel fees (all as provided in accordance with
applicable corporate law) reasonably incurred by such indemnitee in connection with the defense or disposition of any action,
suit or other proceeding, whether civil or criminal, before any court or administrative or investigative body in which he may
be or may have been involved as a party or otherwise or with which he may be or may have been threatened, while acting in any
capacity set forth above in this paragraph or thereafter by reason of his having acted in any such capacity, except with respect
to any matter as to which he shall have been adjudicated not to have acted in good faith in the reasonable belief that his action
was in the best interest of the Fund and furthermore, in the case of any criminal proceeding, so long as he had no reasonable
cause to believe that the conduct was unlawful, provided, however, that (1) no indemnitee shall be indemnified hereunder against
any liability to the Fund or its shareholders or any expense of such indemnitee arising by reason of (i) willful misfeasance,
(ii) bad faith, (iii) gross negligence, (iv) reckless disregard of the duties involved in the conduct of his position (the conduct
referred to in such clauses (i) through (iv) being sometimes referred to herein as &#8220;disabling conduct&#8221;), (2) as to
any matter disposed of by settlement or a compromise payment by such indemnitee, pursuant to a consent decree or otherwise, no
indemnification either for said payment or for any other expenses shall be provided unless there has been a determination that
such settlement or compromise is in the best interests of the Fund and that such indemnitee appears to have acted in good faith
in the reasonable belief that his action was in the best interest of the Fund and did not involve disabling conduct by such indemnitee
and (3) with respect to any action, suit or other proceeding voluntarily prosecuted by any indemnitee as plaintiff, indemnification
shall be mandatory only if the prosecution of such action, suit or other proceeding by such indemnitee was authorized by a majority
of the full Board of the Fund. Notwithstanding the foregoing the Fund shall not be obligated to provide any such indemnification
to the extent such provision would waive any right which the Fund cannot lawfully waive.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Fund shall make advance payments in connection with the expenses of defending any action with respect to which indemnification
might be sought hereunder if the Fund receives a written affirmation of the indemnitee&#8217;s good faith belief that the standard
of conduct necessary for indemnification has been met and a written undertaking to reimburse the Fund unless it is subsequently
determined that he is entitled to such indemnification and if the trustees of the Fund determine that the facts then known to
them would not preclude indemnification. In addition, at least one of the following conditions must be met: (A) the indemnitee
shall provide a security for his undertaking, (B) the Fund shall be insured against losses arising by reason of any lawful advances,
or (C) a majority of a quorum of trustees of the Fund who are neither &#8220;interested persons&#8221; of the Fund (as defined
in Section&#160;2(a)(19) of the Act) nor parties to the proceeding (&#8220;Disinterested Non-Party Trustees&#8221;) or an independent
legal counsel in a written opinion, shall determine, based on a review of readily available facts (as opposed to a full trial-type
inquiry), that there is reason to believe that the indemnitee ultimately will be found entitled to indemnification.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
All determinations with respect to indemnification hereunder shall be made (1) by a final decision on the merits by a court or
other body before whom the proceeding was brought that such indemnitee is not liable by reason of disabling conduct or, (2) in
the absence of such a decision, by (i) a majority vote of a quorum of the Disinterested Non-party Trustees of the Fund, or (ii)
if such a quorum is not obtainable or even, if obtainable, if a majority vote of such quorum so directs, independent legal counsel
in a written opinion.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
rights accruing to any indemnitee under these provisions shall not exclude any other right to which he may be lawfully entitled.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reference
is made to Section&#160;7 of the Sales Agreement, which is filed as Exhibit (h)(i) to this Registration Statement.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
underwriting indemnification provisions, if any, to be added by amendment.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the Registrant and the other funds in the Gabelli/GAMCO Fund Complex jointly maintain, at their own expense, E&amp;O/D&amp;O insurance
policies for the benefit of its directors/trustees, officers and certain affiliated persons. The Registrant pays a pro rata portion
of the premium on such insurance policies.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liability arising under the Securities Act of 1933 may be permitted to directors, officers and controlling
persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion
of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and
is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by
the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense
of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities
being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed
in the Securities Act and will be governed by the final adjudication of such issue.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
31. <i>Business and Other Connections of Investment Adviser</i></b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investment Adviser, a limited liability company organized under the laws of the State of New York, acts as investment adviser
to the Registrant. The Registrant is fulfilling the requirement of this Item 31 to provide a list of the officers of the Investment
Adviser, together with information as to any other business, profession, vocation or employment of a substantial nature engaged
in by the Investment Adviser or those officers during the past two years, by incorporating by reference the information contained
in the Form ADV of the Investment Adviser filed with the commission pursuant to the Investment Advisers Act of 1940 (Commission
File No. 801-26202).</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
32. <i>Location of Accounts and Records</i></b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accounts and records of the Registrant are maintained in part at the office of the Investment Adviser at One Corporate Center,
Rye, New York 10580-1422, in part at the offices of the Registrant&#8217;s custodian, The Bank of New York Mellon, at 240 Greenwich
Street, New York, NY 10286, in part at the offices of the Registrant&#8217;s sub-administrator, BNY Mellon Investment Servicing
(US) Inc., at 760 Moore Road, King of Prussia, Pennsylvania 19406, and in part at the offices of the Registrant&#8217;s transfer
agent, American Stock Transfer, at 6201 15th Avenue, Brooklyn, New York 11219.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
33. <i>Management Services</i></b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
34. <i>Undertakings</i></b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 1px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not applicable.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 1px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not applicable.</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 1px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant undertakes:</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to file, during
    a period in which offers or sales are being made, a post-effective amendment to this Registration Statement:</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 180px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to include any prospectus
    required by Section&#160;10(a)(3) of the Securities Act;</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 180px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to reflect in the
    prospectus any facts or events after the effective date of the registration statement (or the most recent post- effective
    amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in
    the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the
    total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high
    end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant
    to Rule&#160;424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum
    aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration
    statement.</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 180px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to include any material
    information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material
    change to such information in the Registration Statement.</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 240px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provided, however,
    that paragraphs a(1), a(2), and a(3) of this section do not apply to the extent the information required to be included in
    a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant
    pursuant to Section&#160;13 or Section&#160;15(d) of the Exchange Act that are incorporated by reference into the registration
    statement, or is contained in a form of prospectus filed pursuant to Rule&#160;424(b) that is part of the registration statement.</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">that for the purpose
    of determining any liability under the Securities Act, each post-effective amendment shall be deemed to be a new registration
    statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to
    be the initial bona fide offering thereof;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to remove from registration
    by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the
    offering;</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">that, for the purpose
    of determining liability under the Securities Act to any purchaser:</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 180px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if the Registrant
    is subject to Rule&#160;430B:</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 240px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each prospectus
    filed by the Registrant pursuant to Rule&#160;424(b)(3) shall be deemed to be part of the registration statement as of the
    date the filed prospectus was deemed part of and included in the registration statement; and</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 240px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each prospectus
    required to be filed pursuant to Rule&#160;424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on
    Rule&#160;430B relating to an offering made pursuant to Rule&#160;415(a)(1)(i), (x), or (xi) for the purpose of providing
    the information required by Section&#160;10(a) of the Securities Act shall be deemed to be part of and included in the registration
    statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first
    contract of sale of securities in the offering described in the prospectus. As provided in Rule&#160;430B, for liability purposes
    of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of
    the registration statement relating to the securities in the registration statement to which that prospectus relates, and
    the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however,
    that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document
    incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration
    statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement
    that was made in the registration statement or prospectus that was part of the registration statement or made in any such
    document immediately prior to such effective date; or</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 180px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if the Registrant
    is subject to Rule&#160;430C: each prospectus filed pursuant to Rule&#160;424(b) under the Securities Act as part of a registration
    statement relating to an offering, other than registration statements relying on Rule&#160;430B or other than prospectuses
    filed in reliance on Rule&#160;430A, shall be deemed to be part of and included in the registration statement as of the date
    it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus
    that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the
    registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract
    of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus
    that was part of the registration statement or made in any such document immediately prior to such date of first use.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">that for the purpose
    of determining liability of the Registrant under the Securities Act to any purchaser in the initial distribution of securities:</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 120px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The undersigned
    Registrant undertakes that in a primary offering of securities of the undersigned Registrant pursuant to this registration
    statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered
    or sold to such purchaser by means of any of the following communications, the undersigned Registrant will be a seller to
    the purchaser and will be considered to offer or sell such securities to the purchaser:</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 180px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any preliminary
    prospectus or prospectus of the undersigned Registrant relating to the offering required to be filed pursuant to Rule&#160;424
    under the Securities Act;</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 180px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">free writing prospectus
    relating to the offering prepared by or on behalf of the undersigned Registrant or used or referred to by the undersigned
    Registrant;</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 180px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the portion of any
    other free writing prospectus or advertisement pursuant to Rule&#160;482 under the Securities Act relating to the offering
    containing material information about the undersigned Registrant or its securities provided by or on behalf of the undersigned
    Registrant; and</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 180px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any other communication
    that is an offer in the offering made by the undersigned Registrant to the purchaser.</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 1px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not Applicable.</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 1px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The undersigned
    Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing
    of the Registrant&#8217;s annual report pursuant to Section&#160;13(a) or Section&#160;15(d) of the Securities Exchange Act
    of 1934 that is incorporated by reference into the registration statement shall be deemed to be a new registration statement
    relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial
    bona fide offering thereof.</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 1px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar as indemnification
    for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of
    the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of
    the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore,
    unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant
    of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any
    action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities
    being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent,
    submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as
    expressed in the Act and will be governed by the final adjudication of such issue.</span></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 1px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant undertakes
    to send by first class mail or other means designed to ensure equally prompt delivery, within two business days of receipt
    of a written or oral request, any prospectus or Statement of Additional Information.</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
required by the Securities Act of 1933, as amended, the Registrant has duly caused this Registration Statement on Form N-2 to be signed
on its behalf by the undersigned, in the City of Rye, State of New York, on the 15<sup>th</sup> day of April, 2024.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GAMCO GLOBAL GOLD, NATURAL RESOURCES
    &amp; INCOME TRUST</span></td></tr>
<tr style="vertical-align: top">
    <td style="width: 55%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 42%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ John
    C. Ball</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John C. Ball</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
required by the Securities Act of 1933, as amended, this Registration Statement has been signed below by the following persons in the
capacities set forth below on the 15<sup>th</sup> day of April, 2024.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 45%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 45%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td></tr>
<tr>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trustee</span></td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calgary
    Avansino</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trustee</span></td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Elizabeth
    C. Bogan</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trustee</span></td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony
    S. Colavita</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trustee</span></td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    P. Conn</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trustee</span></td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vincent
    D. Enright</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trustee</span></td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frank
    J. Fahrenkopf, Jr.</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trustee</span></td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    J. Melarkey</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trustee</span></td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agnes
    Mullady</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trustee</span></td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salvatore
    M. Salibello</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trustee</span></td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthonie
    C. van Ekris</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trustee</span></td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salvatore
    J. Zizza</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    John C. Ball</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    and Treasurer (Principal Executive, <br/>
Financial Officer and Accounting Officer)</span></td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John
    C. Ball</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    John C. Ball</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attorney-in-Fact</span></td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John
    C. Ball</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 1px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to a Power
    of Attorney</span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>EXHIBIT
INDEX</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-l.htm">Opinion and Consent of Skadden, Arps, Slate, Meagher&amp; Flom LLP with respect to legality</a></span></td></tr>
<tr style="vertical-align: top; background-color: white">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-n.htm">Consent of Independent Registered Public Accounting Firm</a></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)(iv)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-siv.htm">Calculation of Filing Fee Table</a></span></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <!-- Field: /Page -->

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(L)
<SEQUENCE>3
<FILENAME>ex99-l.htm
<DESCRIPTION>OPINION AND CONSENT OF SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-right: 0; margin-top: 0; margin-bottom: 3pt; width: 100%"><DIV STYLE="margin-top: 0; margin-right: 0; font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><A HREF="ggn-n2a_041524.htm">GAMCO Global Gold, Natural Resources &amp; Income Trust N-2/A</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 99.(l)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">[Letterhead of Skadden, Arps, Slate, Meagher &amp;
Flom LLP]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 48pt; text-align: center">April 15, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">GAMCO Global Gold, Natural Resources &amp; Income Trust<BR>
One Corporate Center</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Rye, New York 10580-1422</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 15pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">RE:</TD><TD>GAMCO Global Gold, Natural Resources &amp; Income Trust</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in; text-indent: 0in"><U>Shelf Registration Statement on Form N-2</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">We have acted as special counsel
to GAMCO Global Gold, Natural Resources &amp; Income Trust, a Delaware statutory trust (the &ldquo;Company&rdquo;), in connection with
the Registration Statement on Form N-2 filed by the Company with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;)
on February 20, 2024, under the Securities Act of 1933 (the &ldquo;Securities Act&rdquo;), as amended by Pre-Effective Amendment No. 1
to the Registration Statement to be filed by the Company on the date hereof (as amended, the &ldquo;Registration Statement&rdquo;). The
Registration Statement relates to the issuance and sale by the Company from time to time, pursuant to Rule 415 of the General Rules and
Regulations of the Commission promulgated under the Securities Act (the &ldquo;Rules and Regulations&rdquo;), of (i)&nbsp;common shares
of the Company, par value $0.001 per share (the &ldquo;Common Shares&rdquo;) and (ii)&nbsp;preferred shares of the Company, par value
$0.001 per share (the &ldquo;Preferred Shares&rdquo;), which may be issued in one or more series. The Common Shares and Preferred Shares
offered pursuant to the Registration Statement are collectively referred to herein as the &ldquo;Securities.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">This opinion is being furnished
in accordance with the requirements of sub paragraph (l)&nbsp;of item 25.2 of Part C of Form N-2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">In rendering the opinions stated
herein, we have examined and relied upon the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-size: 10pt">(a)</FONT><FONT STYLE="font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">the Registration Statement; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-size: 10pt">(b)</FONT><FONT STYLE="font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">an executed copy of a certificate of Peter Goldstein, Secretary of the Company, dated the date hereof
(the &ldquo;Secretary&rsquo;s Certificate&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-size: 10pt">(c)</FONT><FONT STYLE="font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">a copy of the Company&rsquo;s Certificate of Trust dated January 4, 2005, and a copy of each Certificate
of Amendment to the Certificate of Trust dated January 12, 2005, September 12, 2007, December 1, 2011 and March 26, 2014, respectively
(collectively, the &ldquo;Certificate of Trust&rdquo;), each as certified by the Secretary of State of the State of Delaware as of April
10, 2024, and each certified pursuant to the Secretary&rsquo;s Certificate;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0pt">&nbsp;&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: left; text-indent: 0">GAMCO Global Gold, Natural Resources &amp; Income Trust</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: left; text-indent: 0">April  15, 2024</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: left; text-indent: 0">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: left; text-indent: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: left; text-indent: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-size: 10pt">(d)</FONT><FONT STYLE="font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT> <FONT STYLE="font-size: 10pt">&nbsp;a copy of the Company&rsquo;s Third Amended and Restated Agreement and Declaration of Trust,
dated as of February&nbsp;16, 2011, certified pursuant to the Secretary&rsquo;s Certificate;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-size: 10pt">(e)</FONT><FONT STYLE="font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">a copy of the Statement of Preferences of the Company&rsquo;s 5.00% Series B Cumulative Preferred
Shares, dated May&nbsp;7, 2013, certified pursuant to the Secretary&rsquo;s Certificate;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-size: 10pt">(f)</FONT><FONT STYLE="font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">a copy of the Company&rsquo;s Third Amended and Restated&nbsp;By-Laws,&nbsp;as amended and in effect
as of the date hereof,&nbsp;certified pursuant to the Secretary&rsquo;s Certificate;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-size: 10pt">(g)</FONT><FONT STYLE="font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">a copy of certain resolutions of the Board of Trustees of the Company, adopted on February&nbsp;13,
2024, certified pursuant to the Secretary&rsquo;s Certificate; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-size: 10pt">(h)</FONT><FONT STYLE="font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-size: 10pt">a copy of a certificate, dated the date hereof, from the Secretary of State of the State of Delaware
with respect to the Company&rsquo;s existence and good standing in the State of Delaware.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">We have also examined originals
or copies, certified or otherwise identified to our satisfaction, of such records of the Company and such agreements, certificates and
receipts of public officials, certificates of officers or other representatives of the Company and others, and such other documents as
we have deemed necessary or appropriate as a basis for the opinions stated below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">In our examination, we have
assumed the genuineness of all signatures, including electronic signatures, the legal capacity and competency of all natural persons,
the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us
as facsimile, electronic, certified or photocopied copies, and the authenticity of the originals of such copies. As to any facts relevant
to the opinions stated herein that we did not independently establish or verify, we have relied upon statements and representations of
officers and other representatives of the Company and others and of public officials, including the facts and conclusions set forth in
the Secretary&rsquo;s Certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">We do not express any opinion
with respect to the laws of any jurisdiction other than the Delaware Statutory Trust Act (the &ldquo;DSTA&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">As used herein &ldquo;Transaction
Documents&rdquo; means any applicable underwriting or purchase agreement and &ldquo;Organizational Documents&rdquo; means those documents
listed in paragraphs (c) through (f) above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">The opinions stated in paragraphs
1 and 2 below presume that all of the following (collectively, the &ldquo;general conditions&rdquo;) shall have occurred prior to the
issuance of the Securities referred to therein:</P>


<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0pt">&nbsp;&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: left; text-indent: 0">GAMCO Global Gold, Natural Resources &amp; Income Trust</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: left; text-indent: 0">April 15, 2024</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: left; text-indent: 0">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: left; text-indent: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(i) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Registration Statement, as finally amended (including all necessary pre-effective and post-effective amendments), has become effective
under the Securities Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(ii) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;an
appropriate prospectus supplement or term sheet with respect to such Securities has been prepared, delivered and filed in compliance with
the Securities Act and the applicable Rules and Regulations;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(iii) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
applicable Transaction Documents shall have been duly authorized, executed and delivered by the Company and the other parties thereto,
including, if such Securities are to be sold or otherwise distributed pursuant to a firm commitment underwritten offering, an &ldquo;at
the market&rdquo; offering or other offering with underwriters or agents, the underwriting, sales agent or other agreement or purchase
agreement with respect thereto;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(iv) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Board of Trustees of the Company, including any duly authorized committee thereof, shall have taken all necessary statutory trust action
to approve the issuance and sale of such Securities and related matters and appropriate officers of the Company have taken all related
action as directed by or under the direction of the Board of Trustees of the Company; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the terms of the applicable Transaction Documents and the issuance and sale of such Securities have been duly established in conformity
with the Organizational Documents so as not to violate any applicable law, or the Organizational Documents, or result in a default under
or breach of any agreement or instrument binding upon the Company, and so as to comply with any requirement or restriction imposed by
any court or governmental body having jurisdiction over the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Based upon the foregoing and
subject to the assumptions stated herein, we are of the opinion that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">1. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With
respect to any Common Shares offered by the Company (the &ldquo;Offered Common Shares&rdquo;), when (a) the general conditions shall have
been satisfied, (b) if the Offered Common Shares are to be certificated, certificates in the form required by the Organizational Documents
representing the Common Shares are duly executed and countersigned and (c) the Offered Common Shares are registered in the Company&rsquo;s
share register and delivered upon payment of the agreed-upon consideration therefor, the Offered Common Shares, when issued and sold or
otherwise distributed in accordance with the provisions of the applicable Transaction Document, will be duly authorized by all requisite
statutory trust action on the part of the Company under the DSTA and validly issued, fully paid and nonassessable, provided that the consideration
therefor is not less than $0.001 per share of Common Shares.</P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 0; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0; margin-bottom: 0pt">&nbsp;&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 0; margin-bottom: 6pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: left; text-indent: 0">GAMCO Global Gold, Natural Resources &amp; Income Trust</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: left; text-indent: 0">April 15, 2024</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: left; text-indent: 0">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: left; text-indent: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0pt; text-align: justify; text-indent: 1in">2. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With
respect to any shares of any series of Preferred Shares offered by the Company (the &ldquo;Offered Preferred Shares&rdquo;), when (a)&nbsp;the
general conditions shall have been satisfied, (b) the Board of Trustees of the Company, or a duly authorized committee thereof, has duly
adopted a Statement of Preferences for the Offered Preferred Shares in accordance with the DSTA and the Organizational Documents, (c)
if the Offered Preferred Shares are to be certificated, certificates in the form required by the Organizational Documents representing
the Offered Preferred Shares are duly executed and countersigned and (d) the Offered Preferred Shares are registered in the Company&rsquo;s
share register and delivered upon payment of the agreed-upon consideration therefor, the Offered Preferred Shares, when issued and sold
or otherwise distributed in accordance with the provisions of the applicable Transaction Document, will be duly authorized by all requisite
statutory trust action on the part of the Company under the DSTA and validly issued, fully paid and nonassessable, provided that the
consideration therefor is not less than $0.001 per share of Preferred Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1in">In rendering the foregoing
opinions we have assumed that the Organizational Documents are the only governing instruments, as defined under the DSTA, of the Company;
the Company has, and since the time of its formation has had, at least one validly admitted and existing trustee of the Company satisfying
the requirements of the DSTA and (i) no procedures have been instituted for and no other event has occurred, including, without limitation,
any action taken by the Company or its Board of Trustees or shareholders, as applicable, that would result in the liquidation, dissolution
or winding-up of the Company, (ii) no event has occurred that has adversely affected the good standing of the Company under the laws of
its jurisdiction of formation, and the Company has taken all actions required by the laws of its jurisdiction of formation to maintain
such good standing and (iii) no grounds exist for the revocation or forfeiture of the Company&rsquo;s Certificate of Trust.</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0 0 0pt; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0">GAMCO Global Gold, Natural Resources &amp; Income Trust</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: left; text-indent: 0">April 15, 2024</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: left; text-indent: 0">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: left; text-indent: 0">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify; text-indent: 1in">We hereby consent to the filing
of this opinion with the Commission as an exhibit to the Registration Statement. We also hereby consent to the reference to our firm under
the heading &ldquo;Legal Matters&rdquo; in the prospectus forming part of the Registration Statement. In giving this consent, we do not
thereby admit that we are within the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the Rules
and Regulations. This opinion is expressed as of the date hereof unless otherwise expressly stated, and we disclaim any undertaking to
advise you of any subsequent changes in the facts stated or assumed herein or of any subsequent changes in applicable laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 24pt 0 10pt 50%">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 24pt 0 10pt 50%">/s/ Skadden, Arps, Slate, Meagher &amp; Flom LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">K.E.B.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">&nbsp;</P>



<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(N)
<SEQUENCE>4
<FILENAME>ex99-n.htm
<DESCRIPTION>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-right: 0; margin-top: 0; margin-bottom: 3pt; width: 100%"><DIV STYLE="margin-top: 0; margin-right: 0; font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><A HREF="ggn-n2a_041524.htm">GAMCO Global Gold, Natural Resources &amp; Income Trust N-2/A</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 99.(n)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: red"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: red"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-weight: normal"><U>CONSENT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: red">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">We hereby consent to the incorporation by reference in this Registration
Statement on Form N-2 of our report dated February 29, 2024, relating to the financial statements and financial highlights, which appears
in GAMCO Global Gold, Natural Resources &amp; Income Trust&#8217;s Annual Report on Form N-CSR for the year ended December 31, 2023. We
also consent to the references to us under the headings &#8220;Financial Statements&#8221; and &quot;Independent Registered Public Accounting
Firm&quot; in such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">/s/ PricewaterhouseCoopers LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">New York, New York</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">April 15, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="border-top: rgb(255,192,0) 1pt dotted; padding-bottom: 3.5pt; padding-top: 3.5pt; border-left: rgb(255,192,0) 1pt dotted; font: italic 9pt Times New Roman, Times, Serif; margin: 0px; padding-left: 3.5pt">PricewaterhouseCoopers LLP, PricewaterhouseCoopers Center, 300 Madison
Avenue, New York, NY 10017<BR>
T: (646) 471 3000, F: (813) 286 6000, www.pwc.com/us</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>5
<FILENAME>ex99-siv.htm
<DESCRIPTION>CALCULATION OF FILING FEE TABLE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<!-- Field: Rule-Page --><DIV STYLE="margin-right: 0; margin-top: 0; margin-bottom: 3pt; width: 100%"><DIV STYLE="margin-top: 0; margin-right: 0; font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><A HREF="ggn-n2a_041524.htm">GAMCO Global Gold, Natural Resources &amp; Income Trust N-2/A</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Exhibit
99.(s)(iv)</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Calculation
of Filing Fee Tables</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
N-2&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Form
Type)</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>GAMCO
Global Gold, Natural Resources &amp; Income Trust</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
Name of Registrant as Specified in its Charter)</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Table
1: Newly Registered and Carry Forward Securities</U></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-top: black 1pt solid; padding: 1pt; width: 7%; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; padding: 1pt; width: 7%; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Security<BR>
Type</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; padding: 1pt; width: 9%; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Security<BR>
Class<BR>
Title</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; padding: 1pt; width: 9%; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Fee<BR>
Calculation<BR>
or Carry<BR>
Forward<BR>
Rule</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; padding: 1pt; width: 8%; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Amount<BR>
Registered</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; padding: 1pt; width: 8%; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Proposed<BR>
Maximum<BR>
Offering<BR>
Price Per<BR>
Unit</B></FONT></TD>
    <TD STYLE="white-space: nowrap; border-top: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 1pt; width: 8%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Maximum<BR>
Aggregate<BR>
Offering<BR>
Price(1)(3)</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; padding: 1pt; width: 3%; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Fee<BR>
Rate</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; padding: 1pt; width: 8%; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Amount of<BR>
Registration<BR>
Fee</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; padding: 1pt; width: 8%; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Carry<BR>
Forward<BR>
Form<BR>
Type</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; padding: 1pt; width: 8%; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Carry<BR>
Forward<BR>
File<BR>
Number</B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; padding: 1pt; width: 8%; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Carry<BR>
Forward<BR>
Initial<BR>
effective<BR>
date</B></FONT></TD>
    <TD STYLE="border: black 1pt solid; padding: 1pt; width: 9%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Filing Fee<BR>
Previously<BR>
Paid In<BR>
Connection<BR>
with<BR>
Unsold<BR>
Securities<BR>
to be<BR>
Carried<BR>
Forward</B></FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Fees to be paid</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Common Shares(2)</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Rule 457(o)</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; padding: 1pt; vertical-align: bottom; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Fees to be paid</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Equity </FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Preferred Shares(2)</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Rule 457(o)</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; padding: 1pt; vertical-align: bottom; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Fees to be paid</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Unallocated (Universal) Shelf</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Unallocated (Universal) Shelf</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Rule 457(o)</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$143,439(1) </FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$147.60</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$21.17</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; padding: 1pt; vertical-align: bottom; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Fees Previously Paid</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: top; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: top; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; padding: 1pt; vertical-align: bottom; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="13" STYLE="border-right: black 1pt solid; padding: 1pt; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Carry Forward Securities</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid"><FONT STYLE="font-size: 10pt">Carry Forward Securities</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Common Shares</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Rule<BR>
415(a)(6)</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">N-2</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">333-255130</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">June&nbsp;16,<BR>
2021</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; padding: 1pt; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid"><FONT STYLE="font-size: 10pt">Carry Forward Securities</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Preferred Shares</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 1pt; text-align: center"><FONT STYLE="font-size: 10pt">Rule<BR>
415(a)(6)</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">N-2</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">333-255130</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">June&nbsp;16,<BR>
2021</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; padding: 1pt; border-bottom: black 1pt solid; border-left: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid"><FONT STYLE="font-size: 10pt">Carry Forward Securities</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Other</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Unallocated (Universal) Shelf</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: black 1pt solid; border-left: black 1pt solid; padding: 1pt; text-align: center"><FONT STYLE="font-size: 10pt">Rule<BR>
415(a)(6)</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$499,856,561(4)</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">N-2</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">333-255130</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">June&nbsp;16,<BR>
2021</FONT></TD>
    <TD STYLE="border-right: black 1pt solid; padding: 1pt; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$54,550(4)</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="5" STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: right"><FONT STYLE="font-size: 10pt">Total Offering Amounts</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; white-space: nowrap; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$500,000,000(1)(3)</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; white-space: nowrap; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$21.17</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; padding: 1pt; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="5" STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: right"><FONT STYLE="font-size: 10pt">Total Fees Previously Paid</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; padding: 1pt; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="5" STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: right"><FONT STYLE="font-size: 10pt">Total Fee Offsets</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; padding: 1pt; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD COLSPAN="5" STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: top; border-left: black 1pt solid; text-align: right"><FONT STYLE="font-size: 10pt">Net Fee Due</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; white-space: nowrap; vertical-align: bottom; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$21.17</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: bottom; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1pt; vertical-align: top; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; padding: 1pt; vertical-align: bottom; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify; width: 95%"><FONT STYLE="font-size: 10pt">Estimated solely for purposes of calculating the registration fee, pursuant to Rule 457(o) under the Securities Act of 1933. The proposed maximum offering price per security will be determined, from time to time, by the Registrant in connection with the sale by the Registrant of the securities registered under this registration statement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">There is being registered hereunder an indeterminate number of common shares and preferred shares as may be sold, from time to time.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">In no event will the aggregate offering price of all securities issued from time to time pursuant to this registration statement exceed $500,000,000.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Included as part of Unallocated (Universal) Shelf. Pursuant to Rule 415(a)(6) under the Securities Act of 1933, the Registrant is carrying forward $499,856,561 aggregate principal offering price of unsold securities (the &ldquo;Unsold Securities&rdquo;) that were previously registered for sale under a Registration Statement on Form N-2 (File No. 333-255130) initially filed on April 8, 2021, as amended on May 26, 2021 and June 14, 2021, declared effective on June 16, 2021, and further amended on June 17, 2021, August 19, 2022 and October 5, 2022 (the &ldquo;Prior Registration Statement&rdquo;). The Registrant previously paid filing fees in the aggregate of $54,550 relating to the securities registered on the Prior Registration Statement. Pursuant to Rule 415(a)(6) under the Securities Act, the filing fees previously paid with respect to the Unsold Securities will continue to be applied to such Unsold Securities. Pursuant to Rule 415(a)(6) under the Securities Act, the offering of Unsold Securities under the Prior Registration Statement will be deemed terminated as of the date of effectiveness of this Registration Statement.</FONT></TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>

    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>ggn-20240415.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +6spw7xRiXhun8uCbn1MSaaPObP9w5dzqelBtm9wHfm6TyshmO+iLyX4aRu2YTcD -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ggn="http://gabelli.com/20240415" elementFormDefault="qualified" targetNamespace="http://gabelli.com/20240415">
    <annotation>
      <appinfo>
        <link:linkbaseRef xlink:type="simple" xlink:href="ggn-20240415_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="ggn-20240415_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="ggn-20240415_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/cef/2023" schemaLocation="https://xbrl.sec.gov/cef/2023/cef-2023.xsd" />
    <import namespace="http://xbrl.sec.gov/cef-pre/2023" schemaLocation="https://xbrl.sec.gov/cef/2023/cef-2023_pre.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
    <element id="ggn_CommonStocksMember" name="CommonStocksMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ggn_SeriesBCumulativePreferredStockMember" name="SeriesBCumulativePreferredStockMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ggn_PreferredStocksMember" name="PreferredStocksMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>ggn-20240415_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/SecurityOnly" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#SecurityOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/AddressTypeOnly" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#AddressTypeOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/RiskOnly" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#RiskOnly" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:loc xlink:type="locator" xlink:href="ggn-20240415.xsd#ggn_CommonStocksMember" xlink:label="loc_ggnCommonStocksMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ggnCommonStocksMember" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="ggn-20240415.xsd#ggn_SeriesBCumulativePreferredStockMember" xlink:label="loc_ggnSeriesBCumulativePreferredStockMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ggnSeriesBCumulativePreferredStockMember" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="ggn-20240415.xsd#ggn_PreferredStocksMember" xlink:label="loc_ggnPreferredStocksMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ggnPreferredStocksMember" xlink:type="arc" order="20" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/AddressTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/RiskOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>ggn-20240415_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="ggn-20240415.xsd#ggn_CommonStocksMember" xlink:label="ggn_CommonStocksMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ggn_CommonStocksMember" xlink:to="ggn_CommonStocksMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ggn_CommonStocksMember_lbl" xml:lang="en-US">Common Stocks [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ggn-20240415.xsd#ggn_SeriesBCumulativePreferredStockMember" xlink:label="ggn_SeriesBCumulativePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ggn_SeriesBCumulativePreferredStockMember" xlink:to="ggn_SeriesBCumulativePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ggn_SeriesBCumulativePreferredStockMember_lbl" xml:lang="en-US">Series B Cumulative Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ggn-20240415.xsd#ggn_PreferredStocksMember" xlink:label="ggn_PreferredStocksMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ggn_PreferredStocksMember" xlink:to="ggn_PreferredStocksMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ggn_PreferredStocksMember_lbl" xml:lang="en-US">Preferred Stocks [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ggn_CommonStocksMember" xlink:to="ggn_CommonStocksMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ggn_CommonStocksMember_doc" xml:lang="en-US">Common Stocks.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ggn_SeriesBCumulativePreferredStockMember" xlink:to="ggn_SeriesBCumulativePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ggn_SeriesBCumulativePreferredStockMember_doc" xml:lang="en-US">Series B Cumulative Preferred Stock.</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>ggn-20240415_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/N2Cover" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#N2Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/N2" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#N2" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" xlink:title="995470 - Disclosure - N-2">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2023/cef-2023.xsd#cef_ProspectusLineItems" xlink:label="loc_cefProspectusLineItems" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:loc xlink:type="locator" xlink:href="ggn-20240415.xsd#ggn_CommonStocksMember" xlink:label="loc_ggnCommonStocksMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ggnCommonStocksMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ggn-20240415.xsd#ggn_SeriesBCumulativePreferredStockMember" xlink:label="loc_ggnSeriesBCumulativePreferredStockMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ggnSeriesBCumulativePreferredStockMember" order="100" />
      <link:loc xlink:type="locator" xlink:href="ggn-20240415.xsd#ggn_PreferredStocksMember" xlink:label="loc_ggnPreferredStocksMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ggnPreferredStocksMember" order="200" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>7</ContextCount>
  <ElementCount>52</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>4</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="ggn-n2a_041524.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995470 - Disclosure - N-2</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cef/role/N2</Role>
      <ShortName>N-2</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>ggn-20240415.xsd</File>
    <File>ggn-20240415_def.xml</File>
    <File>ggn-20240415_lab.xml</File>
    <File>ggn-20240415_pre.xml</File>
    <File doctype="N-2/A" isN2Prospectus="true" isUsgaap="true" original="ggn-n2a_041524.htm">ggn-n2a_041524.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="5">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="15">http://xbrl.sec.gov/cef/2023</BaseTaxonomy>
    <BaseTaxonomy items="42">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ggn-n2a_041524.htm": {
   "nsprefix": "ggn",
   "nsuri": "http://gabelli.com/20240415",
   "dts": {
    "schema": {
     "local": [
      "ggn-20240415.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/2006/xbrldi-2006.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/cef/2023/cef-2023.xsd",
      "https://xbrl.sec.gov/cef/2023/cef-2023_pre.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023_lab.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "ggn-20240415_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "ggn-20240415_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ggn-20240415_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ggn-n2a_041524.htm"
     ]
    }
   },
   "keyStandard": 52,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 3,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2023": 4
   },
   "contextCount": 7,
   "entityCount": 1,
   "segmentCount": 4,
   "elementCount": 200,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 42,
    "http://xbrl.sec.gov/cef/2023": 15,
    "http://fasb.org/us-gaap/2023": 5
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/cef/role/N2",
     "longName": "995470 - Disclosure - N-2",
     "shortName": "N-2",
     "isDefault": "true",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-15",
      "name": "dei:AmendmentDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ggn-n2a_041524.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-04-15",
      "name": "dei:AmendmentDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ggn-n2a_041524.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "cef_AcquiredFundFeesAndExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundFeesAndExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "cef_AcquiredFundFeesAndExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundFeesAndExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "cef_AcquiredFundFeesEstimatedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundFeesEstimatedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees Estimated, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "cef_AcquiredFundIncentiveAllocationNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundIncentiveAllocationNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Incentive Allocation, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Total Annual Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AllRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AllRisksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Risks:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AnnualCoverageReturnRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualCoverageReturnRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Coverage Return Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "cef_AnnualDividendPayment": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualDividendPayment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "cef_AnnualDividendPaymentCurrent": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualDividendPaymentCurrent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Current"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "cef_AnnualDividendPaymentInitial": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualDividendPaymentInitial",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Initial"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "cef_AnnualExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "cef_AnnualInterestRateCurrentPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualInterestRateCurrentPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Current [Percent]"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "cef_AnnualInterestRateInitialPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualInterestRateInitialPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Initial [Percent]"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "cef_AnnualInterestRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "AnnualInterestRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "cef_BasisOfTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "BasisOfTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "cef_BdcFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "BdcFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BDC File Number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r89"
     ]
    },
    "cef_BusinessDevelopmentCompanyFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "BusinessDevelopmentCompanyFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Development Company [Flag]"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "cef_CapitalStockTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "CapitalStockTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r30",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r64",
      "r65",
      "r66",
      "r67",
      "r68",
      "r69",
      "r70",
      "r73",
      "r74",
      "r75",
      "r76",
      "r77",
      "r78",
      "r79",
      "r174",
      "r175",
      "r177"
     ]
    },
    "ggn_CommonStocksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20240415",
     "localname": "CommonStocksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stocks [Member]",
        "documentation": "Common Stocks."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r7",
      "r8",
      "r10",
      "r11",
      "r17",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r53",
      "r80",
      "r81",
      "r82",
      "r83",
      "r84",
      "r176"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r17",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r53",
      "r80",
      "r81",
      "r82",
      "r83",
      "r84",
      "r176"
     ]
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r90",
      "r91",
      "r161"
     ]
    },
    "cef_DistributionServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DistributionServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution/Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_DistributionsMayReducePrincipalTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DistributionsMayReducePrincipalTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distributions May Reduce Principal [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "cef_DividendAndInterestExpensesOnShortSalesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DividendAndInterestExpensesOnShortSalesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend and Interest Expenses on Short Sales [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_DividendExpenseOnPreferredSharesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DividendExpenseOnPreferredSharesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Expenses on Preferred Shares [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r90",
      "r91",
      "r161"
     ]
    },
    "cef_DividendReinvestmentAndCashPurchaseFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "DividendReinvestmentAndCashPurchaseFees",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Reinvestment and Cash Purchase Fees"
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "cef_EffectsOfLeveragePurposeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "EffectsOfLeveragePurposeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage, Purpose [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_EffectsOfLeverageTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "EffectsOfLeverageTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_EffectsOfLeverageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "EffectsOfLeverageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "cef_ExpenseExampleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "cef_ExpenseExampleYear01": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYear01",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Year 01"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "cef_ExpenseExampleYears1to10": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYears1to10",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 10"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "cef_ExpenseExampleYears1to3": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYears1to3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 3"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "cef_ExpenseExampleYears1to5": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ExpenseExampleYears1to5",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 5"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "cef_FeeTableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "FeeTableAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Table [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "cef_FinancialHighlightsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "FinancialHighlightsAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "cef_GeneralDescriptionOfRegistrantAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "GeneralDescriptionOfRegistrantAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Description of Registrant [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "cef_HighestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "HighestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "cef_HighestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "HighestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "cef_HighestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "HighestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "cef_IncentiveAllocationMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveAllocationMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "cef_IncentiveAllocationMinimumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveAllocationMinimumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Minimum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "cef_IncentiveAllocationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveAllocationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "cef_IncentiveFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IncentiveFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_InterestExpensesOnBorrowingsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "InterestExpensesOnBorrowingsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expenses on Borrowings [Percent]"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "us-gaap_InterestRateRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestRateRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate Risk [Member]",
        "documentation": "The risk associated with changes in interest rates that effect the value of an interest-bearing asset or liability, and a servicing asset or liability."
       }
      }
     },
     "auth_ref": []
    },
    "cef_IntervalFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "IntervalFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interval Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r91",
      "r158",
      "r159",
      "r160"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "cef_InvestmentObjectivesAndPracticesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "InvestmentObjectivesAndPracticesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Objectives and Practices [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "cef_LatestNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LatestNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest NAV (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "cef_LatestPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LatestPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "cef_LatestSharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LatestSharePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Share Price (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "cef_LoanServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LoanServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "cef_LongTermDebtDividendsAndCovenantsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtDividendsAndCovenantsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Dividends and Covenants [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Issuance and Substitution [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "cef_LongTermDebtPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtPrincipal",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Principal"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "cef_LongTermDebtStructuringTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtStructuringTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Structuring [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "cef_LongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "cef_LongTermDebtTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LongTermDebtTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "cef_LowestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LowestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "cef_LowestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LowestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "cef_LowestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "LowestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fee not based on Net Assets, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "cef_ManagementFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ManagementFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "us-gaap_NetAssetValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetAssetValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NAV Per Share",
        "documentation": "Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r61",
      "r68",
      "r69",
      "r71",
      "r72",
      "r75",
      "r85"
     ]
    },
    "cef_NetExpenseOverAssetsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NetExpenseOverAssetsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Expense over Assets [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_NewCefOrBdcRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NewCefOrBdcRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New CEF or BDC Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r91",
      "r158",
      "r159",
      "r160"
     ]
    },
    "cef_NoPublicTradingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NoPublicTradingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Public Trading [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "cef_NoTradingHistoryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "NoTradingHistoryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading History [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "cef_OtherAnnualExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_OtherAnnualExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_OtherAnnualExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_OtherAnnualExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_OtherAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherAnnualExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_OtherExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "cef_OtherFeederFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherFeederFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Feeder Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_OtherMasterFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherMasterFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Master Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_OtherSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "cef_OtherSecurityDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherSecurityDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "cef_OtherSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "cef_OtherTransactionExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_OtherTransactionExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_OtherTransactionExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_OtherTransactionExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_OtherTransactionExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesBasisMaximum",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesBasisMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_OtherTransactionFeesBasisNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesBasisNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_OtherTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OtherTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_OutstandingSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "cef_OutstandingSecurityAuthorizedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityAuthorizedShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Authorized [Shares]"
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "cef_OutstandingSecurityHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "cef_OutstandingSecurityNotHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityNotHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Not Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "cef_OutstandingSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "OutstandingSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockLiquidationPreference",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Liquidating Preference",
        "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r6",
      "r9",
      "r175",
      "r178"
     ]
    },
    "cef_PreferredStockRestrictionsArrearageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PreferredStockRestrictionsArrearageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Arrearage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "cef_PreferredStockRestrictionsOtherTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PreferredStockRestrictionsOtherTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Other [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ggn_PreferredStocksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20240415",
     "localname": "PreferredStocksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stocks [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_PrimaryShelfFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PrimaryShelfFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf [Flag]"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "cef_PrimaryShelfQualifiedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PrimaryShelfQualifiedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf Qualified [Flag]"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "cef_ProspectusLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ProspectusLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "cef_ProspectusTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ProspectusTable",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "cef_PurposeOfFeeTableNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "PurposeOfFeeTableNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purpose of Fee Table , Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "cef_RegisteredClosedEndFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RegisteredClosedEndFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered Closed-End Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "cef_ReturnAtMinusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtMinusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_ReturnAtMinusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtMinusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_ReturnAtPlusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtPlusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_ReturnAtPlusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtPlusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_ReturnAtZeroPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ReturnAtZeroPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Zero [Percent]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_RightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Subject to Other than Majority Vote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "cef_RiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RiskAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_RiskFactorsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RiskFactorsTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk Factors [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "cef_RiskTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "RiskTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_SalesLoadPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SalesLoadPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Load [Percent]"
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "cef_SecurityDividendsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityDividendsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Dividends [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "cef_SecurityLiabilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityLiabilitiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liabilities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "cef_SecurityLiquidationRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityLiquidationRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liquidation Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "cef_SecurityObligationsOfOwnershipTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityObligationsOfOwnershipTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Obligations of Ownership [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "cef_SecurityPreemptiveAndOtherRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityPreemptiveAndOtherRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Preemptive and Other Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "cef_SecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "cef_SecurityVotingRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SecurityVotingRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Voting Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "cef_SeniorSecuritiesAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAmount",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "cef_SeniorSecuritiesAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "cef_SeniorSecuritiesAverageMarketValuePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAverageMarketValuePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Average Market Value per Unit"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Averaging Method, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "cef_SeniorSecuritiesCoveragePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesCoveragePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "cef_SeniorSecuritiesCvgPerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesCvgPerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "cef_SeniorSecuritiesHeadingsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesHeadingsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Headings, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Annualized, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r133",
      "r140"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Audited, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r134",
      "r140"
     ]
    },
    "cef_SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Involuntary Liquidating Preference per Unit (Deprecated 2023-01-31)"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "cef_SeniorSecuritiesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r132",
      "r140"
     ]
    },
    "cef_SeniorSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SeniorSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ggn_SeriesBCumulativePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://gabelli.com/20240415",
     "localname": "SeriesBCumulativePreferredStockMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B Cumulative Preferred Stock [Member]",
        "documentation": "Series B Cumulative Preferred Stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "cef_SharePriceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SharePriceTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "cef_SharePricesNotActualTransactionsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "SharePricesNotActualTransactionsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Prices Not Actual Transactions [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "cef_ShareholderTransactionExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "ShareholderTransactionExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Transaction Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r30",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r64",
      "r65",
      "r66",
      "r67",
      "r68",
      "r69",
      "r70",
      "r73",
      "r74",
      "r75",
      "r76",
      "r77",
      "r78",
      "r79",
      "r174",
      "r175",
      "r177"
     ]
    },
    "cef_TotalAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "TotalAnnualExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "cef_UnderwritersCompensationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "UnderwritersCompensationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriters Compensation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "cef_WaiversAndReimbursementsOfFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WaiversAndReimbursementsOfFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Waivers and Reimbursements of Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "cef_WarrantsOrRightsCalledAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsCalledAmount",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Amount"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "cef_WarrantsOrRightsCalledPeriodDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsCalledPeriodDate",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Period [Date]"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "cef_WarrantsOrRightsCalledTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsCalledTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Title"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "cef_WarrantsOrRightsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2023",
     "localname": "WarrantsOrRightsExercisePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482134/820-10-35-54B"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "59",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482134/820-10-35-59"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "4"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "5"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "6"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "Instruction 2"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "c"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "d"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "a"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "b"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "c"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "e"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "3"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "1"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "2"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "3"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "4"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a, g, h"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "f"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "g"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "i"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 11"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 4"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 5"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 6"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "a"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "b"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 9"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 2"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 3"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "2"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "3",
   "Subparagraph": "Instruction 2"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "4",
   "Subparagraph": "Instruction 3"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "5"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 4"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 5"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "2",
   "Paragraph": "b, d"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "a"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "3"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "4"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 2"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 3"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 4"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instructions 4, 5"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "c"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "e"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r175": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
  },
  "r178": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001999371-24-004808-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001999371-24-004808-xbrl.zip
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M*)FQL[/S_SX@7 \F-0]P /R_\P,:F&7G#%(E(];;;;%^M[]S+^=]MKH?'%W
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MR$@^43R=,@CU#?/AC@02L?YNIX_+SKG*V#'^RYF_SJ.@_28&#%"E$%O$QY)
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MI0!M#U7@TF0.^^P7C(3V6-\4*QG\Y]=5UY=";ZK9OD!A*U7Q>DWDI@VZ=;5
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M<(Q$J 1SQ#D^O$CR(F7.1YKT+6/F(T!E\D43G;8!@(&.#1WM@"!F$NNVJ':
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MK=8#&J\H/O0AP,OV[QUY';Q/NS*_XYVGR^=/9"ASU1<":\))\(QNI0(]!,E
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M2,BP[^\?"N]#",D:1&RJU,;Z JF[,A-R6/!IT=&1KOUVK4LO3W((TA&3]S.
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M   0    9V=N+3(P,C0P-#$U+GAS9,U6;4_;,!#^/FG_P<O7*4U?@*VA'=I
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M%'?+#,6] ;87$96;KH] Y$4NPRIM7*;]JL\?8!)4GSL:,94#ZF]D,*1,*FV
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M @)AFNA,)A+!-;E0!?JBM)>[:88-0M(AIK'@X(1K--:BW@%/QA0C*XT?-/V
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MDE2,/&M%!&9^?H\R"]+9T?:KADA&D<#CG0:,*+1W%NT=#G06>/@&-39?L&3
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M9'V1LM40:6C:>,2=9R0HO4QCDEUQP$B_2\(%BF$PHD6BM^-KK:V0YK(V2.D
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M#Z])H0[!0)[OJA2:7RROKW"]/V4E.9K>^_8JE(M6^N!7'TEI?IG?4;"T!SN
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MU.(>&W'72N/O_=!V#<EP\_CTY)AS,>S=OX$6@QK7.FJ6=N!'1=W2#GQ?Y,4
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MGD1;N#X#4)9"31K[X25=1!PB37>P@0UP5 I2%8JYP2@E7$:-N>&<&,U;7#$
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M&OR&]%M$J@3NCQ_&*,_8RKN'#!Y#,U 0&:A<918OU,EDSXM<6![H4VHN2F=
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M3(T4VL%1&.?,,92F/]V1 QIARROVF1:5YKYDPY.>SF8SWEP4IIS)"VPF_40
M"P26_5Q(=WYXBBU&@<NC2$V@?<G(IVC2N3:Y,K)T.H&-M@H=^LABI+>=0VGD
M'G'%>0FRL6\5>^)/8VTUZ@/1'4K;IF&,G:L '$Z3Y7"P/ G[F#FK8M)+\O@(
M0#= K !Y/[ ZU%Y>T\?_=L:3=](1T)0&^5>*(<IW[.P[ZB)E+NU&O5JS:^N
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M,FF.2LXZJBTF>H)DN#-NE/3&HW^XEPF>Q.H5RD0T0UZK7&V9)IL<ZQV85\E
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MXZ4!(8C19U6=5%JFTUQO[J[=CB06J VK*5I!V $86D8(1H ARIRTULU:D,U
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M*\A%BK:]!@'L/W,X/R5K9'>25HQM]:U%9Q:RCNT>%4E<[SP6D59T4>Y %^I
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MN9H,$2J22^,E$&19H@AF>A\!K@B>($$$]P+"\#9;3NB'IR6;.F J8L##3+2
M1R):9";_CA'D"'<;#UTAG_$.+'+8"I%D!OZ-B7"YW@(ZO&$0/?N'N=D)6^$
M+4( =2\C<SVB(0 &:J].,_48@37CS(\% @%_AW>S8U,%Y#%Q2!L0-,S;#A-P
MD].8,<J&SZG!]ZJVN6.H>[DT/^%S"*:JJUU@;-@,UI<=X5P3- 0#H?EE;I_
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M^'RO)0XB*168%'&M1F#Y<(3K$D#,.Y\+;NCL$F$VAA%T8\&1Y=E-XK));U>
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M(P7^2PF3I.>M]*8,K&8,O^"7PD"N\AMJ;67VT"AIJ3$&55.DW"C1(XAHF<K
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M%X ,%5#U8@W_V?$!J_;SQ=!8#W,X<=\(/2*H>F-S(OC+""+<Y7!_YJ/;D7V
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M7V-R)X,(?\(T,I40KR0?F'<%O;<2[&BP3EU.28V#_,7I4C)<'?,%]JD=E*5
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M"X26[?%[OK1,S28S+XY'-M%S@TQT=E_45P3:*K;9!!,,-YN%F.+B8,1Y4>5
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MQWR9^ :#N/IXAI,MEQC]]O-@,$>07)V?$8$A-H%RBJ209O^C.HLY+8K=9[,
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MG+K=8B6DD:3]D6(&\P[?[6 [1Q1*[W9.+R_P/[8&VS980>$A-UU1LL!@H['
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M "C*$IPBO7%:S"*IL;/."HRFIW,X$0(V*<@:+CN6\=VQC(-OS#*0^AR/)TW
ML\IL42[_N9G:_!5%*'W^[O?];O?A:^81/4)K\MN3W/I=DALEN;WHDMP>,<FM
M$Q3?5% <?F-!H67-@R+_F!1L2B5Q1JC"S<1H@2Z68@^CR) :0VYR:NH^;I:
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M'BBB+6T2QVE%:)CL?."L>U7.U!6KR/G&+/?2 @D;(JD,,KOQ$$P5&=- RR=
M0J3WHYI=RXIT$B(#'42/TD$,)5O3W1_8.WX=FQ' :S!(:6UJ%==VYPSFCCU
M?_C GKIG,5H;=JCK<?%WD/].YJ@H+>>F98DT,R @.I@G3ZRE28[X+6C@P'<Y
M&=.=41)!K6<G)'W<Q)9HG9+U:VX'*#5.>YYQG&:EEU*JB:2.MAL%J6C$.&>D
M=;P[;43C454JRA-+1 >5WGR+=+;U$^,]E*<#,S-N1J.&BQO]QS"TRRSJ0/>U
MTR&#Q3\FEH4K-3K5GS18IEFU V*9_0KK4M^\C%:@M=UDUVL]8SHG*A"=D(++
ME+Q@8L2^&?-"P%:<&TXDI'PJSS$$5I\>2WM)*7#V>!J/^,TLA4U!_6"T'6*[
MW#BC>B(%N=.M"OAV.G1HJ"N7?#?=*%;'S;Z._$.C#K/7YHQ::<.E0_(ND6>^
M"ECQN*+2K%F<4KJS=G)N*6#S':[*3<HU=^-YB<CG*-9/Q<UXBSMZ@9F7!/^T
MIJY)86.SY-/Z)$9;%<A&?;P2!W;@)[FCY%&_)XJL<I%PE94MF*0,);Z]^)2B
MN.G-EWM)"KTZ3<6?,R0XKXH 1PN63,&ZKE6Q0Z.CL"GQ,,\WG4QUG/7MLPBP
MR'-31>IDX>D$GF.(% )/^"%7\[Q+CLO:HO$9SSKERD@6US9^ZGJ;&RUY?CO#
M#P+?4VMU*-2N&";=9JLQ)!RFL\' ,&X\$G@T*;7CPB,$-V)<0E+D8XNJCFE
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MVY"R+A:: <HM:JAL@$+!-@W<N.LY00D=_,:,E_?!\ #F7U)3]E#G@.QQ3?&
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M]$T8CQ*0._>H9>@;)U?*.C=8XZ(K6#K"SFD\PK*/@5*Q&)L%C(/K#<QHGL]
M]BKL7CU:O;*Y[[7/BB<%N^E0Z8IKNC9G 11=!O2(^W5W>I2%;HPTAZ;KRH%)
M&+GDEA.8[5W/O&B&W5=!TZ^K2ZMUQ"(&[5RS6_>H'K[?=+C!YL.-A\#-G70W
M=VJ(&R(^8^)Y=]BCYW5)GN/%-KZ 8'U_M(C#&#/.IB(WEI,PM+VAPK.68JZ$
MUY0!3A#!A?'WL)R12XAG9["R1(Q"NN#: >XIBTH[\2$E3(N[((^:FT.2A9L1
M$- "7F@$IYASX2'#9K-R;-=/*6XVI?EP#?"RWSU(TD4R4;P;<0UJ^ X&>N"
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M3J=;4;&#ST+%OFSFD6 W4393?&?)-B..&F ;-:2W3%LO<8@$=P+3QJ%!*W.
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M58V@QVKN)J?5(I6Z806^GS=KP1H;[22:A#3?T+QB&[U$\&<#-P.L%YWX&!]
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M7J )(?_^W'7=I*-JBD_V?OPE%%DUS+,L7I0P&_VO'_X&WR]T\&M4V89QIAO
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MU4=G$[ @#"/V^!)^VV@IN$0B'+2%,S<_3"?3JG3<B(Z*_[Q8SW-DEZC'XC7
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ME5=Q]M2862=G?OA;/]H_>,J29F/BSI<'@&X%^GU*,2830SVB&.J'I"CS>8G
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M)Y]G*V=:4CJX]J-A7*0EI0L6^2P<Q*,01JZF$959C)=9.$O+<1*7F*H?!:"
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ME78YZP3:*!GC"O#C(*P7>9GJ/'&]/.LH4%'$>HL52* 33!/ZVS"]3C-\9%B
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M"C"BCX%1D-(8 !H AV@F1HXGOZ(BWUS=8/:#.\!V/F.-&OM@(T,#.Y5UGB.
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M-[WXFY93_3$GP\:!'IWMSDT42>OC_3>'>V&K,U CFD$D.%".1D4@H_H(R#/
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M)6ZLH?LO62S[N/JQ!K=#'JM)3<<-G"=A5+$($]CO>#V$@P"$'@-3K/0QCO&
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ME!*A+8Q3<AXSM($,L%*W_Q+'AVM55,GEC:%HX!CP0MAG0\\Y ;H&Y_=R"H?
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MO)2 6%JSMB?54ORE;RGNM!3?W_,]Q9<AMY]^5V[U=&Q3G>/8@=_#8;\OLX[
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MVATAP0"QQ>__'U!+ 0(4 Q0    ( &Z'CUCWYQ[U/1$  &E6   *
M      "  0    !E>#DY+6PN:'1M4$L! A0#%     @ ;H>/6&Y\7>@K!
MUPX   H              ( !91$  &5X.3DM;BYH=&U02P$"% ,4    " !N
MAX]8E%H7VZH)  !A=P  #               @ &X%0  97@Y.2US:78N:'1M
M4$L! A0#%     @ ;H>/6/,]8@EE P  H0T  !               ( !C!\
M &=G;BTR,#(T,#0Q-2YX<V102P$"% ,4    " !NAX]8-M.^$/("  "1#P
M%               @ $?(P  9V=N+3(P,C0P-#$U7V1E9BYX;6Q02P$"% ,4
M    " !NAX]8B.<SI> "  !-$0  %               @ %#)@  9V=N+3(P
M,C0P-#$U7VQA8BYX;6Q02P$"% ,4    " !NAX]8Z&0[39P"  !P"P  %
M            @ %5*0  9V=N+3(P,C0P-#$U7W!R92YX;6Q02P$"% ,4
M" !NAX]83#4%WZ!P 0 N=@H $@              @ $C+   9V=N+6XR85\P
?-#$U,C0N:'1M4$L%!@     (  @ [@$  /.< 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>ggn-n2a_041524_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cef="http://xbrl.sec.gov/cef/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ggn="http://gabelli.com/20240415"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ggn-20240415.xsd" xlink:type="simple"/>
    <context id="AsOf2024-04-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001313510</identifier>
        </entity>
        <period>
            <startDate>2024-04-15</startDate>
            <endDate>2024-04-15</endDate>
        </period>
    </context>
    <context id="From2024-04-152024-04-15_dei_BusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001313510</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-15</startDate>
            <endDate>2024-04-15</endDate>
        </period>
    </context>
    <context id="AsOf2024-04-10_custom_CommonStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001313510</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ggn:CommonStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-10</instant>
        </period>
    </context>
    <context id="From2024-04-102024-04-10_custom_CommonStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001313510</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ggn:CommonStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-10</startDate>
            <endDate>2024-04-10</endDate>
        </period>
    </context>
    <context id="From2024-04-102024-04-10_custom_SeriesBCumulativePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001313510</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ggn:SeriesBCumulativePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-10</startDate>
            <endDate>2024-04-10</endDate>
        </period>
    </context>
    <context id="AsOf2024-04-10_custom_SeriesBCumulativePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001313510</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ggn:SeriesBCumulativePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-10</instant>
        </period>
    </context>
    <context id="From2024-04-152024-04-15_custom_PreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001313510</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ggn:PreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-15</startDate>
            <endDate>2024-04-15</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-04-15" id="Fact000003">true</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-04-15" id="Fact000004">0001313510</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-04-15" id="xdx2ixbrl0013">N-2/A</dei:DocumentType>
    <dei:EntityWellKnownSeasonedIssuer contextRef="AsOf2024-04-15" id="xdx2ixbrl0052">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityFileNumber contextRef="AsOf2024-04-15" id="Fact000010">333-277179</dei:EntityFileNumber>
    <dei:InvestmentCompanyActFileNumber contextRef="AsOf2024-04-15" id="Fact000011">811-21698</dei:InvestmentCompanyActFileNumber>
    <dei:EntityInvCompanyType contextRef="AsOf2024-04-15" id="Fact000012">N-2</dei:EntityInvCompanyType>
    <dei:DocumentRegistrationStatement contextRef="AsOf2024-04-15" id="Fact000014">true</dei:DocumentRegistrationStatement>
    <dei:PreEffectiveAmendment contextRef="AsOf2024-04-15" id="Fact000015">true</dei:PreEffectiveAmendment>
    <dei:PreEffectiveAmendmentNumber contextRef="AsOf2024-04-15" id="Fact000016">1</dei:PreEffectiveAmendmentNumber>
    <dei:PostEffectiveAmendment contextRef="AsOf2024-04-15" id="Fact000017">false</dei:PostEffectiveAmendment>
    <dei:InvestmentCompanyActRegistration contextRef="AsOf2024-04-15" id="Fact000018">true</dei:InvestmentCompanyActRegistration>
    <dei:InvestmentCompanyRegistrationAmendment contextRef="AsOf2024-04-15" id="Fact000019">true</dei:InvestmentCompanyRegistrationAmendment>
    <dei:InvestmentCompanyRegistrationAmendment contextRef="AsOf2024-04-15" id="Fact000020">true</dei:InvestmentCompanyRegistrationAmendment>
    <dei:InvestmentCompanyRegistrationAmendmentNumber contextRef="AsOf2024-04-15" id="Fact000021">55</dei:InvestmentCompanyRegistrationAmendmentNumber>
    <dei:EntityRegistrantName contextRef="AsOf2024-04-15" id="Fact000022">GAMCO GLOBAL GOLD, NATURAL RESOURCES &amp; INCOME TRUST</dei:EntityRegistrantName>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-04-15" id="Fact000023">One Corporate Center</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-04-15" id="Fact000024">Rye</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-04-15" id="Fact000025">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-04-15" id="Fact000026">10580-1422</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-04-15" id="Fact000027">(800)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-04-15" id="Fact000028">422-3554</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName
      contextRef="From2024-04-152024-04-15_dei_BusinessContactMember"
      id="Fact000029">John C. Ball</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1
      contextRef="From2024-04-152024-04-15_dei_BusinessContactMember"
      id="Fact000030">GAMCO Global Gold, Natural Resources &amp; Income Trust</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="From2024-04-152024-04-15_dei_BusinessContactMember"
      id="Fact000031">One Corporate Center</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="From2024-04-152024-04-15_dei_BusinessContactMember"
      id="Fact000032">Rye</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="From2024-04-152024-04-15_dei_BusinessContactMember"
      id="Fact000033">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="From2024-04-152024-04-15_dei_BusinessContactMember"
      id="Fact000034">10580-1422</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="From2024-04-152024-04-15_dei_BusinessContactMember"
      id="Fact000035">(914)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="From2024-04-152024-04-15_dei_BusinessContactMember"
      id="Fact000036">921-5070</dei:LocalPhoneNumber>
    <dei:ApproximateDateOfCommencementOfProposedSaleToThePublic contextRef="AsOf2024-04-15" id="Fact000037">From time to time after the effective date of this Registration Statement.</dei:ApproximateDateOfCommencementOfProposedSaleToThePublic>
    <dei:DividendOrInterestReinvestmentPlanOnly contextRef="AsOf2024-04-15" id="Fact000038">false</dei:DividendOrInterestReinvestmentPlanOnly>
    <dei:DelayedOrContinuousOffering contextRef="AsOf2024-04-15" id="Fact000039">true</dei:DelayedOrContinuousOffering>
    <cef:PrimaryShelfFlag contextRef="AsOf2024-04-15" id="Fact000040">true</cef:PrimaryShelfFlag>
    <dei:EffectiveUponFiling462e contextRef="AsOf2024-04-15" id="Fact000041">false</dei:EffectiveUponFiling462e>
    <dei:AdditionalSecuritiesEffective413b contextRef="AsOf2024-04-15" id="Fact000042">false</dei:AdditionalSecuritiesEffective413b>
    <dei:EffectiveWhenDeclaredSection8c contextRef="AsOf2024-04-15" id="Fact000043">false</dei:EffectiveWhenDeclaredSection8c>
    <dei:NewEffectiveDateForPreviousFiling contextRef="AsOf2024-04-15" id="Fact000044">false</dei:NewEffectiveDateForPreviousFiling>
    <dei:AdditionalSecurities462b contextRef="AsOf2024-04-15" id="Fact000045">false</dei:AdditionalSecurities462b>
    <dei:NoSubstantiveChanges462c contextRef="AsOf2024-04-15" id="Fact000046">false</dei:NoSubstantiveChanges462c>
    <dei:ExhibitsOnly462d contextRef="AsOf2024-04-15" id="Fact000047">false</dei:ExhibitsOnly462d>
    <cef:RegisteredClosedEndFundFlag contextRef="AsOf2024-04-15" id="Fact000048">true</cef:RegisteredClosedEndFundFlag>
    <cef:BusinessDevelopmentCompanyFlag contextRef="AsOf2024-04-15" id="Fact000049">false</cef:BusinessDevelopmentCompanyFlag>
    <cef:IntervalFundFlag contextRef="AsOf2024-04-15" id="Fact000050">false</cef:IntervalFundFlag>
    <cef:PrimaryShelfQualifiedFlag contextRef="AsOf2024-04-15" id="Fact000051">true</cef:PrimaryShelfQualifiedFlag>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-04-15" id="Fact000053">false</dei:EntityEmergingGrowthCompany>
    <cef:NewCefOrBdcRegistrantFlag contextRef="AsOf2024-04-15" id="Fact000054">false</cef:NewCefOrBdcRegistrantFlag>
    <dei:AmendmentDescription contextRef="AsOf2024-04-15" id="Fact000055">THE
REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL
THE REGISTRANT SHALL FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION STATEMENT SHALL THEREAFTER BECOME
EFFECTIVE IN ACCORDANCE WITH SECTION 8(a) OF THE SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME EFFECTIVE
ON SUCH DATE AS THE SECURITIES AND EXCHANGE COMMISSION, ACTING PURSUANT TO SAID SECTION 8(a), MAY DETERMINE.</dei:AmendmentDescription>
    <us-gaap:SharePrice
      contextRef="AsOf2024-04-10_custom_CommonStocksMember"
      decimals="INF"
      id="Fact000056"
      unitRef="USDPShares">4.11</us-gaap:SharePrice>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2024-04-10_custom_CommonStocksMember"
      decimals="INF"
      id="Fact000057"
      unitRef="USDPShares">4.10</us-gaap:NetAssetValuePerShare>
    <us-gaap:SharePrice
      contextRef="AsOf2024-04-10_custom_CommonStocksMember"
      decimals="INF"
      id="Fact000058"
      unitRef="USDPShares">4.11</us-gaap:SharePrice>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2024-04-10_custom_CommonStocksMember"
      decimals="INF"
      id="Fact000059"
      unitRef="USDPShares">4.10</us-gaap:NetAssetValuePerShare>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="From2024-04-102024-04-10_custom_CommonStocksMember"
      decimals="INF"
      id="Fact000060"
      unitRef="Shares">154296778</cef:OutstandingSecurityNotHeldShares>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="From2024-04-102024-04-10_custom_SeriesBCumulativePreferredStockMember"
      decimals="INF"
      id="Fact000061"
      unitRef="Shares">3180762</cef:OutstandingSecurityNotHeldShares>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="AsOf2024-04-10_custom_SeriesBCumulativePreferredStockMember"
      decimals="INF"
      id="Fact000062"
      unitRef="USDPShares">25</us-gaap:PreferredStockLiquidationPreference>
    <cef:SeniorSecuritiesAmt
      contextRef="AsOf2024-04-10_custom_SeriesBCumulativePreferredStockMember"
      decimals="0"
      id="Fact000063"
      unitRef="USD">79519050</cef:SeniorSecuritiesAmt>
    <cef:InvestmentObjectivesAndPracticesTextBlock contextRef="AsOf2024-04-15" id="Fact000065">&lt;p id="xdx_80C_ecef--InvestmentObjectivesAndPracticesTextBlock_dU_zKXuIxU6QLW3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"&gt;&lt;b&gt;&lt;span id="gg2a005"&gt;&lt;/span&gt;INVESTMENT
OBJECTIVES AND POLICIES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Investment
Objectives&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Fund&#x2019;s primary investment objective is to provide a high level of current income. The Fund&#x2019;s secondary investment
objective is to seek capital appreciation consistent with the Fund&#x2019;s strategy and its primary objective. Under normal market
conditions, the Fund will attempt to achieve its objectives by investing at least 80% of its assets in equity securities of companies
principally engaged in the gold industry and the natural resources industries. The Fund will invest at least 25% of its assets
in the equity securities of companies principally engaged in the gold industry, which includes companies principally engaged in
the exploration, mining, fabrication, processing, distribution or trading of gold or the financing, managing, controlling or operating
of companies engaged in &#x201c;gold-related&#x201d; activities. In addition, the Fund will invest at least 25% of its assets in
the equity securities of companies principally engaged in the group of industries that constitute the natural resources industries,
which include companies principally engaged in the exploration, production or distribution of natural resources, such as gas,
oil, paper, food and agriculture, forestry products, metals (other than gold) and minerals as well as related transportation companies
and equipment manufacturers. The Fund may invest in the securities of companies located anywhere in the world. Under normal market
conditions, the Fund will invest at least 40% of its assets in the securities of issuers located in at least three countries other
than the United States. For this purpose an issuer will be treated as located outside the United States if it is either organized
or headquartered outside the United States and has a substantial portion of its operations or sales outside the United States.
Equity securities may include common stocks, preferred stocks, convertible securities, warrants, depository receipts and equity
interests in trusts and other entities. Other Fund investments may include investment companies, securities of issuers subject
to reorganization or other risk arbitrage investments, certain derivative instruments, debt (including obligations of the United
States government) and money market instruments. The Fund may invest up to 10% of its total assets in securities rated below investment
grade by recognized statistical rating agencies or unrated securities of comparable quality, including securities of issuers in
default, which are likely to have the lowest rating. These securities, which may be preferred shares or debt, are predominantly
speculative and involve major risk exposure to adverse conditions. Securities that are rated lower than &#x201c;BBB&#x201d; by S&amp;amp;P,
or lower than &#x201c;Baa&#x201d; by Moody&#x2019;s or unrated securities considered by the Investment Adviser to be of comparable
quality, are commonly referred to as &#x201c;junk bonds&#x201d; or &#x201c;high yield&#x201d; securities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="-sec-ix-redline: true"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Principally
engaged, as used in this Prospectus, means a company that derives at least 50% of its revenues or earnings or devotes at least
50% of its assets to gold or natural resources related activities, as the case may be. As part of its investment strategy, the
Fund intends to generate gains through an option strategy of writing (selling) covered call options on equity securities in its
portfolio. When the Fund sells a covered call option, it generates gains in the form of the premium paid by the buyer of the call
option, but the Fund forgoes the opportunity to participate in any increase in the value of the underlying equity security above
the exercise price of the option.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
information contained under the headings &#x201c;Additional Fund Information&#x2014;Investment Objectives and Policies&#x201d; in
the Fund&#x2019;s Annual Report is incorporated herein by reference.&lt;/span&gt;&lt;/p&gt;

</cef:InvestmentObjectivesAndPracticesTextBlock>
    <cef:RiskFactorsTableTextBlock contextRef="AsOf2024-04-15" id="Fact000067">&lt;p id="xdx_807_ecef--RiskFactorsTableTextBlock_dU_z4nYaARZRjwf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"&gt;&lt;b&gt;&lt;span id="gg2a006"&gt;&lt;/span&gt;RISK
FACTORS AND SPECIAL CONSIDERATIONS&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
information contained under the heading &#x201c;Additional Fund Information&#x2014;Risk Factors and Special Considerations&#x201d;
in the Fund&#x2019;s Annual Report is incorporated herein by reference.&lt;/span&gt;&lt;/p&gt;

</cef:RiskFactorsTableTextBlock>
    <cef:CapitalStockTableTextBlock contextRef="AsOf2024-04-15" id="Fact000069">&lt;p id="xdx_800_ecef--CapitalStockTableTextBlock_dU_zjVW7v5Rkb3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"&gt;&lt;b&gt;&lt;span id="gg2a012"&gt;&lt;/span&gt;DESCRIPTION
OF THE SHARES&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;The
following is a brief description of the terms of the Fund&#x2019;s shares. This description does not purport to be complete and
is qualified by reference to the Fund&#x2019;s Agreement and Declaration of Trust and its By-Laws. For complete terms of the shares,
please refer to the actual terms of each series, which are set forth in the Agreement and Declaration of Trust.&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Common
Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Fund is an unincorporated statutory trust organized under the laws of Delaware pursuant to a Certificate of Trust dated as of
January 4, 2005. The Fund is authorized to issue an unlimited number of common shares of beneficial interest, par value $0.001
per share. Each common share of beneficial interest has one vote and, when issued and paid for in accordance with the terms of
the applicable offering, will be fully paid and non-assessable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Though
the Fund expects to pay distributions monthly on the common shares of beneficial interest, it is not obligated to do so. All common
shares of beneficial interest are equal as to distributions, assets and voting privileges and have no conversion, preemptive or
other subscription rights. The Fund will send annual and semiannual reports, including financial statements, to all holders of
its shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Offerings
of shares require approval by the Fund&#x2019;s Board of Trustees. Any additional offering of common shares of beneficial interest
will be subject to the requirements of the 1940 Act, which provides that common stock may not be issued at a price below the then
current net asset value, exclusive of sales load, except in connection with an offering to existing holders of common shares or
with the consent of a majority of the Fund&#x2019;s common shareholders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Fund&#x2019;s common shares of beneficial interest are listed on the NYSE American under the symbol &#x201c;GGN.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Fund&#x2019;s common shares have historically traded at both a premium and discount to NAV. Since the Fund commenced trading on
the NYSE American, the Fund&#x2019;s common shares have traded at a discount to net asset value as low as (25.36)% and a premium
as high as 56.07%. Unlike open-end funds, closed-end funds like the Fund do not continuously offer shares and do not provide daily
redemptions. Rather, if a shareholder determines to buy additional common shares or sell shares already held, the shareholder
may do so by trading through a broker on the NYSE American or otherwise. The average weekly trading volume of common shares on
the NYSE American during the period from January 1, 2023 to December 31, 2023 was 2,276,588 shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Shares
of closed-end investment companies often trade on an exchange at prices lower than net asset value. Because the market value of
the common shares may be influenced by such factors as dividend and distribution levels (which are in turn affected by expenses),
dividend and distribution stability, net asset value, market liquidity, relative demand for and supply of such shares in the market,
unrealized gains, general market and economic conditions and other factors beyond the control of the Fund, the Fund cannot assure
you that common shares will trade at a price equal to or higher than net asset value in the future. The common shares are designed
primarily for long term investors and you should not purchase the common shares if you intend to sell them soon after purchase.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subject
to the rights of the outstanding preferred shares, the Fund&#x2019;s common shares vote as a single class on election of Trustees
and on additional matters with respect to which the 1940 Act, the Fund&#x2019;s Agreement and Declaration of Trust, By-Laws or
resolutions adopted by the Trustees provide for a vote of the Fund&#x2019;s common shares. See &#x201c;Anti-Takeover Provisions
of the Fund&#x2019;s Governing Documents.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Fund is a closed-end, non-diversified, management investment company and as such its shareholders do not, and will not, have the
right to require the Fund to repurchase their shares. The Fund, however, may repurchase its common shares from time to time as
and when it deems such a repurchase advisable, subject to maintaining required asset coverage for each series of outstanding preferred
shares. The Board has authorized such repurchases to be made when the Fund&#x2019;s common shares are trading at a discount from
net asset value of 7.5% or more (or such other percentage as the Board of the Fund may determine from time to time). Pursuant
to the 1940 Act, the Fund may repurchase its common shares on a securities exchange (provided that the Fund has informed its shareholders
within the preceding six months of its intention to repurchase such shares) or pursuant to tenders and may also repurchase shares
privately if the Fund meets certain conditions regarding, among other things, distribution of net income for the preceding fiscal
year, status of the seller, price paid, brokerage commissions, prior notice to shareholders of an intention to purchase shares
and purchasing in a manner and on a basis that does not discriminate unfairly against the other shareholders through their interest
in the Fund.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
the Fund repurchases its common shares for a price below net asset value, the net asset value of the common shares that remain
outstanding will be enhanced, but this does not necessarily mean that the market price of the outstanding common shares will be
affected, either positively or negatively. The repurchase of common shares will reduce the total assets of the Fund available
for investment and may increase the Fund&#x2019;s expense ratio. In total through December 31, 2023, the Fund has repurchased and
retired 11,667,349 common shares in the open market at an average price of $3.58 per share and at an average discount of approximately
12.6% per share. During the year ended December 31, 2023, the Fund did not repurchase any common shares in the open market.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Book
Entry&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
common shares sold through this offering will initially be held in the name of Cede &amp;amp; Co. as nominee for the Depository Trust
Company (&#x201c;DTC&#x201d;). The Fund will treat Cede &amp;amp; Co. as the holder of record of the common shares for all purposes.
In accordance with the procedures of DTC, however, purchasers of common shares will be deemed the beneficial owners of shares
purchased for purposes of distributions, voting and liquidation rights. Purchasers of common shares may obtain registered certificates
by contacting the transfer agent.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Preferred
Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Currently,
an unlimited number of the Fund&#x2019;s shares have been classified by the Board of Trustees as preferred shares, par value $0.001
per share. The terms of such preferred shares may be fixed by the Board of Trustees and would materially limit and/or qualify
the rights of the holders of the Fund&#x2019;s common shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 7, 2013, the Fund completed the placement of $100 million of preferred shares consisting of 4 million shares designated as
the Series B Preferred Shares and paying dividends of an annual rate equal to 5.00% of liquidation preference. The Series B Preferred
Shares are senior to the common shares and result in the financial leveraging of the common shares. Such leveraging tends to magnify
both the risks and opportunities to common shareholders. Dividends on the preferred shares are cumulative. The Fund is required
by the 1940 Act and by the Statement of Preferences to meet certain asset coverage tests with respect to the Series B Preferred
Shares. If the Fund fails to meet these requirements and does not correct such failure, the Fund may be required to redeem, in
part or in full, the Series B Preferred Shares at the redemption price of $25 per share plus an amount equal to the accumulated
and unpaid dividends whether or not declared on such shares in order to meet the requirements. Additionally, failure to meet the
foregoing asset coverage requirements could restrict the Fund&#x2019;s ability to pay dividends to common shareholders or repurchase
common shares and could lead to sales of portfolio securities at inopportune times. The income received on the Fund&#x2019;s assets
may vary in a manner unrelated to the fixed rate, which could have either a beneficial or detrimental impact on net investment
income and gains available to common shareholders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Series B Preferred Shares are listed on the NYSE American under the ticker symbol &#x201c;GGN PrB.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
a liquidation, each holder of the preferred shares will be entitled to receive out of the assets of the Fund available for distribution
to shareholders (after payment of claims of the Fund&#x2019;s creditors but before any distributions with respect to the Fund&#x2019;s
common shares or any other shares of the Fund ranking junior to the preferred shares as to liquidation payments) an amount per
share equal to such share&#x2019;s liquidation preference plus any accumulated but unpaid distributions (whether or not earned
or declared, excluding interest thereon) to the date of distribution, and such shareholders shall be entitled to no further participation
in any distribution or payment in connection with such liquidation. Each series of the preferred shares will rank on a parity
with any other series of preferred shares of the Fund as to the payment of distributions and the distribution of assets upon liquidation,
and will be junior to the Fund&#x2019;s obligations with respect to any outstanding senior securities representing debt. If the
Fund has insufficient investment income and gains, all or a portion of the distributions to preferred shareholders would come
from the common shareholders&#x2019; capital. Such distributions reduce the net assets attributable to common shareholders since
the liquidation preference of the preferred shareholders is constant. The preferred shares carry one vote per share on all matters
on which such shares are entitled to vote. The preferred shares will, upon issuance, be fully paid and nonassessable and will
have no preemptive, exchange or conversion rights. The Board of Trustees may by resolution classify or reclassify any authorized
but unissued capital shares of the Fund from time to time by setting or changing the preferences, conversion or other rights,
voting powers, restrictions, limitations as to distributions or terms or conditions of redemption. The Fund will not issue any
class of shares senior to the preferred shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Redemption,
Purchase and Sale of Preferred Shares By the Fund.&lt;/i&gt; The terms of any preferred shares are expected to provide that (i) they
are redeemable by the Fund at any time (either after the date of initial issuance, or after some period of time following initial
issuance) in whole or in part at the original purchase price per share plus accumulated dividends per share, (ii) the Fund may
tender for or purchase preferred shares and (iii) the Fund may subsequently resell any shares so tendered for or purchased. Any
redemption or purchase of preferred shares by the Fund will reduce the leverage applicable to the common shares, while any resale
of preferred shares by the Fund will increase that leverage.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Rating
Agency Guidelines.&lt;/i&gt; The Series B Preferred Shares are rated A2 by Moody&#x2019;s. Upon issuance, any new publicly issued series
of preferred shares may be rated by Moody&#x2019;s or Fitch, in which case the following description of rating agency guidelines
would also be applicable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Fund expects that it would be required under any applicable rating agency guidelines to maintain assets having in the aggregate
a discounted value at least equal to a Basic Maintenance Amount (as defined in the applicable Statement of Preferences and summarized
below), for its outstanding preferred shares, including the Series B Preferred Shares. To the extent any particular portfolio
holding does not satisfy the applicable rating agency&#x2019;s guidelines, all or a portion of such holding&#x2019;s value will
not be included in the calculation of discounted value (as defined by such rating agency). The Moody&#x2019;s and Fitch guidelines
would also impose certain diversification requirements and industry concentration limitations on the Fund&#x2019;s overall portfolio,
and apply specified discounts to securities held by the Fund (except certain money market securities).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
&#x201c;Basic Maintenance Amount&#x201d; is generally equal to (a) the sum of (i) the aggregate liquidation preference of any preferred
shares then outstanding plus (to the extent not included in the liquidation preference of such preferred shares) an amount equal
to the aggregate accumulated but unpaid distributions (whether or not earned or declared) in respect of such preferred shares,
(ii) the Fund&#x2019;s other liabilities (excluding dividends and other distributions payable on the Fund&#x2019;s common shares),
(iii) any other current liabilities of the Fund (including amounts due and payable by the Fund pursuant to reverse repurchase
agreements and payables for assets purchased) less (b) the value of the Fund&#x2019;s assets if such assets are either cash or
evidences of indebtedness which mature prior to or on the date of redemption or repurchase of preferred shares or payment of another
liability and are either U.S. government securities or evidences of indebtedness rated at least &#x201c;Aaa,&#x201d; &#x201c;P-1&#x201d;,
&#x201c;VMIG-1&#x201d; or &#x201c;MIG-1&#x201d; by Moody&#x2019;s or &#x201c;AAA&#x201d;, &#x201c;SP-1+&#x201d; or &#x201c;A-1+&#x201d; by
S&amp;amp;P and are held by the Fund for distributions, the redemption or repurchase of preferred shares or the Fund&#x2019;s liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
the Fund does not cure in a timely manner a failure to maintain a discounted value of its portfolio equal to the Basic Maintenance
Amount in accordance with the requirements of any applicable rating agency or agencies then rating the preferred shares at the
request of the Fund, the Fund may, and in certain circumstances would be required to, mandatorily redeem preferred shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Any
rating agency providing a rating for the preferred shares, including the Series B Preferred Shares, at the request of the Fund
may, at any time, change or withdraw any such rating. The Board, without further action by the shareholders, may amend, alter,
add to or repeal certain of the definitions and related provisions of the applicable Statement of Preferences that have been adopted
by the Fund pursuant to the rating agency guidelines if the Board determines that such modification is necessary to prevent a
reduction in rating of the preferred shares, including the Series B Preferred Shares, by Moody&#x2019;s or such other rating agency,
as the case may be, and any such amendment, alteration or repeal will be deemed not to affect the preferences, rights or powers
of the holders of preferred shares, provided that the Board shall have obtained confirmation from the rating agency that such
modification would not adversely affect its then current rating of the preferred shares, including the Series B Preferred Shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
described by Moody&#x2019;s and Fitch, any ratings assigned to the preferred shares are assessments of the capacity and willingness
of the Fund to pay the obligations of each series of the preferred shares. Any ratings on the preferred shares are not recommendations
to purchase, hold or sell shares of any series, in as much as the ratings do not comment as to market price or suitability for
a particular investor. The rating agency guidelines also do not address the likelihood that an owner of preferred shares will
be able to sell such shares on an exchange, in an auction or otherwise. Any ratings would be based on current information furnished
to Moody&#x2019;s and Fitch by the Fund and the Investment Adviser and information obtained from other sources. Any ratings may
be changed, suspended or withdrawn as a result of changes in, or the unavailability of, such information. The rating agency guidelines
would apply to the preferred shares, as the case may be, only so long as such rating agency is rating such shares at the request
of the Fund. The Fund expects that it would pay fees to Moody&#x2019;s and Fitch for rating any preferred shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
rating agency guidelines will apply to the preferred shares, as the case may be, only so long as such rating agency is rating
such shares at the request of the Fund. The Fund will pay fees to the rating agencies for rating any series of the preferred shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Asset
Maintenance Requirements.&lt;/i&gt; In addition to the requirements summarized under &#x201c;&#x2014;Rating Agency Guidelines&#x201d; above,
the Fund must also satisfy asset maintenance requirements under the 1940 Act with respect to its preferred shares. Under the 1940
Act, such debt or preferred shares may be issued only if immediately after such issuance the value of the Fund&#x2019;s total assets
(less ordinary course liabilities) is at least 300% of the amount of any debt outstanding and at least 200% of the amount of any
preferred stock and debt outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Fund will be required under the preferred shares&#x2019; Statement of Preferences (the &#x201c;Statement of Preferences&#x201d;)
to determine whether it has, as of the last business day of each March, June, September and December of each year, an &#x201c;asset
coverage&#x201d; (as defined in the 1940 Act) of at least 200% (or such higher or lower percentage as may be required at the time
under the 1940 Act) with respect to all outstanding senior securities of the Fund that are debt or stock, including any outstanding
preferred shares. If the Fund fails to maintain the asset coverage required under the 1940 Act on such dates and such failure
is not cured within 60 calendar days, the Fund may, and in certain circumstances will be required to, mandatorily redeem the number
of preferred shares sufficient to satisfy such asset coverage. See &#x201c;&#x2014;Redemption&#x201d; below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Distributions.
&lt;/i&gt;Holders of any fixed rate preferred shares will be entitled to receive, when, as and if declared by the Board of Trustees,
out of funds legally available therefor, cumulative cash distributions, at an annual rate set forth in the applicable Prospectus
Supplement, payable with such frequency as set forth in the applicable Prospectus Supplement. Such distributions will accumulate
from the date on which such shares are issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;





&lt;p id="xdx_84A_ecef--PreferredStockRestrictionsOtherTextBlock_hus-gaap--StatementClassOfStockAxis__custom--PreferredStocksMember_dU_zvLNFVF0mmFc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Restrictions
on Dividends and Other Distributions for the Preferred Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;So
long as any preferred shares are outstanding, the Fund may not pay any dividend or distribution (other than a dividend or distribution
paid in common shares or in options, warrants or rights to subscribe for or purchase common shares) in respect of the common shares
or call for redemption, redeem, purchase or otherwise acquire for consideration any common shares (except by conversion into or
exchange for shares of the Fund ranking junior to the preferred shares as to the payment of dividends and the distribution of
assets upon liquidation), unless:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 30px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 30px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the Fund has declared
    and paid (or provided to the relevant dividend paying agent) all cumulative distributions on the Fund&#x2019;s outstanding
    preferred shares due on or prior to the date of such common share dividend or distribution;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 30px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 30px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the Fund has redeemed
    the full number of preferred shares to be redeemed pursuant to any mandatory redemption provision in the Fund&#x2019;s Governing
    Documents; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 30px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 30px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;after making the
    distribution, the Fund meets applicable asset coverage requirements described under &#x201c;&#x2014;Rating Agency Guidelines&#x201d;
    and &#x201c;&#x2014;Asset Maintenance Requirements.&#x201d;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;No
complete distribution due for a particular dividend period will be declared or made on any series of the preferred shares for
any dividend period, or part thereof, unless full cumulative distributions due through the most recent dividend payment dates
therefor for all outstanding series of preferred shares of the Fund ranking on a parity with such series as to distributions have
been or contemporaneously are declared and made. If full cumulative distributions due have not been made on all outstanding preferred
shares of the Fund ranking on a parity with such series of preferred shares as to the payment of distributions, any distributions
being paid on the preferred shares will be paid as nearly pro rata as possible in proportion to the respective amounts of distributions
accumulated but unmade on each such series of preferred shares on the relevant dividend payment date. The Fund&#x2019;s obligation
to make distributions on the preferred shares will be subordinate to its obligations to pay interest and principal, when due,
on any of the Fund&#x2019;s senior securities representing debt.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_856_zWXSzbZxcbV4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Redemption&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Mandatory
Redemption Relating to Asset Coverage Requirements.&lt;/i&gt; The Fund may, at its option, consistent with its Governing Documents and
the 1940 Act, and in certain circumstances will be required to, mandatorily redeem preferred shares in the event that:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 30px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 30px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the Fund fails to
    maintain the asset coverage requirements specified under the 1940 Act on a quarterly valuation date (generally the last business
    day of March, June, September and December) and such failure is not cured on or before a stated period, following such failure
    (60 calendar days in the case of the Series B Preferred Shares); or&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 30px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 30px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the Fund fails to
    maintain the asset coverage requirements as calculated in accordance with the applicable rating agency guidelines as of any
    monthly valuation date, and such failure is not cured on or before a stated period after such valuation date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
redemption price for preferred shares subject to mandatory redemption will be the liquidation preference, as stated in the Prospectus
Supplement accompanying the issuance of such preferred shares, plus an amount equal to any accumulated but unpaid distributions
(whether or not earned or declared) to the date fixed for redemption, plus any applicable redemption premium determined by the
Board of Trustees and included in the Statement of Preferences.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
number of preferred shares that will be redeemed in the case of a mandatory redemption will equal (and may, if the applicable
Statement of Preferences so provides, exceed) the minimum number of outstanding preferred shares, the redemption of which, if
such redemption had occurred immediately prior to the opening of business on the applicable cure date, would have resulted in
the relevant asset coverage requirement having been met or, if the required asset coverage cannot be so restored, all of the preferred
shares. In the event that preferred shares are redeemed due to a failure to satisfy the 1940 Act asset coverage requirements,
the Fund may, but is not required to, redeem a sufficient number of preferred shares so that the Fund&#x2019;s assets exceed the
asset coverage requirements under the 1940 Act after the redemption by 10% (that is, 220% asset coverage) or some other amount
specified in the Statement of Preferences. In the event that preferred shares are redeemed due to a failure to satisfy applicable
rating agency guidelines, the Fund may, but is not required to, redeem a sufficient number of preferred shares so that the Fund&#x2019;s
discounted portfolio value (as determined in accordance with the applicable rating agency guidelines) after redemption exceeds
the asset coverage requirements of each applicable rating agency by up to 10% (that is, 110% rating agency asset coverage) or
some other amount specified in the Statement of Preferences.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
the Fund does not have funds legally available for the redemption of, or is otherwise unable to redeem, all the preferred shares
to be redeemed on any redemption date, the Fund will redeem on such redemption date that number of shares for which it has legally
available funds, or is otherwise able to redeem, from the holders whose shares are to be redeemed ratably on the basis of the
redemption price of such shares, and the remainder of those shares to be redeemed will be redeemed on the earliest practicable
date on which the Fund will have funds legally available for the redemption of, or is otherwise able to redeem, such shares upon
written notice of redemption.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
fewer than all of the Fund&#x2019;s outstanding preferred shares are to be redeemed, the Fund, at its discretion and subject to
the limitations of its Governing Documents and the 1940 Act, will select the one or more series of preferred shares from which
shares will be redeemed and the amount of preferred shares to be redeemed from each such series. If less than all preferred shares
of a series are to be redeemed, such redemption will be made as among the holders of that series pro rata in accordance with the
respective number of shares of such series held by each such holder on the record date for such redemption (or by such other equitable
method as the Fund may determine). If fewer than all the preferred shares held by any holder are to be redeemed, the notice of
redemption mailed to such holder will specify the number of shares to be redeemed from such holder, which may be expressed as
a percentage of shares held on the applicable record date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Optional
Redemption of Fixed Rate Preferred Shares.&lt;/i&gt; Fixed Rate Preferred Shares will not be subject to optional redemption by the Fund
until the date, if any, specified in the applicable Prospectus Supplement, unless such redemption is necessary, in the judgment
of the Fund, to maintain the Fund&#x2019;s status as a RIC under the Code or as otherwise provided in the applicable Statement
of Preferences. Commencing on such date and thereafter, the Fund may at any time redeem such Fixed Rate Preferred Shares in whole
or in part for cash at a redemption price per share equal to the initial liquidation preference per share plus accumulated and
unpaid distributions (whether or not earned or declared) to the redemption date plus, if applicable, any redemption premium. Such
redemptions are subject to the notice requirements set forth under &#x201c;&#x2014;Redemption Procedures&#x201d; and the limitations
of the Governing Documents and 1940 Act. The foregoing requirements may be modified in the case of any particular series of preferred
shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Redemption
Procedures.&lt;/i&gt; A notice of redemption with respect to an optional redemption will be given to the holders of record of fixed
rate preferred shares selected for redemption not less than 15 days (subject to NYSE American requirements) nor, more than 40
days prior to the date fixed for redemption. Preferred shareholders may receive shorter notice in the event of a mandatory redemption.
Each notice of redemption will state (i) the redemption date, (ii) the number or percentage of preferred shares to be redeemed
(which may be expressed as a percentage of such shares outstanding), (iii) the CUSIP number(s) of such shares, (iv) the redemption
price (specifying the amount of accumulated distributions to be included therein), (v) the place or places where such shares are
to be redeemed, (vi) that distributions on the shares to be redeemed will cease to accumulate on such redemption date, (vii) the
provision of the Statement of Preferences, as applicable, under which the redemption is being made and (viii) any conditions precedent
to such redemption. No defect in the notice of redemption or in the mailing thereof will affect the validity of the redemption
proceedings, except as required by applicable law.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
holders of any preferred shares, whether subject to a variable or fixed rate, will not have the right to redeem any of their shares
at their option.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_ecef--SecurityLiquidationRightsTextBlock_hus-gaap--StatementClassOfStockAxis__custom--PreferredStocksMember_dU_zBGimj7jqjE" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidation
Preference.&lt;/i&gt; In the event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Fund,
the holders of preferred shares will be entitled to receive a preferential liquidating distribution, which is expected to equal
the original purchase price per preferred share plus accumulated and unpaid dividends, whether or not declared, before any distribution
of assets is made to holders of common shares. After payment of the full amount of the liquidating distribution to which they
are entitled, the holders of preferred shares will not be entitled to any further participation in any distribution of assets
by the Fund.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_855_ztVpl2lOdsK8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_ecef--SecurityVotingRightsTextBlock_hus-gaap--StatementClassOfStockAxis__custom--PreferredStocksMember_dU_zW9tZD5HUJu9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Voting
Rights.&lt;/i&gt; Except as otherwise stated in this Prospectus, specified in the Governing Documents or resolved by the Board or as
otherwise required by applicable law, holders of preferred shares shall be entitled to one vote per share held on each matter
submitted to a vote of the shareholders of the Fund and will vote together with holders of common shares and of any other preferred
shares then outstanding as a single class.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the election of the Fund&#x2019;s Trustees, holders of the outstanding preferred shares, voting together as a single
class, will be entitled to elect two of the Fund&#x2019;s Trustees, and the remaining Trustees will be elected by holders of common
shares and holders of preferred shares, voting together as a single class. In addition, if (i) at any time dividends and distributions
on outstanding preferred shares are unpaid in an amount equal to at least two full years&#x2019; dividends and distributions thereon
and sufficient cash or specified securities have not been deposited with the applicable paying agent for the payment of such accumulated
dividends and distributions or (ii) at any time holders of any other series of preferred shares are entitled to elect a majority
of the Trustees of the Fund under the 1940 Act or the applicable Statement of Preferences creating such shares, then the number
of Trustees constituting the Board automatically will be increased by the smallest number that, when added to the two Trustees
elected exclusively by the holders of preferred shares as described above, would then constitute a simple majority of the Board
as so increased by such smallest number. Such additional Trustees will be elected by the holders of the outstanding preferred
shares, voting together as a single class, at a special meeting of shareholders which will be called as soon as practicable and
will be held not less than ten nor more than twenty days after the mailing date of the meeting notice. If the Fund fails to send
such meeting notice or to call such a special meeting, the meeting may be called by any preferred shareholder on like notice.
The terms of office of the persons who are Trustees at the time of that election will continue. If the Fund thereafter pays, or
declares and sets apart for payment in full, all dividends and distributions payable on all outstanding preferred shares for all
past dividend periods or the holders of other series of preferred shares are no longer entitled to elect such additional Trustees,
the additional voting rights of the holders of the preferred shares as described above will cease, and the terms of office of
all of the additional Trustees elected by the holders of the preferred shares (but not of the Trustees with respect to whose election
the holders of common shares were entitled to vote or the two Trustees the holders of preferred shares have the right to elect
as a separate class in any event) will terminate automatically.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
1940 Act requires that, in addition to any approval by shareholders that might otherwise be required, the approval of the holders
of a majority of any outstanding preferred shares (as defined in the 1940 Act), voting separately as a class, would be required
to (1) adopt any plan of reorganization that would adversely affect the preferred shares, and (2) take any action requiring a
vote of security holders under Section 13(a) of the 1940 Act, including, among other things, changes in the Fund&#x2019;s classification
as a closed-end investment company or changes in its fundamental investment restrictions. As a result of these voting rights,
the Fund&#x2019;s ability to take any such actions may be impeded to the extent that there are any preferred shares outstanding.
Additionally, the affirmative vote of the holders of a &#x201c;majority of the outstanding&#x201d; (as defined in the 1940 Act)
preferred shares of any series of the Fund&#x2019;s preferred shares, voting separately from the holders of any other series of
the Fund&#x2019;s preferred shares (to the extent its rights are affected differently), shall be required with respect to any matter
that materially and adversely affects the rights, preferences or powers of that series in a manner different from that of other
series or classes of the Fund&#x2019;s shares. The affirmative vote of the holders of a &#x201c;majority of the outstanding&#x201d;
(as defined in the 1940 Act) preferred shares, voting separately as one class, shall be required to amend, alter or repeal the
provisions of  the Fund&#x2019;s Agreement and Declaration of Trust or By-laws, whether by merger, consolidation or otherwise,
if such amendment, alteration or repeal would affect adversely the rights, preferences or powers expressly set forth in any statement
of preferences of the Fund&#x2019;s preferred shares, unless, in each case, the Fund obtains written confirmation from any rating
agency then rating the preferred shares at the Fund&#x2019;s request that such amendment, alteration or repeal would not impair
the rating then assigned by such rating agency to such preferred shares, in which case the vote or consent of the holders of the
preferred shares is not required. No matter shall be deemed to adversely affect any rights, preferences or powers of the preferred
shares unless such matter (i) adversely alters or abolishes any right or preference of such series; (ii) creates, adversely alters
or abolishes any right in respect of redemption of such series; or (iii) creates or adversely alters (other than to abolish) any
restriction on transfer applicable to such series. An increase in the number of authorized preferred shares of the Fund pursuant
to the Agreement and Declaration of Trust or the issuance of additional shares of any series of preferred shares of the Fund pursuant
to the Agreement and Declaration of Trust shall not in and of itself be considered to adversely affect the rights, preferences
or powers of a series of preferred shares. The class votes of holders of preferred shares described above will in each case be
in addition to any other vote required to authorize the action in question.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
foregoing voting provisions will not apply to any series of preferred shares if, at or prior to the time when the act with respect
to which such vote otherwise would be required will be effected, such shares will have been redeemed or called for redemption
and sufficient cash or cash equivalents provided to the applicable paying agent to effect such redemption. The holders of preferred
shares will have no preemptive rights or rights to cumulative voting.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_851_zNYbsrqLi0yk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Limitation
on Issuance of Preferred Shares.&lt;/i&gt; So long as the Fund has preferred shares outstanding, subject to receipt of approval from
the rating agencies of each series of preferred shares outstanding, and subject to compliance with the Fund&#x2019;s investment
objectives, policies and restrictions, the Fund may issue and sell shares of one or more other series of additional preferred
shares provided that the Fund will, immediately after giving effect to the issuance of such additional preferred shares and to
its receipt and application of the proceeds thereof (including, without limitation, to the redemption of preferred shares to be
redeemed out of such proceeds), have an &#x201c;asset coverage&#x201d; for all senior securities of the Fund which are stock, as
defined in the 1940 Act, of at least 200% of the sum of the liquidation preference of the preferred shares of the Fund then outstanding
and all indebtedness of the Fund constituting senior securities and no such additional preferred shares will have any preference
or priority over any other preferred shares of the Fund upon the distribution of the assets of the Fund or in respect of the payment
of dividends or distributions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Fund will consider from time to time whether to offer additional preferred shares or securities representing indebtedness and
may issue such additional securities if the Board concludes that such an offering would be consistent with the Fund&#x2019;s Governing
Documents and applicable law, and in the best interest of existing common shareholders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Book
Entry.&lt;/i&gt; Fixed Rate Preferred Shares will initially be held in the name of Cede &amp;amp; Co. as nominee for DTC. The Fund will
treat Cede &amp;amp; Co. as the holder of record of preferred shares for all purposes. In accordance with the procedures of DTC, however,
purchasers of Fixed Rate Preferred Shares will be deemed the beneficial owners of stock purchased for purposes of dividends, voting
and liquidation rights.&lt;/span&gt;&lt;/p&gt;

</cef:CapitalStockTableTextBlock>
    <cef:PreferredStockRestrictionsOtherTextBlock
      contextRef="From2024-04-152024-04-15_custom_PreferredStocksMember"
      id="Fact000075">&lt;p id="xdx_84A_ecef--PreferredStockRestrictionsOtherTextBlock_hus-gaap--StatementClassOfStockAxis__custom--PreferredStocksMember_dU_zvLNFVF0mmFc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Restrictions
on Dividends and Other Distributions for the Preferred Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;So
long as any preferred shares are outstanding, the Fund may not pay any dividend or distribution (other than a dividend or distribution
paid in common shares or in options, warrants or rights to subscribe for or purchase common shares) in respect of the common shares
or call for redemption, redeem, purchase or otherwise acquire for consideration any common shares (except by conversion into or
exchange for shares of the Fund ranking junior to the preferred shares as to the payment of dividends and the distribution of
assets upon liquidation), unless:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 30px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 30px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the Fund has declared
    and paid (or provided to the relevant dividend paying agent) all cumulative distributions on the Fund&#x2019;s outstanding
    preferred shares due on or prior to the date of such common share dividend or distribution;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 30px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 30px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;the Fund has redeemed
    the full number of preferred shares to be redeemed pursuant to any mandatory redemption provision in the Fund&#x2019;s Governing
    Documents; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 30px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 30px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;after making the
    distribution, the Fund meets applicable asset coverage requirements described under &#x201c;&#x2014;Rating Agency Guidelines&#x201d;
    and &#x201c;&#x2014;Asset Maintenance Requirements.&#x201d;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;No
complete distribution due for a particular dividend period will be declared or made on any series of the preferred shares for
any dividend period, or part thereof, unless full cumulative distributions due through the most recent dividend payment dates
therefor for all outstanding series of preferred shares of the Fund ranking on a parity with such series as to distributions have
been or contemporaneously are declared and made. If full cumulative distributions due have not been made on all outstanding preferred
shares of the Fund ranking on a parity with such series of preferred shares as to the payment of distributions, any distributions
being paid on the preferred shares will be paid as nearly pro rata as possible in proportion to the respective amounts of distributions
accumulated but unmade on each such series of preferred shares on the relevant dividend payment date. The Fund&#x2019;s obligation
to make distributions on the preferred shares will be subordinate to its obligations to pay interest and principal, when due,
on any of the Fund&#x2019;s senior securities representing debt.&lt;/span&gt;&lt;/p&gt;

</cef:PreferredStockRestrictionsOtherTextBlock>
    <cef:SecurityLiquidationRightsTextBlock
      contextRef="From2024-04-152024-04-15_custom_PreferredStocksMember"
      id="Fact000079">&lt;p id="xdx_84D_ecef--SecurityLiquidationRightsTextBlock_hus-gaap--StatementClassOfStockAxis__custom--PreferredStocksMember_dU_zBGimj7jqjE" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidation
Preference.&lt;/i&gt; In the event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Fund,
the holders of preferred shares will be entitled to receive a preferential liquidating distribution, which is expected to equal
the original purchase price per preferred share plus accumulated and unpaid dividends, whether or not declared, before any distribution
of assets is made to holders of common shares. After payment of the full amount of the liquidating distribution to which they
are entitled, the holders of preferred shares will not be entitled to any further participation in any distribution of assets
by the Fund.&lt;/span&gt;&lt;/p&gt;

</cef:SecurityLiquidationRightsTextBlock>
    <cef:SecurityVotingRightsTextBlock
      contextRef="From2024-04-152024-04-15_custom_PreferredStocksMember"
      id="Fact000081">&lt;p id="xdx_84B_ecef--SecurityVotingRightsTextBlock_hus-gaap--StatementClassOfStockAxis__custom--PreferredStocksMember_dU_zW9tZD5HUJu9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Voting
Rights.&lt;/i&gt; Except as otherwise stated in this Prospectus, specified in the Governing Documents or resolved by the Board or as
otherwise required by applicable law, holders of preferred shares shall be entitled to one vote per share held on each matter
submitted to a vote of the shareholders of the Fund and will vote together with holders of common shares and of any other preferred
shares then outstanding as a single class.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the election of the Fund&#x2019;s Trustees, holders of the outstanding preferred shares, voting together as a single
class, will be entitled to elect two of the Fund&#x2019;s Trustees, and the remaining Trustees will be elected by holders of common
shares and holders of preferred shares, voting together as a single class. In addition, if (i) at any time dividends and distributions
on outstanding preferred shares are unpaid in an amount equal to at least two full years&#x2019; dividends and distributions thereon
and sufficient cash or specified securities have not been deposited with the applicable paying agent for the payment of such accumulated
dividends and distributions or (ii) at any time holders of any other series of preferred shares are entitled to elect a majority
of the Trustees of the Fund under the 1940 Act or the applicable Statement of Preferences creating such shares, then the number
of Trustees constituting the Board automatically will be increased by the smallest number that, when added to the two Trustees
elected exclusively by the holders of preferred shares as described above, would then constitute a simple majority of the Board
as so increased by such smallest number. Such additional Trustees will be elected by the holders of the outstanding preferred
shares, voting together as a single class, at a special meeting of shareholders which will be called as soon as practicable and
will be held not less than ten nor more than twenty days after the mailing date of the meeting notice. If the Fund fails to send
such meeting notice or to call such a special meeting, the meeting may be called by any preferred shareholder on like notice.
The terms of office of the persons who are Trustees at the time of that election will continue. If the Fund thereafter pays, or
declares and sets apart for payment in full, all dividends and distributions payable on all outstanding preferred shares for all
past dividend periods or the holders of other series of preferred shares are no longer entitled to elect such additional Trustees,
the additional voting rights of the holders of the preferred shares as described above will cease, and the terms of office of
all of the additional Trustees elected by the holders of the preferred shares (but not of the Trustees with respect to whose election
the holders of common shares were entitled to vote or the two Trustees the holders of preferred shares have the right to elect
as a separate class in any event) will terminate automatically.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
1940 Act requires that, in addition to any approval by shareholders that might otherwise be required, the approval of the holders
of a majority of any outstanding preferred shares (as defined in the 1940 Act), voting separately as a class, would be required
to (1) adopt any plan of reorganization that would adversely affect the preferred shares, and (2) take any action requiring a
vote of security holders under Section 13(a) of the 1940 Act, including, among other things, changes in the Fund&#x2019;s classification
as a closed-end investment company or changes in its fundamental investment restrictions. As a result of these voting rights,
the Fund&#x2019;s ability to take any such actions may be impeded to the extent that there are any preferred shares outstanding.
Additionally, the affirmative vote of the holders of a &#x201c;majority of the outstanding&#x201d; (as defined in the 1940 Act)
preferred shares of any series of the Fund&#x2019;s preferred shares, voting separately from the holders of any other series of
the Fund&#x2019;s preferred shares (to the extent its rights are affected differently), shall be required with respect to any matter
that materially and adversely affects the rights, preferences or powers of that series in a manner different from that of other
series or classes of the Fund&#x2019;s shares. The affirmative vote of the holders of a &#x201c;majority of the outstanding&#x201d;
(as defined in the 1940 Act) preferred shares, voting separately as one class, shall be required to amend, alter or repeal the
provisions of  the Fund&#x2019;s Agreement and Declaration of Trust or By-laws, whether by merger, consolidation or otherwise,
if such amendment, alteration or repeal would affect adversely the rights, preferences or powers expressly set forth in any statement
of preferences of the Fund&#x2019;s preferred shares, unless, in each case, the Fund obtains written confirmation from any rating
agency then rating the preferred shares at the Fund&#x2019;s request that such amendment, alteration or repeal would not impair
the rating then assigned by such rating agency to such preferred shares, in which case the vote or consent of the holders of the
preferred shares is not required. No matter shall be deemed to adversely affect any rights, preferences or powers of the preferred
shares unless such matter (i) adversely alters or abolishes any right or preference of such series; (ii) creates, adversely alters
or abolishes any right in respect of redemption of such series; or (iii) creates or adversely alters (other than to abolish) any
restriction on transfer applicable to such series. An increase in the number of authorized preferred shares of the Fund pursuant
to the Agreement and Declaration of Trust or the issuance of additional shares of any series of preferred shares of the Fund pursuant
to the Agreement and Declaration of Trust shall not in and of itself be considered to adversely affect the rights, preferences
or powers of a series of preferred shares. The class votes of holders of preferred shares described above will in each case be
in addition to any other vote required to authorize the action in question.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
foregoing voting provisions will not apply to any series of preferred shares if, at or prior to the time when the act with respect
to which such vote otherwise would be required will be effected, such shares will have been redeemed or called for redemption
and sufficient cash or cash equivalents provided to the applicable paying agent to effect such redemption. The holders of preferred
shares will have no preemptive rights or rights to cumulative voting.&lt;/span&gt;&lt;/p&gt;

</cef:SecurityVotingRightsTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139819670289232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>N-2 - USD ($)<br></strong></div></th>
<th class="th"><div>Apr. 15, 2024</div></th>
<th class="th"><div>Apr. 10, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001313510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentDescription', window );">Amendment Description</a></td>
<td class="text">THE
REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL
THE REGISTRANT SHALL FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION STATEMENT SHALL THEREAFTER BECOME
EFFECTIVE IN ACCORDANCE WITH SECTION 8(a) OF THE SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME EFFECTIVE
ON SUCH DATE AS THE SECURITIES AND EXCHANGE COMMISSION, ACTING PURSUANT TO SAID SECTION 8(a), MAY DETERMINE.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInvCompanyType', window );">Entity Inv Company Type</a></td>
<td class="text">N-2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Securities Act File Number</a></td>
<td class="text">333-277179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_InvestmentCompanyActFileNumber', window );">Investment Company Act File Number</a></td>
<td class="text">811-21698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">N-2/A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreEffectiveAmendment', window );">Pre-Effective Amendment</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreEffectiveAmendmentNumber', window );">Pre-Effective Amendment Number</a></td>
<td class="text">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PostEffectiveAmendment', window );">Post-Effective Amendment</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_InvestmentCompanyActRegistration', window );">Investment Company Act Registration</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_InvestmentCompanyRegistrationAmendment', window );">Investment Company Registration Amendment</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_InvestmentCompanyRegistrationAmendmentNumber', window );">Investment Company Registration Amendment Number</a></td>
<td class="text">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GAMCO
GLOBAL GOLD, NATURAL RESOURCES & INCOME TRUST<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Corporate Center<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Rye<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10580-1422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">422-3554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_ApproximateDateOfCommencementOfProposedSaleToThePublic', window );">Approximate Date of Commencement of Proposed Sale to Public</a></td>
<td class="text">From time to time after the effective date of this Registration Statement.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DividendOrInterestReinvestmentPlanOnly', window );">Dividend or Interest Reinvestment Plan Only</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DelayedOrContinuousOffering', window );">Delayed or Continuous Offering</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_PrimaryShelfFlag', window );">Primary Shelf [Flag]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EffectiveUponFiling462e', window );">Effective Upon Filing, 462(e)</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AdditionalSecuritiesEffective413b', window );">Additional Securities Effective, 413(b)</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EffectiveWhenDeclaredSection8c', window );">Effective when Declared, Section 8(c)</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_NewEffectiveDateForPreviousFiling', window );">New Effective Date for Previous Filing</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AdditionalSecurities462b', window );">Additional Securities. 462(b)</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_NoSubstantiveChanges462c', window );">No Substantive Changes, 462(c)</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_ExhibitsOnly462d', window );">Exhibits Only, 462(d)</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_RegisteredClosedEndFundFlag', window );">Registered Closed-End Fund [Flag]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_BusinessDevelopmentCompanyFlag', window );">Business Development Company [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_IntervalFundFlag', window );">Interval Fund [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_PrimaryShelfQualifiedFlag', window );">Primary Shelf Qualified [Flag]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_NewCefOrBdcRegistrantFlag', window );">New CEF or BDC Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_InvestmentObjectivesAndPracticesTextBlock', window );">Investment Objectives and Practices [Text Block]</a></td>
<td class="text"><p id="xdx_80C_ecef--InvestmentObjectivesAndPracticesTextBlock_dU_zKXuIxU6QLW3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a005"></span>INVESTMENT
OBJECTIVES AND POLICIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment
Objectives</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s primary investment objective is to provide a high level of current income. The Fund&#8217;s secondary investment
objective is to seek capital appreciation consistent with the Fund&#8217;s strategy and its primary objective. Under normal market
conditions, the Fund will attempt to achieve its objectives by investing at least 80% of its assets in equity securities of companies
principally engaged in the gold industry and the natural resources industries. The Fund will invest at least 25% of its assets
in the equity securities of companies principally engaged in the gold industry, which includes companies principally engaged in
the exploration, mining, fabrication, processing, distribution or trading of gold or the financing, managing, controlling or operating
of companies engaged in &#8220;gold-related&#8221; activities. In addition, the Fund will invest at least 25% of its assets in
the equity securities of companies principally engaged in the group of industries that constitute the natural resources industries,
which include companies principally engaged in the exploration, production or distribution of natural resources, such as gas,
oil, paper, food and agriculture, forestry products, metals (other than gold) and minerals as well as related transportation companies
and equipment manufacturers. The Fund may invest in the securities of companies located anywhere in the world. Under normal market
conditions, the Fund will invest at least 40% of its assets in the securities of issuers located in at least three countries other
than the United States. For this purpose an issuer will be treated as located outside the United States if it is either organized
or headquartered outside the United States and has a substantial portion of its operations or sales outside the United States.
Equity securities may include common stocks, preferred stocks, convertible securities, warrants, depository receipts and equity
interests in trusts and other entities. Other Fund investments may include investment companies, securities of issuers subject
to reorganization or other risk arbitrage investments, certain derivative instruments, debt (including obligations of the United
States government) and money market instruments. The Fund may invest up to 10% of its total assets in securities rated below investment
grade by recognized statistical rating agencies or unrated securities of comparable quality, including securities of issuers in
default, which are likely to have the lowest rating. These securities, which may be preferred shares or debt, are predominantly
speculative and involve major risk exposure to adverse conditions. Securities that are rated lower than &#8220;BBB&#8221; by S&amp;P,
or lower than &#8220;Baa&#8221; by Moody&#8217;s or unrated securities considered by the Investment Adviser to be of comparable
quality, are commonly referred to as &#8220;junk bonds&#8221; or &#8220;high yield&#8221; securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="-sec-ix-redline: true"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principally
engaged, as used in this Prospectus, means a company that derives at least 50% of its revenues or earnings or devotes at least
50% of its assets to gold or natural resources related activities, as the case may be. As part of its investment strategy, the
Fund intends to generate gains through an option strategy of writing (selling) covered call options on equity securities in its
portfolio. When the Fund sells a covered call option, it generates gains in the form of the premium paid by the buyer of the call
option, but the Fund forgoes the opportunity to participate in any increase in the value of the underlying equity security above
the exercise price of the option.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained under the headings &#8220;Additional Fund Information&#8212;Investment Objectives and Policies&#8221; in
the Fund&#8217;s Annual Report is incorporated herein by reference.</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_RiskFactorsTableTextBlock', window );">Risk Factors [Table Text Block]</a></td>
<td class="text"><p id="xdx_807_ecef--RiskFactorsTableTextBlock_dU_z4nYaARZRjwf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a006"></span>RISK
FACTORS AND SPECIAL CONSIDERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained under the heading &#8220;Additional Fund Information&#8212;Risk Factors and Special Considerations&#8221;
in the Fund&#8217;s Annual Report is incorporated herein by reference.</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_CapitalStockTableTextBlock', window );">Capital Stock [Table Text Block]</a></td>
<td class="text"><p id="xdx_800_ecef--CapitalStockTableTextBlock_dU_zjVW7v5Rkb3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b><span id="gg2a012"></span>DESCRIPTION
OF THE SHARES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following is a brief description of the terms of the Fund&#8217;s shares. This description does not purport to be complete and
is qualified by reference to the Fund&#8217;s Agreement and Declaration of Trust and its By-Laws. For complete terms of the shares,
please refer to the actual terms of each series, which are set forth in the Agreement and Declaration of Trust.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund is an unincorporated statutory trust organized under the laws of Delaware pursuant to a Certificate of Trust dated as of
January 4, 2005. The Fund is authorized to issue an unlimited number of common shares of beneficial interest, par value $0.001
per share. Each common share of beneficial interest has one vote and, when issued and paid for in accordance with the terms of
the applicable offering, will be fully paid and non-assessable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Though
the Fund expects to pay distributions monthly on the common shares of beneficial interest, it is not obligated to do so. All common
shares of beneficial interest are equal as to distributions, assets and voting privileges and have no conversion, preemptive or
other subscription rights. The Fund will send annual and semiannual reports, including financial statements, to all holders of
its shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offerings
of shares require approval by the Fund&#8217;s Board of Trustees. Any additional offering of common shares of beneficial interest
will be subject to the requirements of the 1940 Act, which provides that common stock may not be issued at a price below the then
current net asset value, exclusive of sales load, except in connection with an offering to existing holders of common shares or
with the consent of a majority of the Fund&#8217;s common shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s common shares of beneficial interest are listed on the NYSE American under the symbol &#8220;GGN.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s common shares have historically traded at both a premium and discount to NAV. Since the Fund commenced trading on
the NYSE American, the Fund&#8217;s common shares have traded at a discount to net asset value as low as (25.36)% and a premium
as high as 56.07%. Unlike open-end funds, closed-end funds like the Fund do not continuously offer shares and do not provide daily
redemptions. Rather, if a shareholder determines to buy additional common shares or sell shares already held, the shareholder
may do so by trading through a broker on the NYSE American or otherwise. The average weekly trading volume of common shares on
the NYSE American during the period from January 1, 2023 to December 31, 2023 was 2,276,588 shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
of closed-end investment companies often trade on an exchange at prices lower than net asset value. Because the market value of
the common shares may be influenced by such factors as dividend and distribution levels (which are in turn affected by expenses),
dividend and distribution stability, net asset value, market liquidity, relative demand for and supply of such shares in the market,
unrealized gains, general market and economic conditions and other factors beyond the control of the Fund, the Fund cannot assure
you that common shares will trade at a price equal to or higher than net asset value in the future. The common shares are designed
primarily for long term investors and you should not purchase the common shares if you intend to sell them soon after purchase.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the rights of the outstanding preferred shares, the Fund&#8217;s common shares vote as a single class on election of Trustees
and on additional matters with respect to which the 1940 Act, the Fund&#8217;s Agreement and Declaration of Trust, By-Laws or
resolutions adopted by the Trustees provide for a vote of the Fund&#8217;s common shares. See &#8220;Anti-Takeover Provisions
of the Fund&#8217;s Governing Documents.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund is a closed-end, non-diversified, management investment company and as such its shareholders do not, and will not, have the
right to require the Fund to repurchase their shares. The Fund, however, may repurchase its common shares from time to time as
and when it deems such a repurchase advisable, subject to maintaining required asset coverage for each series of outstanding preferred
shares. The Board has authorized such repurchases to be made when the Fund&#8217;s common shares are trading at a discount from
net asset value of 7.5% or more (or such other percentage as the Board of the Fund may determine from time to time). Pursuant
to the 1940 Act, the Fund may repurchase its common shares on a securities exchange (provided that the Fund has informed its shareholders
within the preceding six months of its intention to repurchase such shares) or pursuant to tenders and may also repurchase shares
privately if the Fund meets certain conditions regarding, among other things, distribution of net income for the preceding fiscal
year, status of the seller, price paid, brokerage commissions, prior notice to shareholders of an intention to purchase shares
and purchasing in a manner and on a basis that does not discriminate unfairly against the other shareholders through their interest
in the Fund.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the Fund repurchases its common shares for a price below net asset value, the net asset value of the common shares that remain
outstanding will be enhanced, but this does not necessarily mean that the market price of the outstanding common shares will be
affected, either positively or negatively. The repurchase of common shares will reduce the total assets of the Fund available
for investment and may increase the Fund&#8217;s expense ratio. In total through December 31, 2023, the Fund has repurchased and
retired 11,667,349 common shares in the open market at an average price of $3.58 per share and at an average discount of approximately
12.6% per share. During the year ended December 31, 2023, the Fund did not repurchase any common shares in the open market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Book
Entry</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
common shares sold through this offering will initially be held in the name of Cede &amp; Co. as nominee for the Depository Trust
Company (&#8220;DTC&#8221;). The Fund will treat Cede &amp; Co. as the holder of record of the common shares for all purposes.
In accordance with the procedures of DTC, however, purchasers of common shares will be deemed the beneficial owners of shares
purchased for purposes of distributions, voting and liquidation rights. Purchasers of common shares may obtain registered certificates
by contacting the transfer agent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred
Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
an unlimited number of the Fund&#8217;s shares have been classified by the Board of Trustees as preferred shares, par value $0.001
per share. The terms of such preferred shares may be fixed by the Board of Trustees and would materially limit and/or qualify
the rights of the holders of the Fund&#8217;s common shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 7, 2013, the Fund completed the placement of $100 million of preferred shares consisting of 4 million shares designated as
the Series B Preferred Shares and paying dividends of an annual rate equal to 5.00% of liquidation preference. The Series B Preferred
Shares are senior to the common shares and result in the financial leveraging of the common shares. Such leveraging tends to magnify
both the risks and opportunities to common shareholders. Dividends on the preferred shares are cumulative. The Fund is required
by the 1940 Act and by the Statement of Preferences to meet certain asset coverage tests with respect to the Series B Preferred
Shares. If the Fund fails to meet these requirements and does not correct such failure, the Fund may be required to redeem, in
part or in full, the Series B Preferred Shares at the redemption price of $25 per share plus an amount equal to the accumulated
and unpaid dividends whether or not declared on such shares in order to meet the requirements. Additionally, failure to meet the
foregoing asset coverage requirements could restrict the Fund&#8217;s ability to pay dividends to common shareholders or repurchase
common shares and could lead to sales of portfolio securities at inopportune times. The income received on the Fund&#8217;s assets
may vary in a manner unrelated to the fixed rate, which could have either a beneficial or detrimental impact on net investment
income and gains available to common shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series B Preferred Shares are listed on the NYSE American under the ticker symbol &#8220;GGN PrB.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
a liquidation, each holder of the preferred shares will be entitled to receive out of the assets of the Fund available for distribution
to shareholders (after payment of claims of the Fund&#8217;s creditors but before any distributions with respect to the Fund&#8217;s
common shares or any other shares of the Fund ranking junior to the preferred shares as to liquidation payments) an amount per
share equal to such share&#8217;s liquidation preference plus any accumulated but unpaid distributions (whether or not earned
or declared, excluding interest thereon) to the date of distribution, and such shareholders shall be entitled to no further participation
in any distribution or payment in connection with such liquidation. Each series of the preferred shares will rank on a parity
with any other series of preferred shares of the Fund as to the payment of distributions and the distribution of assets upon liquidation,
and will be junior to the Fund&#8217;s obligations with respect to any outstanding senior securities representing debt. If the
Fund has insufficient investment income and gains, all or a portion of the distributions to preferred shareholders would come
from the common shareholders&#8217; capital. Such distributions reduce the net assets attributable to common shareholders since
the liquidation preference of the preferred shareholders is constant. The preferred shares carry one vote per share on all matters
on which such shares are entitled to vote. The preferred shares will, upon issuance, be fully paid and nonassessable and will
have no preemptive, exchange or conversion rights. The Board of Trustees may by resolution classify or reclassify any authorized
but unissued capital shares of the Fund from time to time by setting or changing the preferences, conversion or other rights,
voting powers, restrictions, limitations as to distributions or terms or conditions of redemption. The Fund will not issue any
class of shares senior to the preferred shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption,
Purchase and Sale of Preferred Shares By the Fund.</i> The terms of any preferred shares are expected to provide that (i) they
are redeemable by the Fund at any time (either after the date of initial issuance, or after some period of time following initial
issuance) in whole or in part at the original purchase price per share plus accumulated dividends per share, (ii) the Fund may
tender for or purchase preferred shares and (iii) the Fund may subsequently resell any shares so tendered for or purchased. Any
redemption or purchase of preferred shares by the Fund will reduce the leverage applicable to the common shares, while any resale
of preferred shares by the Fund will increase that leverage.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Rating
Agency Guidelines.</i> The Series B Preferred Shares are rated A2 by Moody&#8217;s. Upon issuance, any new publicly issued series
of preferred shares may be rated by Moody&#8217;s or Fitch, in which case the following description of rating agency guidelines
would also be applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund expects that it would be required under any applicable rating agency guidelines to maintain assets having in the aggregate
a discounted value at least equal to a Basic Maintenance Amount (as defined in the applicable Statement of Preferences and summarized
below), for its outstanding preferred shares, including the Series B Preferred Shares. To the extent any particular portfolio
holding does not satisfy the applicable rating agency&#8217;s guidelines, all or a portion of such holding&#8217;s value will
not be included in the calculation of discounted value (as defined by such rating agency). The Moody&#8217;s and Fitch guidelines
would also impose certain diversification requirements and industry concentration limitations on the Fund&#8217;s overall portfolio,
and apply specified discounts to securities held by the Fund (except certain money market securities).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
&#8220;Basic Maintenance Amount&#8221; is generally equal to (a) the sum of (i) the aggregate liquidation preference of any preferred
shares then outstanding plus (to the extent not included in the liquidation preference of such preferred shares) an amount equal
to the aggregate accumulated but unpaid distributions (whether or not earned or declared) in respect of such preferred shares,
(ii) the Fund&#8217;s other liabilities (excluding dividends and other distributions payable on the Fund&#8217;s common shares),
(iii) any other current liabilities of the Fund (including amounts due and payable by the Fund pursuant to reverse repurchase
agreements and payables for assets purchased) less (b) the value of the Fund&#8217;s assets if such assets are either cash or
evidences of indebtedness which mature prior to or on the date of redemption or repurchase of preferred shares or payment of another
liability and are either U.S. government securities or evidences of indebtedness rated at least &#8220;Aaa,&#8221; &#8220;P-1&#8221;,
&#8220;VMIG-1&#8221; or &#8220;MIG-1&#8221; by Moody&#8217;s or &#8220;AAA&#8221;, &#8220;SP-1+&#8221; or &#8220;A-1+&#8221; by
S&amp;P and are held by the Fund for distributions, the redemption or repurchase of preferred shares or the Fund&#8217;s liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Fund does not cure in a timely manner a failure to maintain a discounted value of its portfolio equal to the Basic Maintenance
Amount in accordance with the requirements of any applicable rating agency or agencies then rating the preferred shares at the
request of the Fund, the Fund may, and in certain circumstances would be required to, mandatorily redeem preferred shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
rating agency providing a rating for the preferred shares, including the Series B Preferred Shares, at the request of the Fund
may, at any time, change or withdraw any such rating. The Board, without further action by the shareholders, may amend, alter,
add to or repeal certain of the definitions and related provisions of the applicable Statement of Preferences that have been adopted
by the Fund pursuant to the rating agency guidelines if the Board determines that such modification is necessary to prevent a
reduction in rating of the preferred shares, including the Series B Preferred Shares, by Moody&#8217;s or such other rating agency,
as the case may be, and any such amendment, alteration or repeal will be deemed not to affect the preferences, rights or powers
of the holders of preferred shares, provided that the Board shall have obtained confirmation from the rating agency that such
modification would not adversely affect its then current rating of the preferred shares, including the Series B Preferred Shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described by Moody&#8217;s and Fitch, any ratings assigned to the preferred shares are assessments of the capacity and willingness
of the Fund to pay the obligations of each series of the preferred shares. Any ratings on the preferred shares are not recommendations
to purchase, hold or sell shares of any series, in as much as the ratings do not comment as to market price or suitability for
a particular investor. The rating agency guidelines also do not address the likelihood that an owner of preferred shares will
be able to sell such shares on an exchange, in an auction or otherwise. Any ratings would be based on current information furnished
to Moody&#8217;s and Fitch by the Fund and the Investment Adviser and information obtained from other sources. Any ratings may
be changed, suspended or withdrawn as a result of changes in, or the unavailability of, such information. The rating agency guidelines
would apply to the preferred shares, as the case may be, only so long as such rating agency is rating such shares at the request
of the Fund. The Fund expects that it would pay fees to Moody&#8217;s and Fitch for rating any preferred shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
rating agency guidelines will apply to the preferred shares, as the case may be, only so long as such rating agency is rating
such shares at the request of the Fund. The Fund will pay fees to the rating agencies for rating any series of the preferred shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Asset
Maintenance Requirements.</i> In addition to the requirements summarized under &#8220;&#8212;Rating Agency Guidelines&#8221; above,
the Fund must also satisfy asset maintenance requirements under the 1940 Act with respect to its preferred shares. Under the 1940
Act, such debt or preferred shares may be issued only if immediately after such issuance the value of the Fund&#8217;s total assets
(less ordinary course liabilities) is at least 300% of the amount of any debt outstanding and at least 200% of the amount of any
preferred stock and debt outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund will be required under the preferred shares&#8217; Statement of Preferences (the &#8220;Statement of Preferences&#8221;)
to determine whether it has, as of the last business day of each March, June, September and December of each year, an &#8220;asset
coverage&#8221; (as defined in the 1940 Act) of at least 200% (or such higher or lower percentage as may be required at the time
under the 1940 Act) with respect to all outstanding senior securities of the Fund that are debt or stock, including any outstanding
preferred shares. If the Fund fails to maintain the asset coverage required under the 1940 Act on such dates and such failure
is not cured within 60 calendar days, the Fund may, and in certain circumstances will be required to, mandatorily redeem the number
of preferred shares sufficient to satisfy such asset coverage. See &#8220;&#8212;Redemption&#8221; below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Distributions.
</i>Holders of any fixed rate preferred shares will be entitled to receive, when, as and if declared by the Board of Trustees,
out of funds legally available therefor, cumulative cash distributions, at an annual rate set forth in the applicable Prospectus
Supplement, payable with such frequency as set forth in the applicable Prospectus Supplement. Such distributions will accumulate
from the date on which such shares are issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>





<p id="xdx_84A_ecef--PreferredStockRestrictionsOtherTextBlock_hus-gaap--StatementClassOfStockAxis__custom--PreferredStocksMember_dU_zvLNFVF0mmFc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restrictions
on Dividends and Other Distributions for the Preferred Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
long as any preferred shares are outstanding, the Fund may not pay any dividend or distribution (other than a dividend or distribution
paid in common shares or in options, warrants or rights to subscribe for or purchase common shares) in respect of the common shares
or call for redemption, redeem, purchase or otherwise acquire for consideration any common shares (except by conversion into or
exchange for shares of the Fund ranking junior to the preferred shares as to the payment of dividends and the distribution of
assets upon liquidation), unless:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Fund has declared
    and paid (or provided to the relevant dividend paying agent) all cumulative distributions on the Fund&#8217;s outstanding
    preferred shares due on or prior to the date of such common share dividend or distribution;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Fund has redeemed
    the full number of preferred shares to be redeemed pursuant to any mandatory redemption provision in the Fund&#8217;s Governing
    Documents; and</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">after making the
    distribution, the Fund meets applicable asset coverage requirements described under &#8220;&#8212;Rating Agency Guidelines&#8221;
    and &#8220;&#8212;Asset Maintenance Requirements.&#8221;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
complete distribution due for a particular dividend period will be declared or made on any series of the preferred shares for
any dividend period, or part thereof, unless full cumulative distributions due through the most recent dividend payment dates
therefor for all outstanding series of preferred shares of the Fund ranking on a parity with such series as to distributions have
been or contemporaneously are declared and made. If full cumulative distributions due have not been made on all outstanding preferred
shares of the Fund ranking on a parity with such series of preferred shares as to the payment of distributions, any distributions
being paid on the preferred shares will be paid as nearly pro rata as possible in proportion to the respective amounts of distributions
accumulated but unmade on each such series of preferred shares on the relevant dividend payment date. The Fund&#8217;s obligation
to make distributions on the preferred shares will be subordinate to its obligations to pay interest and principal, when due,
on any of the Fund&#8217;s senior securities representing debt.</span></p>

<p id="xdx_856_zWXSzbZxcbV4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Redemption</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Mandatory
Redemption Relating to Asset Coverage Requirements.</i> The Fund may, at its option, consistent with its Governing Documents and
the 1940 Act, and in certain circumstances will be required to, mandatorily redeem preferred shares in the event that:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Fund fails to
    maintain the asset coverage requirements specified under the 1940 Act on a quarterly valuation date (generally the last business
    day of March, June, September and December) and such failure is not cured on or before a stated period, following such failure
    (60 calendar days in the case of the Series B Preferred Shares); or</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Fund fails to
    maintain the asset coverage requirements as calculated in accordance with the applicable rating agency guidelines as of any
    monthly valuation date, and such failure is not cured on or before a stated period after such valuation date.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
redemption price for preferred shares subject to mandatory redemption will be the liquidation preference, as stated in the Prospectus
Supplement accompanying the issuance of such preferred shares, plus an amount equal to any accumulated but unpaid distributions
(whether or not earned or declared) to the date fixed for redemption, plus any applicable redemption premium determined by the
Board of Trustees and included in the Statement of Preferences.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of preferred shares that will be redeemed in the case of a mandatory redemption will equal (and may, if the applicable
Statement of Preferences so provides, exceed) the minimum number of outstanding preferred shares, the redemption of which, if
such redemption had occurred immediately prior to the opening of business on the applicable cure date, would have resulted in
the relevant asset coverage requirement having been met or, if the required asset coverage cannot be so restored, all of the preferred
shares. In the event that preferred shares are redeemed due to a failure to satisfy the 1940 Act asset coverage requirements,
the Fund may, but is not required to, redeem a sufficient number of preferred shares so that the Fund&#8217;s assets exceed the
asset coverage requirements under the 1940 Act after the redemption by 10% (that is, 220% asset coverage) or some other amount
specified in the Statement of Preferences. In the event that preferred shares are redeemed due to a failure to satisfy applicable
rating agency guidelines, the Fund may, but is not required to, redeem a sufficient number of preferred shares so that the Fund&#8217;s
discounted portfolio value (as determined in accordance with the applicable rating agency guidelines) after redemption exceeds
the asset coverage requirements of each applicable rating agency by up to 10% (that is, 110% rating agency asset coverage) or
some other amount specified in the Statement of Preferences.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Fund does not have funds legally available for the redemption of, or is otherwise unable to redeem, all the preferred shares
to be redeemed on any redemption date, the Fund will redeem on such redemption date that number of shares for which it has legally
available funds, or is otherwise able to redeem, from the holders whose shares are to be redeemed ratably on the basis of the
redemption price of such shares, and the remainder of those shares to be redeemed will be redeemed on the earliest practicable
date on which the Fund will have funds legally available for the redemption of, or is otherwise able to redeem, such shares upon
written notice of redemption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
fewer than all of the Fund&#8217;s outstanding preferred shares are to be redeemed, the Fund, at its discretion and subject to
the limitations of its Governing Documents and the 1940 Act, will select the one or more series of preferred shares from which
shares will be redeemed and the amount of preferred shares to be redeemed from each such series. If less than all preferred shares
of a series are to be redeemed, such redemption will be made as among the holders of that series pro rata in accordance with the
respective number of shares of such series held by each such holder on the record date for such redemption (or by such other equitable
method as the Fund may determine). If fewer than all the preferred shares held by any holder are to be redeemed, the notice of
redemption mailed to such holder will specify the number of shares to be redeemed from such holder, which may be expressed as
a percentage of shares held on the applicable record date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Optional
Redemption of Fixed Rate Preferred Shares.</i> Fixed Rate Preferred Shares will not be subject to optional redemption by the Fund
until the date, if any, specified in the applicable Prospectus Supplement, unless such redemption is necessary, in the judgment
of the Fund, to maintain the Fund&#8217;s status as a RIC under the Code or as otherwise provided in the applicable Statement
of Preferences. Commencing on such date and thereafter, the Fund may at any time redeem such Fixed Rate Preferred Shares in whole
or in part for cash at a redemption price per share equal to the initial liquidation preference per share plus accumulated and
unpaid distributions (whether or not earned or declared) to the redemption date plus, if applicable, any redemption premium. Such
redemptions are subject to the notice requirements set forth under &#8220;&#8212;Redemption Procedures&#8221; and the limitations
of the Governing Documents and 1940 Act. The foregoing requirements may be modified in the case of any particular series of preferred
shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption
Procedures.</i> A notice of redemption with respect to an optional redemption will be given to the holders of record of fixed
rate preferred shares selected for redemption not less than 15 days (subject to NYSE American requirements) nor, more than 40
days prior to the date fixed for redemption. Preferred shareholders may receive shorter notice in the event of a mandatory redemption.
Each notice of redemption will state (i) the redemption date, (ii) the number or percentage of preferred shares to be redeemed
(which may be expressed as a percentage of such shares outstanding), (iii) the CUSIP number(s) of such shares, (iv) the redemption
price (specifying the amount of accumulated distributions to be included therein), (v) the place or places where such shares are
to be redeemed, (vi) that distributions on the shares to be redeemed will cease to accumulate on such redemption date, (vii) the
provision of the Statement of Preferences, as applicable, under which the redemption is being made and (viii) any conditions precedent
to such redemption. No defect in the notice of redemption or in the mailing thereof will affect the validity of the redemption
proceedings, except as required by applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
holders of any preferred shares, whether subject to a variable or fixed rate, will not have the right to redeem any of their shares
at their option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_ecef--SecurityLiquidationRightsTextBlock_hus-gaap--StatementClassOfStockAxis__custom--PreferredStocksMember_dU_zBGimj7jqjE" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation
Preference.</i> In the event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Fund,
the holders of preferred shares will be entitled to receive a preferential liquidating distribution, which is expected to equal
the original purchase price per preferred share plus accumulated and unpaid dividends, whether or not declared, before any distribution
of assets is made to holders of common shares. After payment of the full amount of the liquidating distribution to which they
are entitled, the holders of preferred shares will not be entitled to any further participation in any distribution of assets
by the Fund.</span></p>

<p id="xdx_855_ztVpl2lOdsK8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_ecef--SecurityVotingRightsTextBlock_hus-gaap--StatementClassOfStockAxis__custom--PreferredStocksMember_dU_zW9tZD5HUJu9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting
Rights.</i> Except as otherwise stated in this Prospectus, specified in the Governing Documents or resolved by the Board or as
otherwise required by applicable law, holders of preferred shares shall be entitled to one vote per share held on each matter
submitted to a vote of the shareholders of the Fund and will vote together with holders of common shares and of any other preferred
shares then outstanding as a single class.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the election of the Fund&#8217;s Trustees, holders of the outstanding preferred shares, voting together as a single
class, will be entitled to elect two of the Fund&#8217;s Trustees, and the remaining Trustees will be elected by holders of common
shares and holders of preferred shares, voting together as a single class. In addition, if (i) at any time dividends and distributions
on outstanding preferred shares are unpaid in an amount equal to at least two full years&#8217; dividends and distributions thereon
and sufficient cash or specified securities have not been deposited with the applicable paying agent for the payment of such accumulated
dividends and distributions or (ii) at any time holders of any other series of preferred shares are entitled to elect a majority
of the Trustees of the Fund under the 1940 Act or the applicable Statement of Preferences creating such shares, then the number
of Trustees constituting the Board automatically will be increased by the smallest number that, when added to the two Trustees
elected exclusively by the holders of preferred shares as described above, would then constitute a simple majority of the Board
as so increased by such smallest number. Such additional Trustees will be elected by the holders of the outstanding preferred
shares, voting together as a single class, at a special meeting of shareholders which will be called as soon as practicable and
will be held not less than ten nor more than twenty days after the mailing date of the meeting notice. If the Fund fails to send
such meeting notice or to call such a special meeting, the meeting may be called by any preferred shareholder on like notice.
The terms of office of the persons who are Trustees at the time of that election will continue. If the Fund thereafter pays, or
declares and sets apart for payment in full, all dividends and distributions payable on all outstanding preferred shares for all
past dividend periods or the holders of other series of preferred shares are no longer entitled to elect such additional Trustees,
the additional voting rights of the holders of the preferred shares as described above will cease, and the terms of office of
all of the additional Trustees elected by the holders of the preferred shares (but not of the Trustees with respect to whose election
the holders of common shares were entitled to vote or the two Trustees the holders of preferred shares have the right to elect
as a separate class in any event) will terminate automatically.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
1940 Act requires that, in addition to any approval by shareholders that might otherwise be required, the approval of the holders
of a majority of any outstanding preferred shares (as defined in the 1940 Act), voting separately as a class, would be required
to (1) adopt any plan of reorganization that would adversely affect the preferred shares, and (2) take any action requiring a
vote of security holders under Section 13(a) of the 1940 Act, including, among other things, changes in the Fund&#8217;s classification
as a closed-end investment company or changes in its fundamental investment restrictions. As a result of these voting rights,
the Fund&#8217;s ability to take any such actions may be impeded to the extent that there are any preferred shares outstanding.
Additionally, the affirmative vote of the holders of a &#8220;majority of the outstanding&#8221; (as defined in the 1940 Act)
preferred shares of any series of the Fund&#8217;s preferred shares, voting separately from the holders of any other series of
the Fund&#8217;s preferred shares (to the extent its rights are affected differently), shall be required with respect to any matter
that materially and adversely affects the rights, preferences or powers of that series in a manner different from that of other
series or classes of the Fund&#8217;s shares. The affirmative vote of the holders of a &#8220;majority of the outstanding&#8221;
(as defined in the 1940 Act) preferred shares, voting separately as one class, shall be required to amend, alter or repeal the
provisions of  the Fund&#8217;s Agreement and Declaration of Trust or By-laws, whether by merger, consolidation or otherwise,
if such amendment, alteration or repeal would affect adversely the rights, preferences or powers expressly set forth in any statement
of preferences of the Fund&#8217;s preferred shares, unless, in each case, the Fund obtains written confirmation from any rating
agency then rating the preferred shares at the Fund&#8217;s request that such amendment, alteration or repeal would not impair
the rating then assigned by such rating agency to such preferred shares, in which case the vote or consent of the holders of the
preferred shares is not required. No matter shall be deemed to adversely affect any rights, preferences or powers of the preferred
shares unless such matter (i) adversely alters or abolishes any right or preference of such series; (ii) creates, adversely alters
or abolishes any right in respect of redemption of such series; or (iii) creates or adversely alters (other than to abolish) any
restriction on transfer applicable to such series. An increase in the number of authorized preferred shares of the Fund pursuant
to the Agreement and Declaration of Trust or the issuance of additional shares of any series of preferred shares of the Fund pursuant
to the Agreement and Declaration of Trust shall not in and of itself be considered to adversely affect the rights, preferences
or powers of a series of preferred shares. The class votes of holders of preferred shares described above will in each case be
in addition to any other vote required to authorize the action in question.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing voting provisions will not apply to any series of preferred shares if, at or prior to the time when the act with respect
to which such vote otherwise would be required will be effected, such shares will have been redeemed or called for redemption
and sufficient cash or cash equivalents provided to the applicable paying agent to effect such redemption. The holders of preferred
shares will have no preemptive rights or rights to cumulative voting.</span></p>

<p id="xdx_851_zNYbsrqLi0yk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Limitation
on Issuance of Preferred Shares.</i> So long as the Fund has preferred shares outstanding, subject to receipt of approval from
the rating agencies of each series of preferred shares outstanding, and subject to compliance with the Fund&#8217;s investment
objectives, policies and restrictions, the Fund may issue and sell shares of one or more other series of additional preferred
shares provided that the Fund will, immediately after giving effect to the issuance of such additional preferred shares and to
its receipt and application of the proceeds thereof (including, without limitation, to the redemption of preferred shares to be
redeemed out of such proceeds), have an &#8220;asset coverage&#8221; for all senior securities of the Fund which are stock, as
defined in the 1940 Act, of at least 200% of the sum of the liquidation preference of the preferred shares of the Fund then outstanding
and all indebtedness of the Fund constituting senior securities and no such additional preferred shares will have any preference
or priority over any other preferred shares of the Fund upon the distribution of the assets of the Fund or in respect of the payment
of dividends or distributions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund will consider from time to time whether to offer additional preferred shares or securities representing indebtedness and
may issue such additional securities if the Board concludes that such an offering would be consistent with the Fund&#8217;s Governing
Documents and applicable law, and in the best interest of existing common shareholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Book
Entry.</i> Fixed Rate Preferred Shares will initially be held in the name of Cede &amp; Co. as nominee for DTC. The Fund will
treat Cede &amp; Co. as the holder of record of preferred shares for all purposes. In accordance with the procedures of DTC, however,
purchasers of Fixed Rate Preferred Shares will be deemed the beneficial owners of stock purchased for purposes of dividends, voting
and liquidation rights.</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">GAMCO Global Gold, Natural Resources & Income Trust<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">One Corporate Center<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Rye<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10580-1422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(914)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">921-5070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">John
C. Ball<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ggn_CommonStocksMember', window );">Common Stocks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetAssetValuePerShare', window );">NAV Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_OutstandingSecurityNotHeldShares', window );">Outstanding Security, Not Held [Shares]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154,296,778<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ggn_SeriesBCumulativePreferredStockMember', window );">Series B Cumulative Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_SeniorSecuritiesAmt', window );">Senior Securities Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79,519,050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreference', window );">Preferred Stock Liquidating Preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_OutstandingSecurityNotHeldShares', window );">Outstanding Security, Not Held [Shares]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,180,762<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ggn_PreferredStocksMember', window );">Preferred Stocks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_SecurityVotingRightsTextBlock', window );">Security Voting Rights [Text Block]</a></td>
<td class="text"><p id="xdx_84B_ecef--SecurityVotingRightsTextBlock_hus-gaap--StatementClassOfStockAxis__custom--PreferredStocksMember_dU_zW9tZD5HUJu9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting
Rights.</i> Except as otherwise stated in this Prospectus, specified in the Governing Documents or resolved by the Board or as
otherwise required by applicable law, holders of preferred shares shall be entitled to one vote per share held on each matter
submitted to a vote of the shareholders of the Fund and will vote together with holders of common shares and of any other preferred
shares then outstanding as a single class.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the election of the Fund&#8217;s Trustees, holders of the outstanding preferred shares, voting together as a single
class, will be entitled to elect two of the Fund&#8217;s Trustees, and the remaining Trustees will be elected by holders of common
shares and holders of preferred shares, voting together as a single class. In addition, if (i) at any time dividends and distributions
on outstanding preferred shares are unpaid in an amount equal to at least two full years&#8217; dividends and distributions thereon
and sufficient cash or specified securities have not been deposited with the applicable paying agent for the payment of such accumulated
dividends and distributions or (ii) at any time holders of any other series of preferred shares are entitled to elect a majority
of the Trustees of the Fund under the 1940 Act or the applicable Statement of Preferences creating such shares, then the number
of Trustees constituting the Board automatically will be increased by the smallest number that, when added to the two Trustees
elected exclusively by the holders of preferred shares as described above, would then constitute a simple majority of the Board
as so increased by such smallest number. Such additional Trustees will be elected by the holders of the outstanding preferred
shares, voting together as a single class, at a special meeting of shareholders which will be called as soon as practicable and
will be held not less than ten nor more than twenty days after the mailing date of the meeting notice. If the Fund fails to send
such meeting notice or to call such a special meeting, the meeting may be called by any preferred shareholder on like notice.
The terms of office of the persons who are Trustees at the time of that election will continue. If the Fund thereafter pays, or
declares and sets apart for payment in full, all dividends and distributions payable on all outstanding preferred shares for all
past dividend periods or the holders of other series of preferred shares are no longer entitled to elect such additional Trustees,
the additional voting rights of the holders of the preferred shares as described above will cease, and the terms of office of
all of the additional Trustees elected by the holders of the preferred shares (but not of the Trustees with respect to whose election
the holders of common shares were entitled to vote or the two Trustees the holders of preferred shares have the right to elect
as a separate class in any event) will terminate automatically.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
1940 Act requires that, in addition to any approval by shareholders that might otherwise be required, the approval of the holders
of a majority of any outstanding preferred shares (as defined in the 1940 Act), voting separately as a class, would be required
to (1) adopt any plan of reorganization that would adversely affect the preferred shares, and (2) take any action requiring a
vote of security holders under Section 13(a) of the 1940 Act, including, among other things, changes in the Fund&#8217;s classification
as a closed-end investment company or changes in its fundamental investment restrictions. As a result of these voting rights,
the Fund&#8217;s ability to take any such actions may be impeded to the extent that there are any preferred shares outstanding.
Additionally, the affirmative vote of the holders of a &#8220;majority of the outstanding&#8221; (as defined in the 1940 Act)
preferred shares of any series of the Fund&#8217;s preferred shares, voting separately from the holders of any other series of
the Fund&#8217;s preferred shares (to the extent its rights are affected differently), shall be required with respect to any matter
that materially and adversely affects the rights, preferences or powers of that series in a manner different from that of other
series or classes of the Fund&#8217;s shares. The affirmative vote of the holders of a &#8220;majority of the outstanding&#8221;
(as defined in the 1940 Act) preferred shares, voting separately as one class, shall be required to amend, alter or repeal the
provisions of  the Fund&#8217;s Agreement and Declaration of Trust or By-laws, whether by merger, consolidation or otherwise,
if such amendment, alteration or repeal would affect adversely the rights, preferences or powers expressly set forth in any statement
of preferences of the Fund&#8217;s preferred shares, unless, in each case, the Fund obtains written confirmation from any rating
agency then rating the preferred shares at the Fund&#8217;s request that such amendment, alteration or repeal would not impair
the rating then assigned by such rating agency to such preferred shares, in which case the vote or consent of the holders of the
preferred shares is not required. No matter shall be deemed to adversely affect any rights, preferences or powers of the preferred
shares unless such matter (i) adversely alters or abolishes any right or preference of such series; (ii) creates, adversely alters
or abolishes any right in respect of redemption of such series; or (iii) creates or adversely alters (other than to abolish) any
restriction on transfer applicable to such series. An increase in the number of authorized preferred shares of the Fund pursuant
to the Agreement and Declaration of Trust or the issuance of additional shares of any series of preferred shares of the Fund pursuant
to the Agreement and Declaration of Trust shall not in and of itself be considered to adversely affect the rights, preferences
or powers of a series of preferred shares. The class votes of holders of preferred shares described above will in each case be
in addition to any other vote required to authorize the action in question.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing voting provisions will not apply to any series of preferred shares if, at or prior to the time when the act with respect
to which such vote otherwise would be required will be effected, such shares will have been redeemed or called for redemption
and sufficient cash or cash equivalents provided to the applicable paying agent to effect such redemption. The holders of preferred
shares will have no preemptive rights or rights to cumulative voting.</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_SecurityLiquidationRightsTextBlock', window );">Security Liquidation Rights [Text Block]</a></td>
<td class="text"><p id="xdx_84D_ecef--SecurityLiquidationRightsTextBlock_hus-gaap--StatementClassOfStockAxis__custom--PreferredStocksMember_dU_zBGimj7jqjE" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation
Preference.</i> In the event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Fund,
the holders of preferred shares will be entitled to receive a preferential liquidating distribution, which is expected to equal
the original purchase price per preferred share plus accumulated and unpaid dividends, whether or not declared, before any distribution
of assets is made to holders of common shares. After payment of the full amount of the liquidating distribution to which they
are entitled, the holders of preferred shares will not be entitled to any further participation in any distribution of assets
by the Fund.</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cef_PreferredStockRestrictionsOtherTextBlock', window );">Preferred Stock Restrictions, Other [Text Block]</a></td>
<td class="text"><p id="xdx_84A_ecef--PreferredStockRestrictionsOtherTextBlock_hus-gaap--StatementClassOfStockAxis__custom--PreferredStocksMember_dU_zvLNFVF0mmFc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restrictions
on Dividends and Other Distributions for the Preferred Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
long as any preferred shares are outstanding, the Fund may not pay any dividend or distribution (other than a dividend or distribution
paid in common shares or in options, warrants or rights to subscribe for or purchase common shares) in respect of the common shares
or call for redemption, redeem, purchase or otherwise acquire for consideration any common shares (except by conversion into or
exchange for shares of the Fund ranking junior to the preferred shares as to the payment of dividends and the distribution of
assets upon liquidation), unless:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Fund has declared
    and paid (or provided to the relevant dividend paying agent) all cumulative distributions on the Fund&#8217;s outstanding
    preferred shares due on or prior to the date of such common share dividend or distribution;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Fund has redeemed
    the full number of preferred shares to be redeemed pursuant to any mandatory redemption provision in the Fund&#8217;s Governing
    Documents; and</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">after making the
    distribution, the Fund meets applicable asset coverage requirements described under &#8220;&#8212;Rating Agency Guidelines&#8221;
    and &#8220;&#8212;Asset Maintenance Requirements.&#8221;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
complete distribution due for a particular dividend period will be declared or made on any series of the preferred shares for
any dividend period, or part thereof, unless full cumulative distributions due through the most recent dividend payment dates
therefor for all outstanding series of preferred shares of the Fund ranking on a parity with such series as to distributions have
been or contemporaneously are declared and made. If full cumulative distributions due have not been made on all outstanding preferred
shares of the Fund ranking on a parity with such series of preferred shares as to the payment of distributions, any distributions
being paid on the preferred shares will be paid as nearly pro rata as possible in proportion to the respective amounts of distributions
accumulated but unmade on each such series of preferred shares on the relevant dividend payment date. The Fund&#8217;s obligation
to make distributions on the preferred shares will be subordinate to its obligations to pay interest and principal, when due,
on any of the Fund&#8217;s senior securities representing debt.</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_BusinessDevelopmentCompanyFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_BusinessDevelopmentCompanyFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_CapitalStockTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 1<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_CapitalStockTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_FinancialHighlightsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_FinancialHighlightsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_GeneralDescriptionOfRegistrantAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_GeneralDescriptionOfRegistrantAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_IntervalFundFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_IntervalFundFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_InvestmentObjectivesAndPracticesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 2<br> -Paragraph b, d<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_InvestmentObjectivesAndPracticesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_NewCefOrBdcRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_NewCefOrBdcRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecurityNotHeldShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br> -Paragraph 4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecurityNotHeldShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PreferredStockRestrictionsOtherTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 1<br> -Paragraph b<br> -Subparagraph 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PreferredStockRestrictionsOtherTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PrimaryShelfFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PrimaryShelfFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PrimaryShelfQualifiedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PrimaryShelfQualifiedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RegisteredClosedEndFundFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RegisteredClosedEndFundFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskFactorsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskFactorsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SecurityLiquidationRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 1<br> -Paragraph a<br> -Subparagraph 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SecurityLiquidationRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SecurityVotingRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 1<br> -Paragraph a<br> -Subparagraph 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SecurityVotingRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SeniorSecuritiesAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 4<br> -Subsection 3<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SeniorSecuritiesAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AdditionalSecurities462b">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AdditionalSecurities462b</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AdditionalSecuritiesEffective413b">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 413<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AdditionalSecuritiesEffective413b</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of changes contained within amended document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ApproximateDateOfCommencementOfProposedSaleToThePublic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ApproximateDateOfCommencementOfProposedSaleToThePublic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:dateOrAsapItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DelayedOrContinuousOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form S-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form F-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DelayedOrContinuousOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DividendOrInterestReinvestmentPlanOnly">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form S-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form F-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DividendOrInterestReinvestmentPlanOnly</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EffectiveUponFiling462e">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection e<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EffectiveUponFiling462e</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EffectiveWhenDeclaredSection8c">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Section 8<br> -Subsection c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EffectiveWhenDeclaredSection8c</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInvCompanyType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInvCompanyType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:invCompanyType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ExhibitsOnly462d">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection d<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ExhibitsOnly462d</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyActFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-4<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyActFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyActRegistration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyActRegistration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyRegistrationAmendment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyRegistrationAmendment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyRegistrationAmendmentNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyRegistrationAmendmentNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:sequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NewEffectiveDateForPreviousFiling">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-4<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NewEffectiveDateForPreviousFiling</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NoSubstantiveChanges462c">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NoSubstantiveChanges462c</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PostEffectiveAmendment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PostEffectiveAmendment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreEffectiveAmendment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreEffectiveAmendment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreEffectiveAmendmentNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreEffectiveAmendmentNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:sequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetAssetValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 54B<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482134/820-10-35-54B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 59<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482134/820-10-35-59<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6A<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-7<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480737/946-205-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetAssetValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ggn_CommonStocksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ggn_CommonStocksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ggn_SeriesBCumulativePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ggn_SeriesBCumulativePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ggn_PreferredStocksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ggn_PreferredStocksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
